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ABSTRACT 
NAIR, KAVITA, M, Doctorate: June: 2019, 
PhD in Biological and Environmental Sciences 
Title: Development of Bio-insecticides Based on Local Qatari Bacillus Thuringiensis 
Strains for the Biological Control of Harmful Dipteran Disease Vectors 
Supervisor of Thesis: Prof. Samir Jaoua. 
The very friendly bacterium Bacillus thuringiensis (Bt) is the main source of 
environment-friendly and safe bioinsecticides used in the control of plant pests and 
animal and human disease vectors. A collection of 441 Qatari Bt strains were 
characterized and classified based on crystal morphology, plasmid patterns, crystal 
protein patterns and cry and cyt genes. In summary, the Bti strain QBT220 was 
recognized as the most efficient against Dipteran insects Aedes Aegypti. Two of its 
clones obtained by plasmid curing showed an increase of 115% in the -endotoxins. As 
example of novel Bt strains, QBT674 is a spherical crystal producing strain 
having cry2 gene but no cuboidal crystals. QBT555 is a Non-Bti strain with molecular 
profile very different from Bti strains, but expresses proteins like Cry11, Cry10 and 
Cyt1A. QBT229 showed high cytolytic activity due to five amino acid replacements in 
its β sheet that enhanced its anti-cancer activity.  
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CHAPTER 1: INTRODUCTION 
Bacillus thuringiensis (Bt) is a rod shaped, Gram positive, spore forming and 
entomopathogenic bacterium (Soberon et al., 2013; Palma et al., 2014). It is a 
ubiquitous microorganism found in many different habitats like soil, water, insect guts, 
plant leaves, etc. (Mashtoly et al., 2010; Despres et al., 2011; Koppenhofer et al., 2012). 
Bt produces many toxins like chitinases, exotoxins, -endotoxins, bacteriocins, 
parasporins, etc (Luara-Salarazar et al., 2016; Periyasamy et al., 2016; Honda et al., 
2017). Bt has been largely explored for their insecticidal parasporal crystals containing 
one or more -endotoxins. The latter produced by Bt depend on the strain and are 
specifically toxic to insect families, depending on the nature of cry genes expressed 
(Jouzani et al., 2008; Periera et al., 2013). The Bt crystals and spores are ingested by 
the insect larvae and reach the midgut. The crystals are solubilized into different 
proteins due to the high pH of the insect midgut. The solubilized -endotoxins are also 
called protoxins, which are cleaved by the proteases of the midgut of the larvae to form 
activated toxins. Once cleaved, the toxins bind specifically to midgut epithelial cells 
membrane receptors on the and bind. The binding of these toxins to the receptors trigger 
the lysis of the cells and forming leaks in the midgut. This causes starvation in the larvae 
and the consequent death (Lopez et al., 2013).  
Most widely studied strains of Bt are Bacillus thuringiensis kurstaki (Btk) and Bacillus 
thuringiensis israelensis (Bti). Btk strains produce bipyramidal and cuboidal shaped 
parasporal crystals. The -endotoxins forming the bipyramidal crystals are toxic to 
Lepidopteran insects and that of cuboidal crystals are toxic to Dipteran insects. On the 
other hand, Bti produces spherical crystals that contain -endotoxin proteins that are 
toxic to Dipteran insects. Bt provides an economic, environment-friendly and very safe 
alternative of insect control (Thomas and Read, 2007). The -endotoxins proteins are 
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encoded by genes carried on one or more extra chromosomal plasmids and their 
expression is under the control of the sporulation dependent sigma factors. Some of the 
-endotoxins proteins are sporulation-independent and are expressed during the 
vegetative phase of life cycle. Each type of -endotoxin is specifically toxic to insect 
families (Abdelmalek et al., 2015).  
The Dipteran specific -endotoxins belong to two groups: Cry (crystalizing protein) 
and Cyt (cytolytic protein). For the complete insecticidal activity, there is a need for 
some accessory proteins like p19 and p20. Cry proteins that are toxic to Dipteran insects 
include Cry4, Cry2, Cry11 and Cry10 and the Cyt proteins including Cyt1A, Cyt2A, 
Cyt1C. Bti strain carry the genes encoding all these Cry, Cyt and accessory proteins.  
The objective of this PhD research work was to characterize, classify and screen the Bt 
strains isolated locally to identify strains that carry Dipteran specific δ- endotoxins. 
Finding a sustainable solution to control Dipteran insects like mosquitoes is the need of 
the hour. World health organization (WHO) considered Malaria and Dengue the two 
most dangerous vector borne diseases prevalent in the world today that need an urgent 
and effective control system (WHO, 2019). More than 50% of the earth’s population 
face the threat of contracting these diseases as they are the cause of the highest 
morbidity and mortality among infectious diseases (WHO, 2012). Their control 
depends on the control of the vector as the treatment of these diseases is neither a 
feasible solution for eradication, nor affordable by everyone (Monath and Vasconcelos, 
2015). Dengue virus is transmitted mostly by Aedes aegypti and preferentially 
transferred among humans (Carrington and Simmons, 2014). Malaria is caused by the 
parasite Plasmodium that is transmitted by Dipteran insect called Anopheles (Mernard 
et al., 2013).  
The human disease-causing vectors like mosquitoes are controlled mostly by methods 
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like chemical insecticides, traps, environmental management strategies, social 
awareness, etc. But, these methods are not sufficient to control the vectors to a level 
where the diseases can be completely eradicated (Horatick et al., 2010; Achee et al., 
2019). Although existing chemical insecticides occupy the major share of the market, 
they are being rendered ineffective every day due to three main reasons: behavioral 
changes in the vector to avoid toxicity, the development of resistance to different 
chemical moieties (Kongmee et al., 2004; Miller et al., 2009), the harmful effects on 
humans, other non-target organisms and environment (Scholte et al., 2004; Ffrench-
Constant, 2005). A more sustainable method of controlling mosquitoes in the form of 
Bti was found about four decades back (Dammak et al., 2010; Lacey et al., 2015). 
Unlike chemical insecticides, Bti -endotoxins are effective at much lower 
concentrations, do not affect non-target organisms, have very low risk of developing 
resistance and can be produced at a large scale at a much smaller cost (Walker 2002; 
Lacey et al., 2015; Jain et al., 2016). The safety of Bti as a bio-control agent of 
mosquitoes have been shown by many studies (Vasquez et al., 2009; Loke et al., 2010; 
Wirth, 2010; Boyer et al., 2011; Tetraeu et al., 2013; Mossa et al., 2018).  
Qatar, like many countries, also rely mainly on chemical insecticides to control these 
vectors of human diseases. Qatar does not produce these insecticides but imports them. 
According to United Nations Commodity Trade Statistics Database, Qatar’s annual 
insecticide imports increased from 800 tons in 2005 to 11000 tons in 2010. Just 
considering the mosquito population of Qatar, it harbors a high diversity of mosquitos. 
A study done in different regions like Doha (highly populated) and Al Khor (less 
populated), found the presence of vectors of both Dengue and Malaria (Mikhail et al., 
2009). Preliminary exploration studies showed the presence of high diversity of Bt 
strains in Qatar. This gave impetus to this project of exploring Qatari environment for 
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Bt strains producing Dipteran specific δ- endotoxins. Extreme climatic conditions and 
lack of use of Bt based commercial insecticides in the unexplored ecologies are the 
advantages in exploring the Qatari ecology for novel and interesting Bt strains.  
Apart from its insecticidal property, Bti is also known for its cytolytic property against 
cancer cells. The cytolytic activity of Bt is contributed to two factors: the anticancer 
parasporin proteins and Cyt proteins (Ohba et al., 2009; Correa et al., 2012). This 
property of the Bt strains were also explored in this study as there is a great need to find 
solution to the increasing mortality rates of cancer (Banner et al., 2009).  
The objectives of the PhD project were: 
(1) The characterization of Bt strains producing spherical crystals based on crystal 
morphology, plasmid content, -endotoxins protein patterns 
(2) The classification of Bt strains into classes and choose true representatives to be 
analyzed on molecular levels 
(3) The screening of Bt strains and identification of the most effective insecticidal 
strain (s) against Dipteran insects 
(4) The investigation of the Bt strains for the presence of -endotoxins proteins and 
coding cry genes 
(5) The evaluation of the cytolytic activity among the Bt strains and identification 
of the most cytolytic strain(s) 
(6) The comparison and identification of the Bti strains that have a higher δ- 
endotoxin yield than the commercially available Bti strains H14 
(7) The exploration of the structural instability among the Bti strains and chose of 
the most promising strains with highly stable plasmids carrying -endotoxins 
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CHAPTER 2: LITERATURE REVIEW 
2.1 Introduction 
Dipteran insects like mosquitoes are disease-transmitting vectors that are 
present worldwide in all types of ecologies. They transmit diseases like yellow fever, 
dengue, malaria, filariasis, etc among humans and animals. More than 3500 species of 
mosquitoes studied and reported, belong to the Dipteran family of insects. These 
disease-carrying vectors are responsible for about 17% deaths due to infections caused 
by parasites, viruses and bacteria (WHO, 2017). According to World Health 
Organization (WHO, 2015), if we consider just one of these diseases, malaria, half the 
world population is at risk. The death tolls of these diseases are too high in developing 
countries and their control using only medications is not a plausible solution (WHO, 
2008; Tolle, 2009). Malaria, transmitted by Anopheles mosquitoes, has caused the death 
of more than 400,000 individuals in 2015 alone. The cases of Dengue, transmitted by 
Aedes aegypti mosquitoes, have increased 30-fold in the last three decades and more 
and more countries are reporting new outbreaks of this disease (WHO, 2018). The lack 
of availability and exorbitant costs of the prophylactic medications and vaccines against 
these diseases make it inaccessible to most of the disease prone developing countries. 
It has been recognized that the control of the vectors of the diseases is a more practical 
solution. From the beginning, all the countries rely heavily on synthetic chemical 
insecticides to eradicate these vectors. These insecticides give quick and prolonged 
results and are hence still occupying almost the entire market for insecticides, despite 
the availability of other alternatives (Federici et al., 2003). Also, today we recognize 
the disadvantages of these chemical compounds and their harmful effects on humans, 
animals, vegetation and environment. The vectors are continuously acquiring resistance 
to these compounds and industries are developing new varieties every day. These 
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compounds give prolonged effect because they are retained in the ecologies and their 
harmful effects on non-target entities are seen for a long time. They develop into 
persistent pollutants of nature that are difficult to remediate.  
Qatar was declared a malaria free country by WHO in 1990 (WHO, 1990). But, 
many cases of malaria have been reported in the last few years among the expatriates 
immigrating to the country (Al-Kuwari, 2009; Khan et al., 2009). As the incidences of 
these cases become more frequent, the country could become vulnerable to this disease, 
especially because now it is evident that the malaria-carrying vector is present in the 
country (Baldacchino et al., 2015). Mikhail et al., (2009) found that Qatar has a huge 
diversity among mosquito species in different areas, rural and urban. According to this 
study, areas like Al Rayyan, Doha, Al Daayan, Al Khor, Al Shamal and Al Zahakira 
have many sub-species of Anopheles, Culex pipiens and Aedes groups. From 2009 to 
2015, the study showed the presence of 5 new species of mosquitoes in Al Khor area 
alone (Kardousha, 2015). The vulnerability is further increased due to the incidences of 
endemic cases reported in the neighbouring country of Saudi Arabia (Fakeeh, 2001; 
Madani et al., 2003; Alsheikh et al., 2013; Memish et al., 2014;). Other vectors like 
Culex tritaeniorhynchus carrying parasite for Rift Valley fever (Balkhy & Memish, 
2003), Culex univittatus carrying virus for dengue like fever, Anopheles stephensi 
carrying parasite for malaria (Ahmed et al., 2011; Alsheikh et al., 2013) are considered 
the main disease-causing vectors in Saudi Arabia. All these vectors are now present in 
Qatar (Mikhal et al., 2009; Kardousha, 2015). 
Biocontrol of mosquitoes is the best method as the products used as insecticides 
can easily decompose in nature into products that are not toxic to other organisms or 
environment (Sanjay and Tiku, 2009). Biological insecticides that are being researched 
include plant-based insecticides (Bilal et al., 2012), bacteria-based insecticide, essential 
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oil-based insecticides (Muturi et al., 2019), bio-diesel by products (Pant et al., 2016), 
etc. Bacillus thuringiensis proteins are preferred among these alternatives because of 
their specificity and lack of harmful effects on humans or other organisms (Regis et al., 
2001, Federici et al., 2005; Bravo et al., 2007; Benfarhat-Touzri et al., 2013). There are 
accounts of using the insecticidal activities of the Bt even before the bacteria itself was 
discovered. It is believed that in ancient Egypt, Bt spores were used as biocontrol agents 
(Sanahuja et al., 2011). In the modern days, the bacterium was discovered when there 
was a sudden outbreak of sotto (sudden) disease that killed the Bombyx mori (silkworm) 
larvae at a very high rate in Japan. In 1901, a Japanese bacteriologist, Ishiwata 
Shigetane, isolated and identified the cause of the disease as a soil bacterium residing 
in the larval midgut causing the death (Bravo et al., 2012). He also recognized that the 
presence and growth of this bacterium was not enough to kill the larvae. The death was 
caused only when the bacterium entered the sporulation stage. A German scientist 
named Ernst Berliner found a similar bacterium in dead flour moth larvae didn’t 
characterize the bacterium itself until 1915. He named the bacterium as thuringiensis 
as he was working in the region called Thuringia (Berliner, 1915). He also named the 
crystal proteins as parasporal bodies but did not associate them with the insecticidal 
properties. Subsequently many different scientists isolated different Bt species from 
different insect larvae. Their combined studies revealed the relationship between the 
parasporal crystals and the insecticidal properties (Angus, 1954). In 1955, Philip Fitz-
James and Hannay characterized these crystals and found that they were proteins 
expressed by the bacteria during the sporulation stage only (Hannay & Fitz-James, 
1955). The first successful field application was done in 1938 and since then 
improvements in the production technology is being continuously done. By 1950s, 
cheaper fermentation technologies were available for the commercial large-scale 
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production of Bt (Qaim and Zilberman, 2003; Kleter et al., 2007). Ever since, spore 
formulations are being used for field applications in countries like United States of 
America (USA) and France (Andrews et al., 1987). As the chemical pesticides were 
already available in the market that gave very efficient results, Bt formulations could 
not compete with them in the market as an insect control agent. In spite of their many 
advantages, they still had some limitations in the commercial productions when 
compared to the synthetic chemical compounds. Research in this field has been 
focusing on these limitations – persistence, stability, resistance, high yield / production, 
toxicity, etc. There is always a need to screen for more strains to identify novel genes 
that could be more efficient against these disease vectors. Depending on the ecology 
from which these strains are isolated, they might have better combinations of δ- 
endotoxins, which can be used for more than one disease vector at the same time 
(Ammouneh et al., 2011). Also, these novel strains could overcome some of the 
limitations of these bio-insecticides that are discussed below. In nature, bacteria and 
insects have developed many symbiotic relationships and hence exist together 
(Feldhaar, 2011). But, in rare cases like this, the bacteria behave like an insect pathogen. 
Bt has achieved this by developing strategies to enter the insects, avoid the immune 
system, and kill it. It is believed that the efficiency of these strategies is due to the long 
process of co-evolution (Vilcinskas, 2010; Baxter et al., 2011). 
Among the different strategies, strain improvement has enhanced the Bt 
commercial production. Some of the strains that were developed gave 10-50-fold more 
protein production than the ones that were initially used. Initially, most of the pesticides 
were produced using Bt kurstaki that produced δ- endotoxins toxic to the lepidopteran 
insects. Later, other strains of Bt israelensis and Bt tenebrionis were used for the toxin 
production against Dipteran and Coleopteran species, respectively (Kaur, 2000). While 
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the research for improving this technology was ongoing, their demand fell sharply in 
1970s as more effective chemical pesticides were introduced in the markets. But, the 
advancements in the field of Biotechnology gave an impetus to this field of research 
(Schnepf & Whiteley, 1981). The cloning technologies changed the face of this research 
completely by introducing the genes from Bt into vectors that are more suitable for 
large-scale production, like E coli.  
Among the large-scale screenings for Bt with insecticidal activities, it was found that 
in nature, there is always a very high percentage of non-insecticidal strains compared 
to the insecticidal ones (Ohba, 1996; Mizuki et al., 1999; Ohba et al., 2000; Ohba et 
al., 2002; Yasutake et al., 2006; Yasutake et al., 2007). This negated the earlier 
assumption that these bacteria co-evolved with the insects that they are toxic to (Maeda 
et al., 2000; Lee et al., 2003). These non-insecticidal strains were screened for other 
activities and it was found that some of them are toxic to nematode parasites and some 
even have cytolytic properties against vertebrate cells including human cancer cell 
lines. In 1999, Mizuki et al. found for the first time parasporal proteins that had 
cytolytic activities against human leukemia T cells. He also tested these against the 
normal T cells. The non-cancerous cells were not sensitive to these parasporal proteins, 
which were later named as parasporins.  
2.2 Bacillus thuringiensis 
2.2.1 Introduction 
Bt is a rod shaped, Gram positive, spore-forming bacteria that are present in a 
variety of ecologies including soil, water, insect midgut, plants, etc. (Margalith & Ben-
Dov, 2000, Fillinger & Lindsey, 2006). They have high adaptability to their individual 
ecologies owing to their 60,000 genes pan-genome (Bazinet, 2017). They are 
commonly used as bio-pesticides or bio-insecticides. The life cycle of Bt consists of 
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two phases: the vegetative division phase and spore development phase (Bulla et al., 
1980). The rod-shaped bacteria that divides into two daughter cells characterizes the 
vegetative phase. On the other hand, sporulation stage constitutes seven stages: axial 
filament formation, forespore septum formation, engulfment and appearance of 
crystals, formation of exosporium along with primordial cell wall and spore coats, spore 
maturation and sporangial lysis (Ibrahim et al., 2010). During this stage, they produce 
proteinaceous inclusion crystals called δ-endotoxins that have insecticidal properties. 
This has identified them as biocontrol agents and tools for genetic engineering of crops. 
There are also many Bt strains that produce crystal proteins but do not have any 
insecticidal properties (Abulreesh et al., 2012). During both phases, they also produce 
other types of proteins that have insecticidal, cytotoxic or bactericidal properties. The 
production of the crystal proteins is seen only simultaneously with the spore formation 
and their appearance is regulated by the same system and hence occurs together. These 
crystals have different physical structures depending on the Bt species and each form is 
specific to certain insect groups. For example, the bipyramidal crystals have insecticidal 
properties against Lepidopteran species while the spherical crystals are toxic to 
Dipteran species. These bacteria and their protein crystals have been used 
commercially as biocontrol agents in field applications for almost four decades. Most 
of the products are based on the spore-crystals formulations from Bt kurstaki HD1 or 
HD73. Also, Bt aizawai HD137 that produces slightly different Cry proteins are also 
used commercially. These two groups are used against Lepidopteran species (Soberon 
et al., 2009). Bt var israelensis has proved to be a successful bio-insecticide against 
Dipteran insects like mosquitoes, black flies, etc. 
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2.2.2 Ecology of Bacillus thuringiensis 
Bt is indigenous to many environments including soil, insect cadavers (Carozzi 
et al., 1991), plant leaves (Smith & Couche, 1991), aquatic bodies (Iriarte et al., 2000), 
sediments in the sea (Maeda et al., 2000), etc. As is evident, the bacterium can be found 
in a wide variety of ecologies but is most frequently found in soil ecologies. They are 
naturally saprophytes that feed on dead and decaying matter. In the absence of these 
conditions, they remain in the form of spores, until nutrients are available again. 
Depending on their presence in different ecologies, their functions in these 
environments are still not clear as some of these bacteria are also found in these 
ecologies without any insecticidal properties (Iriarte et al., 2000). Because the Bt 
formulations have been used for field applications for many decades now, their 
ecologies are broadly classified as native or artificial. The native ecologies are ones 
where the Bt formulations have never been applied. The strains found in these ecologies 
are strictly local or naturally occurring. Artificial ecologies, on the contrary are the 
ecologies where commercially available Bt formulations have been introduced and even 
the local strains have been eventually affected by these applications (Stahly et al., 
1991).  
2.2.3 Life cycle of Bacillus thuringiensis 
The life cycle of Bt is divided into two phases: the symmetrically dividing 
vegetative phase and the asymmetrically dividing sporulation phase (Bulla et al., 1980). 
The vegetative phase is the normal phase that is continued until the bacteria encounters 
a stressful condition. Once it encounters a stress environment or conditions, the 
sporulation stage is self-induced. Interestingly, during sporulation, the cell also forms 
some crystal proteins that are lethal to many of its susceptible insect targets. It is 
believed that these proteins are a survival strategy of the bacterium. By killing the host 
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larvae, Bt ensures the regeneration of a suitable environment for it to enter the 
vegetative phase again and continue the divisions (Ibrahim et al., 2010).  
The vegetative phase is characterized by 2-5 µm long and 1µm wide, rod shaped 
bacteria. During this phase, each bacterium grows and doubles in size and forms a 
septum exactly in the middle and the new large bacterium divides into two equal 
daughter cells. This continues till the bacteria have favourable conditions. The 
sporulation phase is characterized by the formation of spores and other associated 
proteins and their subsequent release after lysis of the rod-shaped bacterium. This phase 
is broadly divided into seven stages (Bechtel & Bulla, 1982).  
During the first stage, the axial filament is formed followed by septum 
formation in stage II. Stage III marks the beginning of the appearance of parasporal 
crystals and endospores. During the next three stages, the cell transforms the nucleoid 
of the spore and forms the spore-coat, cell wall and cortex. The fidelity in these stages 
are important to ensure that the spores can regenerate and enter the vegetative phase 
when favourable conditions are available. The final stage is marked by spore 
maturation, lysis of the mother cell and release of spores and parasporal crystals (figure 
1). 
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Figure 1. Stages of life cycle of Bt (Li et al., 2012) 
[1: spore; 2: crystal; (a): vegetative stage; (b): mid-sporulation stage (c): complete 
sporulation and spores and crystal released] 
 
 
 
Figure 2. Types of parasporal crystals observed among the Bt strains (Nair et al., 2018b) 
  
2.3 Bt toxins 
Bt produces many proteins that are toxic to a wide range of organisms. 
Depending on the subspecies and strains, the proteins produced are toxic to different 
insects, nematodes, molluscs, and human cancer cells, other bacteria, etc (Kondo et al., 
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2002; Van Frankenhuyzen, 2009; Ohba et al., 2009; Pena et al., 2013; Wang et al., 
2013; Van Frankenhuyzen, 2013;). The evolution of such diversified protein families 
produced by different subspecies of single bacteria is not very well understood. Because 
most of the research involving Bt has focused on its insecticidal activities, the mode of 
action of these insecticidal δ- endotoxins are fairly understood. By laboratory and field 
selection pressure experiments, it is now known that the pH of the larval gut, the types 
of proteases in the gut and the receptors present on the epithelial cells of the gut could 
induce the evolution of the types of δ- endotoxins produced by the Bt strains (De Maagd 
et al., 2003; Chougule & Bonning, 2012).  
Nine different types of toxins have been identified in Bt so far – α-exotoxin, β-
exotoxin, γ-exotoxin, δ-endotoxin, louse factor exotoxin, water soluble toxin, 
vegetative insecticidal protein (Vip), mouse factor toxin and enterotoxin (Rowe & 
Margartis, 1987; WHO, 1999). The δ-endotoxins and Vip are given more importance 
due to their diverse insecticidal activities and commercial applications. Among these δ- 
endotoxins, two major groups are Cry (crystal) and Cyt (cytolytic) proteins. These two 
families of proteins combine and form the parasporal crystals during the sporulation 
stage. The other proteins expressed by Bt include vegetative insecticidal proteins, 
secretory insecticidal proteins, chitinases, bacteriocins, parasporins, helper proteins like 
p19 and p20, proteases, phospholipases, etc.  
Bacteriocins are antimicrobial proteins produced by Bt against a wide range of 
microorganisms (Delves-Broughton, 2005; Fguira et al., 2014). Many study groups 
have isolated strains that produce these proteins. They have also proposed possible 
industrial application of these bacteriocins: prevention of food-spoilage, prevention of 
plant diseases, prevention of honeybee bacterial diseases, etc (Cherif et al., 2003; 
Chehimi et al., 2007; Cherif et al., 2008; Lee et al., 2009; Rea et al., 2010; Kamoun et 
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al., 2011). These bacteriocins have both bacteriolytic as well as bacteriostatic effects 
(de la Fuentes-Salcido et al., 2012).  
The vegetative insecticidal proteins (Vip), as the name suggests, are produced 
during the vegetative phase of the Bt and are secreted out (Bi et al., 2014). They also 
have insecticidal activities and are usually found in Bt strains that are toxic to 
Lepidopteran, Hemipteran and/or Coleopteran insects (Sattar & Maiti, 2011). These 
strains that express Vip proteins have broader range of target organisms (Donova et al., 
2001; Milne et al., 2008). These Vip proteins are widely classified into two groups: 
Class I with Vip1, Vip4 and Vip2 and Class II with Vip3 (Sun et al., 2013; Cickmore 
et al., http://www.lifesci.sussex.ac.uk/Home/Neil_Crickmore/Bt/). The first class 
consists of binary proteins that are cleaved and activated, and the other single chain 
proteins are included in the second class. So far, more than 80 different types of Vip 
proteins have been identified  
(http://www.lifesci.sussex.ac.uk/home/Neil_Crickmore/Bt/vip.html).  
Secretory insecticidal proteins (Sip), like Vip, are expressed by Bt during 
vegetative phase and are secreted outside into the medium. It shows insecticidal 
activities against Coleopteran insects.  Although it is proposed that their mode of action 
is through pore formation, the exact mechanisms is not understood well (Donovan et 
al., 2006). Also, they have been shown to have additive effect with the δ- endotoxins, 
but the mechanism of synergism has not been reported yet.  
Chitinases are enzymes that convert the complex, insoluble chitin into its 
monomers. The gene for chitinase has been isolated from many different organisms 
including gram positive and negative bacteria, fungi, animals, plants, etc. Chitinase is 
produced by Bt and is secreted outside which makes Bt a very attractive tool for 
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chitinase production on industrial level. Apart from this, the chitinase production 
enhances the insecticidal activity of the Bt δ- endotoxins (Wiwat et al., 2000; Liu et al., 
2002; Sneh et al., 2009). Many different chitniase genes have been isolated from 
different Bt strains and cloned with the δ- endotoxins in order to develop or just enhance 
the insecticidal activity against different insect groups (Barboza-Corona et al., 2003; 
Thamthiankul et al., 2001; Arora et al., 2003).  
Like Cry proteins, some parasporins also have a three-domain structure and 
have low to medium homology with some of the Cry proteins. Hence, all the six known 
parasporins are included under the Cry nomenclature 
(http://parasporin.fitc.pref.fukuoka.jp/). But, they do not show any insecticidal 
activities (Mizuki et al., 1999). On the contrary they specifically act against human 
cancer cell lines (Brasseur et al., 2015). It has been recognized that these different 
parasporins have toxicity to a range of cell types, but the pathways triggered by these 
proteins are not completely understood. Different studies have given explanations like, 
induction of apoptotic pathways (Lee et al., 2000; Ohba et al., 2009), increasing plasma 
membrane permeability (Abe et al., 2008), selective pore-formation (Zhuang et al., 
2002; Ohba et al., 2009), or a combination of these modes (Phonnok et al., 2010). They 
also form spherical crystals and need solubilisation at a higher pH and activation by 
proteases to be converted to a toxin (Mizuki et al., 1999; Mizuki et al., 2000; Ohba et 
al., 2009).  
Cry proteins usually have their own domain that will help them crystallize, but 
some Cry proteins require the helper or accessory proteins like p19 and p20 for this 
conformational change which are part of the operon encoding the cry11A gene (Shao 
et al., 2001; Berry et al., 2002; Ibrahim et al., 2010). These helper proteins also have 
functional roles like enhancing the insecticidal activities of certain Cry proteins like 
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Cry11A (Xu et al., 2001). The accessory protein p20 especially has been shown to be 
involved in stabilization of certain δ- endotoxins also, like in case of Cyt1Aa during 
heterologous expression (Manasherob et al., 2006; Nisnevitch et al., 2006) 
2.4 Bt δ-endotoxins 
2.4.1 Introduction 
During sporulation, Bt produces one or more δ-endotoxins and usually form a 
parasporal crystalline structure. Cry (crystal) and Cyt (cytolytic) proteins are the two 
major families of proteins that constitute δ-endotoxins (Mahler & Halvorson, 1980). 
Both these groups of proteins are usually encoded by genes on large mega-plasmid in 
Bt. This mega-plasmid is called pBtoxis in Bti and are about 128 kb long (Ben-Dov et 
al., 1999; Berry et al., 2005). Bti also contains many large and small plasmids 
depending on the species. The number and size of plasmids differ with one species to 
another (Aptosoglou et al., 1997; Gonzalez et al., 1980). Gel electrophoresis of genome 
extraction samples from each strain shows a specific plasmid patterns (Vilas-Boas et 
al., 2004). This is one way of characterizing newly isolated strains. 
Cry proteins are the δ- endotoxins with a structural domain that is involved in 
crystallization of the parasporal inclusions. They usually have strong insecticidal 
activity against some insect groups or at least have amino acid sequence similarity to 
the existing Cry proteins. There are currently about 800 cry genes that have been 
reported (Crickmore et al., 2011) and grouped into 74 families of genes. The translated 
polypeptide lengths vary from 369 amino acids to 1344 amino acids. Among these Cry 
toxins, other groups are also included and designated with a Cry name due to their 
sequence similarities – ETX/MTX like toxins (Bokori-Brown et al., 2011), Binary like 
toxins (Berry, 2012), parasporins (Mizuki et al., 1999; Akiba et al., 2009), etc.  
Cyt proteins on the other hand form a part of the crystal structure, but none of 
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them can form crystals on its own. They are more specific to certain subspecies like Bt 
israelensis. Their target insects are also specific. They are more toxic to Dipteran 
insects like mosquitoes and black flies (de Maag et al., 2003). It also has cytolytic 
activity against mammalian and insect cells. It has been divided into three gene families 
and 11 halotypes (Crickmore et al., 2014). It is characterized by its haemolytic and 
cytotoxic properties. Cyt proteins on its own are not highly insecticidal, but greatly 
enhance the toxicity of Cry proteins by synergistic actions (Bravo et al., 2007).  
2.4.2 Taxonomy and Nomenclature of Bt δ endotoxins 
In early 1960s, Bt was classified into the Bacillus genera. Their insecticidal 
activities, serological analysis and biochemical tests allowed the scientists to group 
them into different subspecies (De-Barjac et al., 1980). H serotyping (immunological 
response to the flagellar antigens) divided the Bt into 69 serotypes and 82 serovars 
(Lecadet et al., 1999). However, this system has its limitations as recognized by 
Soufiane & Cote (2009). As the economic demand for Bt strains increased, there was a 
need to have a better system of categorizing the isolates. In 1973, Bt was defined as a 
separate species in the Bacillus genus. Differentiation techniques like 16s rRNA and 
23s rRNA sequences, amplified fragment length polymorphism (AFLP), multi-locus 
sequence typing, and multi-locus enzyme electrophoresis have been used, but at the 
same time supported the idea of putting Bt under the species Bc (Helgason et al., 2000; 
Ticknor et al., 2001; Helgason et al., 2004; Zhong et al., 2007). The gene gyrB has been 
the only technique so far that has help resolve this issue. It showed immense differences 
between these three groups and hence Bt is now a separate species of genus Bacillus 
(Park et al., 2007).  
The first Bt crystal (cry) gene was identified in 1981 (Schnepf & Whiteley, 
1981). Since then, more than 700 δ- endotoxin genes have been identified. This huge 
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database demanded a systematic nomenclature. The very first system developed for the 
nomenclature included the name of the δ- endotoxin followed by a roman number. This 
system depended on the insecticidal specificity of each δ- endotoxin. For example, all 
the δ- endotoxins that are toxic to Lepidopteran strains, Lepidopteran and Dipteran 
insects, Coleopteran insects and Dipteran alone were grouped as CryI, CryII, CryIII & 
CryIV, respectively (Hofte & Whiteley, 1989).  The complications and limitations of 
this system included: lack of system to include the non-toxic strains, the delay in 
naming the toxin till all the bioassays against each group of insects analysed, lack of 
information about the structural or sequence similarities between the δ- endotoxins, etc 
(Crickmore et al., 1998). In order to overcome these limitations, a committee was 
appointed to develop a new Toxin Nomenclature system 
(http://www.lifesci.sussex.ac.uk/home/Neil_Crickmore/Bt/ (accessed on 30 November, 
2018); Crickmore et al., 1998). In this new system, the type of protein is followed by 
four parts according to its similarity to an existing protein sequence. For the four parts, 
Arabic number is assigned for the first and the last part and the second and third part is 
assigned with capital and small alphabets. The primary ranking depicts less than 45% 
identity, secondary ranking depicts less than 78% identity, tertiary ranking depicts less 
than or equal to 95% identity and the quaternary ranking depicts more than 95% 
sequence identity.  
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Figure 3. Overview of the current nomenclature system (Palma et al., 2014) 
 
 
This nomenclature is used for the Cry, Cyt, Vip and Sip proteins 
(http://www.lifesci.sussex.ac.uk/home/Neil_Crickmore/Bt/ (accessed on 30 November, 
2015); Crickmore et al., 1998).  The main advantage of this system is the possibility to 
include even the δ- endotoxins that have amino acid sequence similarity to the existing 
δ- endotoxins without any insecticidal activity. Also, it can include the similar proteins 
that do not form a part of the crystal structures (Barloy et al., 1996) and some that are 
even expressed by entirely different bacteria (Varani et al., 2013).  
2.4.3 Structure of Bt δ endotoxins 
Almost all Cry proteins share a three-domain structure. The domain I share 
structural similarities with the pore-forming domain of another protein named α-PFTs 
colicin A. This indicates that the first domain is involved in the pore formation in the 
insect gut epithelial cell membranes. Seven amphipathic helices have been recognized 
for this domain: α1, α2, α3, α4, α5, α6, α7. The length of these helices was found to be 
enough to span the insect cells’s lipid bilayer membrane. All this gave evidence that 
this domain is involved in penetration of the lipid bilayer plasma membrane and 
consequent pore formation (Florez et al., 2012). Domain II consists of three anti-
parallel β sheet structures that form a β prism. They are involved in receptor binding, 
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oligomerization and membrane insertion (Pigott & Ellar, 2007; Fujii et al., 2013). 
Domain III has a more complex structure as well as function in Cry.  
 
 
Figure 4. Structure of Cry proteins (Palma et al., 2014) 
 
 
Structurally, it is a β sandwich of two anti-parallel β sheets that is folded into a 
jellyroll topology. Each β sheet consists of two loops at the Domain I - Domain III 
interface and five strands. Considering the structural similarity with other known 
proteins and the 3D structure itself, it is deduced that this domain is involved in receptor 
binding (Jurat-Fuentes et al., 2004; Sarkar et al., 2009; Sengupta et al., 2013) and 
maintaining protein stability (Masson et al., 2002).  
Structures of all Cyt proteins are known and they have high similarities between 
each other. Cyt protein has a single α-β domain. The core is formed by a β sheet, which 
is surrounded by two α helix hairpins (Cohen et al., 2008; Cohen et al., 2011). The β 
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sheet consists of six anti-parallel β strands. These strands are bordered by α1 and α2 on 
one side, and α3 and α4 on the other (Li et al., 1996; Cohen et al., 2011; Cohen et al., 
2008;). Analysis of the 3D structure and the sequence similarities with other known 
proteins, suggest that the structure of Cyt protein has the ability of non-specific pore-
forming ability (Lin et al., 2004; Weng et al., 2004) and can trigger the oligomerization 
of other protein domains especially the Cry proteins (Weng et al., 2004).  
 
 
 
Figure 5. Structure of a Cyt protein (Xu et al., 2014) 
 
 
2.4.4 Mode of action of Bt δ endotoxins 
Once the insecticidal larvae ingest the Cry toxins, it is solubilized due to the 
alkaline conditions of the gut. The disulphide bonds are broken to form a protoxin. This 
step is affected by factors like the type of Cry protein, physiological conditions of the 
midgut, presence of helper proteins, etc (Aronson et al., 1991; Naimov et al., 2011). 
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Once solubilized, these protoxins are activated by specific midgut proteases to form the 
active toxin molecule. This cleavage occurs on both N and C terminal of the protoxin 
(Bravo et al., 2004; Yamaguchi et al., 2010; Ai et al., 2013; Guo et al., 2012). Once 
activated these toxin molecules cross the peritrophic matrix, which may reduce the 
availability of Cry toxins that reach the membrane receptors. The next crucial step is 
the binding of these activated toxin molecules to specific receptors on the membrane. 
This decides the host range of the Bt strains. The receptors that Cry proteins bind to, 
are aminopeptidase, cadherin, alkaline phosphatase, ABC transporter and other Cry 
binding proteins and molecules (Pigott & Ellar, 2007; Bravo et al., 2011; Jurat-Fuentes 
& Jackson, 2012; Stalinski et al., 2015). Once the binding is complete, the mode of 
action has been explained by many study groups but is still a controversial topic. Two 
models have been proposed: Pore formation model and Signal pathway model. 
According to the pore formations pathway, the activated toxin binds to multiple primary 
receptors. Once localized, they bind to the secondary receptors, which are usually 
cadherin molecules (Arenas et al., 2010; Bravo et al., 2011). This interaction leads to 
cleavage of N terminal, which induces the oligomer formation (Gomez et al., 2002) and 
insertion into the membrane. The pores thus formed will cause the osmotic lysis of the 
cell (Pacheco et al., 2009; Soberon et al., 2009; Bravo et al., 2011; Zhang et al., 2017). 
The second model is signal pathway. As per this model, specific binding between the 
Cry toxins and the cadherin proteins will induce the Mg2+ dependent signalling pathway 
that ultimately causes cell death (Zhang et al., 2005). 
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Figure 6. Mode of action of δ- endotoxins (Adang et al., 2014) 
 
 
Cyt proteins do not require specific receptors on the insect epithelial cell 
membrane. Instead, they bind directly to saturated membrane lipids such as 
sphingomyelin, phosphatidylcholine and phosphatidylethanolamine (Rodriguez-
Almazan et al., 2011). The proteases of the insect midgut activate the Cyt protoxin by 
cleaving at the N terminal. The C terminal α1 and α2 bind to the membrane lipids, 
which triggers the self-oligomerization. Then the C terminal β5, β6 and β7 penetrate 
the membrane and 6 such domains come together to form the β barrel across the 
membrane. This creates channels and makes the membrane permeable. The cytosol 
components start leaking and cause cell death subsequently (Rodriguez-Almazan et al., 
2011). Another model says that the binding of the C terminal α1 and α2 to the 
membrane and insertion of β5, β6 and β7 domains in the membrane act as a detergent 
and disturb the integrity of the membrane and dissolve causing cell death (Butko, 2003). 
Both the models are considered true and is thought to be toxin concentration dependent. 
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At the low concentrations, the permeability model may be true, while the high Cyt 
concentration might trigger a detergent like model.  
Another important function of Cyt protein is its synergistic action with Cry 
proteins. Cyt has been found to be able to bind to the Cry proteins (Perez et al., 2005; 
Canton et al., 2011). This enables the Cry proteins to bind to the membrane at more 
sites than their own receptors alone. This in turn enhances the insecticidal properties of 
the Cry proteins. It not only binds, but also triggers the oligomerization of the Cry toxins 
like Cry11A (Carmona et al., 2011; Perez et al., 2007; Hua et al., 2008). This is also 
the reason why the insects do not develop resistance against the Cry proteins of the 
strains that also express the Cyt proteins.  
The δ- endotoxins once bound to the insect midgut epithelial cells trigger a 
cascade of histopathological events in the larval midgut, which eventually leads to its 
death (Abdelkefi-Mesrati et al., 2011). An insect larval midgut typically consists of a 
chitin rich peritropic membrane and midgut epithelial cells. The epithelial cells are of 
two types: columnar and goblet cells. The columnar cells with the microvilli give the 
brush border appearance along with the closely intercalated goblet cells (Jamoussi et 
al., 2013). The cells affected by the δ- endotoxins show some common characteristics: 
loss of tight associations among the epithelial cells, degenerated columnar and goblet 
cells, loss of microvilli, vacuolated organelles, clustered chromatin, shrunk nucleus, 
appearance of degenerated cells in the lumen, etc (Rouis et al., 2007, El-Ghany et al., 
2015). These events are then followed by starvation and larval death. The sequence of 
these events or the pathways of signalling molecules that trigger these events are not 
very clear (Canton et al., 2015).  
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2.5 Resistance of insects to Bt 
It was believed that the insects would never develop resistance to the bio-
pesticides based on Bt δ- endotoxins as these two organisms have co-evolved. But, 
considering the multi-step toxicity of the δ- endotoxins, resistance should have been 
expected. The resistant varieties of insects developed in laboratory as well as in the 
field after applications (Ferre & Van Rie, 2002). It was seen that the development of 
the resistance was much easier in the field conditions with high genetic diversity 
compared to the laboratory selections. However, laboratory selection experiments were 
carried out to identify the possible mechanism of resistance development. Most insect 
species developed resistance to the subspecies Bt kurstaki. Substituting this subspecies 
with Bt aizawai could resolve the issue. But, resistance to this new subspecies also 
started developing rapidly (Lambert et al., 1992). The mechanisms used by the insects 
to develop resistance include: alteration of the activation of δ- endotoxin step (Oppert 
et al., 1997), enhanced immune response (Hernandez-Martinez et al., 2010), alteration 
of the membrane receptors that were specific to the δ- endotoxins (Griffith & Aroian, 
2005), sequestering the toxin molecule (Gunning et al., 2005; Ma et al., 2005), etc. 
Most cases reporting the resistance are due to the alterations in receptor molecules.  
So, to control the Lepidopteran and Coleopteran insects, new and toxic 
subspecies or strains are constantly being isolated or engineered for field applications. 
Resistance management was also included in this field of research. The possible 
strategies for this purpose included using high dosages, spatial or temporal refugia, 
using combinations of δ- endotoxins or crop rotations (Alstad & Andow, 1995; Gould, 
1998).  
Among the Bti strains, the resistant strains were isolated from the field as well 
as selected in the laboratory among the Culex species (Wirth, 2010). But this resistance 
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was unstable in both cases. These resistances were developed against individual Cry 
proteins. But when two or more Cry proteins were expressed together, the resistance 
was greatly reduced. When Cyt protein was included with the Cry protein (s), the 
resistance developed was negligible or non-existent (Wirth & Georghiou, 1997; 
Georghou & Wirth, 1997; Wirth et al., 1997). This is due to the ability of Cyt protein 
to act as a receptor for the Cry proteins to bind to more sites other than their specific 
receptors (Wirth et al., 2012). Many studies have shown that the combinations of Cry 
proteins definitely delayed the development of resistance but including Cyt protein with 
these combinations avoided the development of resistance all together, under both field 
and laboratory selection pressures (Wirth, 2010; Wirth et al., 2005). This strategy can 
overcome the resistance developed due to alteration in the genes encoding the 
membrane receptors. This makes Bti a very strong candidate as a biocontrol agent for a 
prolonged period.  
2.6 Non-target effects of Bt 
δ- endotoxins from Bt have been used extensively for many applications 
including transgenic plants, bio-pesticides, sources of industrially important proteins, 
etc. As with any technology, environmental safety of Bt has been questioned. The 
effects of transgenic plants have been the most studied as the field applications of this 
technology have been going on for more than half a century. Studies to test the effect 
on arthropods could not find any adverse effects of the transgenic plants despite many 
crop rotations (Naranjo, 2005; Marvier et al., 2007; Duan et al., 2010; Li et al., 2011; 
Xu et al., 2012). Studies on the effects of transgenic crops on soil nematodes showed 
that a two year long study could not detect any difference between the community 
structure of the fields with transgenic plants and the fields with non-transgenic plants. 
The same studies on the laboratory level showed that the number of nematodes 
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increased after application of transgenic plants because they were becoming resistant 
to these Bt toxins (Li & Liu, 2013). Studies conducted to test the safety of these toxins 
towards mammalian cells have also been conducted and could not find any adverse 
effects (Brodirick et al., 2006; Gill & Ellar, 2002). Even the microbiota of the fields 
growing the transgenic plants do not show significant effects (Farias et al., 2014). In 
case of applications including direct use of δ- endotoxins as bio-pesticides on the field 
as well as laboratory levels, no non-target effects have been found by the many studies 
that have been conducted worldwide (Saxena & Stotzky, 2000; Sears et al., 2001). In 
conclusion, although no toxic effects have been detected towards non-target organisms, 
the presence of transgenic plants with Bt toxins has been found to develop resistance 
among the non-target insects against the Bt δ- endotoxins, but only due to the transgenic 
plants harbouring Bt δ- endotoxins. Direct applications of the proteins do not allow 
them to persist in nature for long and hence do not have an effect of toxicity or 
resistance development.  
2.7 Cytolytic activity / Anti-cancer property of Bt 
As mentioned before, majority of Bt isolates in all ecologies are non-
insecticidal. On testing, it was found that some of these strains have anti-cancer 
activities. This activity is attributed to two groups of proteins: Parasporins (also called 
as non-insecticidal Cry proteins as they are included in the nomenclature) and the 
cytolytic proteins Cyt. Cyt1Aa and Cyt2Ba have shown anticancer activities (Nair et 
al., 2018b). At the same time, dosages that showed toxicity in cancer cell lines, did not 
affect the normal cells (Celandroni et al., 2014). This activity could also be directed 
specifically to certain cell types by conjugating the Cyt proteins with a signal peptide. 
This construct specifically lysed the murine hybridoma cells (Cohen et al., 2007) and 
did not affect the normal cells. Other properties of cells can also be utilized for cytolytic 
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activity (Correa et al., 2012; Aldeewan et al., 2014). For example, conjugating the 
insulin to the Cyt protein directed the cytolytic activity towards only the cells that had 
high number of insulin receptors (Al-yahyee & Ellar, 1996).  
Bt also expresses parasporal proteins that have no known effects on 
invertebrates but show cytotoxic effects on cancer cell lines. These are commonly 
known as parasporins and they have no structural homology and very low sequence 
homology with the known Cry proteins. These parasporins also have no insecticidal 
activities (Knowles et al., 1992). But they are included in the Cry protein groups for 
nomenclature. Cry31A (Parasporin 1), Cry41A (Parasporin 3), Cry45A (Parasporin 4), 
Cry46A (Parasporin 2), Cry63A (Parasporin 6) and Cry 64A (Parasporin 5) (Ohba et 
al., 2009; http://parasporin.fitc.pref.fukuoka.jp/). They preferentially kill the cancer 
cells of human leukemic T cell lines and HeLa cell lines, without affecting the normal 
cells like erythrocytes or T-cells (Mizuki et al., 1999; Knowles et al., 1992). 
Interestingly, like Cry proteins and their spectrum of target organisms, parasporins also 
have a spectrum of cancer cell lines that are sensitive (Ito et al., 2004; Yamashita et al., 
2005; Katayama et al., 2005; Okumura et al., 2005; Kitada et al., 2006). But, unlike 
Cry proteins, some parasporins’ mechanism of action does not involve the membrane 
pore-forming strategy. Instead, the parasporin induces controlled apoptosis in human 
cancer cells lines (Katayama et al., 2007). Other parasporins increase the membrane 
permeability by oligomerization at the membrane after binding to specific receptors, 
like the Cry toxin strategy.  
Overall parasporins are considered as possible anti-cancer drugs that need a few 
improvements. It is expected that these proteins could induce some immunological 
complications. The solution would be to find the specific receptors on the cancer cells 
that are recognized by the parasporins and work towards a targeted therapy (Ohba et 
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al., 2009; Periyasamy et al., 2016).  
2.8 Bacillus thuringiensis israelensis (Bti) 
2.8.1 Introduction 
Bti is the first subspecies that was found to be toxic to the Dipteran species. It 
is the most efficient biological alternative for controlling the disease vectors (Fillinger 
et al., 2006; Margalith & Ben-Dov, 2000). Bti forms spherical crystals composed of δ-
endotoxins. The most attractive feature of this biocontrol agent is the absence of 
resistance among the insect species even after applications for many decades (Kamgang 
et al., 2011; Loke et al., 2010; Tetreau et al., 2013; Vasquez et al., 2009). The lack of 
resistance development is due to the different modes of actions among the δ- endotoxins 
and their synergistic activities. There are four main toxins that are present: Cry4Aa, 
Cry4Ba, Cry11Aa and Cyt1Aa (Crickmore et al., 1995). Bti reproduces and persists in 
different ecologies under natural conditions. Applied formulation of spores and crystals 
usually settles to the bottom of the water bodies within 24 to 48 hours (Boisvert & 
Boisvert, 1999: Tilquin et al., 2008; Tetreau et al., 2012a; 2012b; 2012c). If ingested, 
the larvae are killed, and the carcass is used by this sporophyte to multiply and make 
the carcasses toxic to other larvae (Khawaled et al., 1990).  
2.8.2 Extra chromosomal genome (plasmids) of Bti 
Bti that was originally isolated from dead Culex pipiens larvae had eight circular 
plasmids having size ranges between 5 kb and 210 kb, and a linear plasmid of about 16 
kb (Carlton & Gonzalez, 1985; Sekar, 1990). The identified and studied plasmids are 
pTX14-1, pTX14-2, pTX14-3, pGIL01, pBtoxis, pBtic100, pBtic235, pXO16 and 
pBtic360. These nine plasmids constitute about 13% of the whole genome of Bti.  These 
plasmids provide the bacteria with high adaptability to changing environment and other 
complications arising with their host (Gillis et al., 2018). To facilitate gene transfer and 
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genome dynamics, the plasmids carry several mobile elements like insertion sequences, 
introns, prophages, transposons, integrons, conjugative elements, mobile insertion 
cassettes, etc (Fiedoruk et al., 2017). Among the nine plasmids, two of the plasmids 
carry the insecticidal δ- endotoxin genes: pBtoxis and pBtic100. The 128 kb pBtoxis 
plasmid has been widely studied and was considered the only plasmid involved in 
insecticidal properties until recently. A new study reported the presence of two new cry 
genes (cry60Aa and cry60Ba) on the 100 kb plasmid designated as pBtic100 (Bolotin 
et al., 2017). Apart from this, not much is known about this 100 kb plasmid.  
pBtoxis plasmid, on the other hand, is very well studied and completely 
sequenced (Berry et al., 2002).  Apart from the genes encoding insecticidal proteins, 
pBtoxis carries the genes for sporulation, transcription regulation, antimicrobial 
peptides, plasmid replication, germination, etc. A representation of pBtoxis plasmid is 
shown in the figure 7. The insecticidal protein genes are closely associated with 
transposons, insertion sequences and other mobile elements. These elements enable 
exchange of plasmids among the strains as well as many recombinant events. Many 
studies have reported that the presence of mobile elements lead to DNA rearrangements 
in the plasmid and consequent structural instability (Zghal & Jaoua, 2006; Driss et al., 
2011).  This property makes the plasmids of Bti unstable in changing environmental 
conditions. Research groups have taken advantage of this instability by artificially 
pushing the Bt strains to lose parts of their whole genome by plasmid curing technique. 
The idea is to make the bacteria selectively lose certain unwanted metabolic activity or 
randomly lose parts of genome to enhance the remaining activities. Some of the 
examples are regulation of gene expression (Park et al., 2007), synthesis of 
antimicrobial bacteriocins (Kamoun et al., 2009), production of δ- endotoxins 
(Gonzalez et al., 1981), etc.  
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Figure 7. Representation of the pBtoxis mega-plasmid encoding the δ- endotoxins 
(Gillis et al., 2018) 
 
 
2.8.3 δ- endotoxin genes of Bti 
The insecticidal activity of Bti depends on four main genes cry4Aa, cry4Ba, 
cry11Aa and cyt1Aa that gave protein products of 134 kD, 128 kD, 72 kD and 27 kD, 
respectively. These genes are encoded by the mega-plasmids called as pBtoxis (Berry 
et al., 2002). Apart from these, the mega-plasmid also contained other δ- endotoxins 
like cry10Aa, cyt2Ba and cyt1Ca (Lee et al., 1985; Thorne et al., 1986). Although the 
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function of Cyt1Ca protein is not clear, Cry10Aa and Cyt2Ba were found in small 
quantities and yet contributing to the insecticidal activity. The largest protoxins have C 
terminal domain that is involved in the crystallization of the entire parasporal crystal 
(Bietlot et al., 1999). The other smaller δ- endotoxins lack this property and hence need 
assistance forming the disulphide bonds of crystallization (Xu et al., 2001). The 
cry11Aa is encoded by an operon that also codes for two other proteins, p19 & p20. 
These helper proteins help stabilize the heterologous expression of δ- endotoxin genes, 
especially Cry11Aa and Cyt1Aa.  
2.8.4 Toxicity of Bti towards Dipteran insects 
Cry4Aa is highly toxic to the larvae of Culex, and less toxic to Anopheles and 
Aedes. Cry4Ba, on the contrary is highly toxic to Anopheles and Aedes but low toxicity 
against Culex (Otieno-Ayayo et al., 2008; Beltrao & Silva-Filha, 2007; Abdulla et al., 
2003). These two proteins are cleaved into active forms of about 65 kD. But, unlike the 
other Cry proteins, these two δ- endotoxins are further processed to two fragments of 
about 45 kd and 20 kD each (Beltrao & Silva-Filha, 2007; Yamagiwa et al., 2004; 
Komano et al., 1998). The Cry11Aa is highly toxic to Aedes and Culex while being 
moderately toxic to Anopheles (Revina et al., 2004; Otieno-Ayayo et al., 2008). This 
toxin also is cleaved to two fragments of about 38 and 30 kD (Yamagiwa et al., 2002; 
Yamagiwa et al., 2004; Dai & Gill, 1993; Revina et al., 2004; Beltrao & Silva-Filha, 
2007). The Cyt1Aa has low insecticidal activity against all three species (Otieno-Ayayo 
et al., 2008). But, it is the most important δ- endotoxin in Bti as it not only enhances 
the activities of Cry4Aa and Cry11Aa, but also delays or prevents the onset of resistance 
among the target insects towards the Cry toxins (Wirth et al., 2005). Other Cry toxins 
like Cry10Aa has synergistic activities with Cry4Ba and Cyt1Aa (Hernandez-Soto et 
al., 2009). Cyt2Ba is synergistic with Cry4Aa, Cry4Ba and Cry11Aa (Manasherob et 
  
53 
 
al., 2006). Unfortunately, Cyt1Ca is not detected in any strains. The transcripts for its 
gene were found but is probably too unstable to be translated (Stein et al., 2006; Itsko 
et al., 2007; Manasherob et al., 2006).  
2.8.5 Limitations of Bti based insecticides 
Currently, Bti is used for commercial applications as bio-insecticides against the 
Dipteran insects. But, by economical standards, it is not yet the perfect strategy for the 
bio-control of these insects. Despite their numerous advantages over the alternate 
chemical products, they are still not able to completely replace the chemical insecticides 
in the market due to their limitations. The most important limitation to consider is its 
low persistence. The low persistence is due to ingestion by non-target organisms, 
weakening due to natural factors like rain and sunlight, encapsulation and 
incapacitation by surrounding organic matter, unavailability of the toxins throughout 
the water bodies due to protein sinking, etc (Ben-Dov, 2014).  
2.9 Non-Bacillus thuringiensis israelensis strains 
Bt var israelensis is not the only subspecies that can produce insecticidal 
proteins against Dipteran insects. Many research groups have isolated other subspecies 
that form spherical crystals but are phylogenetically different to the Bt israelensis. Bt 
jegathesan (Btj) was isolated by Sun et al. (2013) that had high insecticidal activities 
against mosquitoes. Bt kenyae (Btk) and Bt entomocidus (Bte) were isolated from 
Mexico, which also displayed the presence of spherical crystals containing four main 
δ- endotoxins usually found in Bti. These proteins were also encoded by the mega-
plasmid of the same size as pBtoxis of Bti. These subspecies had comparable 
insecticidal activities against the Dipteran insects. In 1996, four strains of Bt were 
isolated from belonging to the subspecies Bt canadensis, Bt thompsoni, Bt jegathesan 
and Bt malaysiensis. These four isolates were found to have the same combinations of 
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δ- endotoxins as well as equally high insecticidal activity compared to Bti (Ragni et al., 
1996). Elluech et al. (2014) found that 10 of their Bt isolates had similarity to be 
included under Bt subspecies, but they differed from the other known subspecies, 
including israelensis. These isolates had spherical crystals, but their protein patterns 
and plasmid patterns differed very much from the reference strain Bti H14. Comparing 
their insecticidal activities with the reference strain showed that they were equally or 
more effective than the reference against Dipteran insect (C capitata). Another 
interesting study involved isolation of six strains of Bt from Brazil, which showed high 
insecticidal activities against A aegypti, but only one of them showed the presence of 
the five δ- endotoxin genes that one would expect including Cry4A, Cry4B, Cry10A, 
Cry11A and Cry11B (Soares-da-Silva et al., 2015). This shows that the other five strains 
probably display novel combinations of δ- endotoxins that needs to be explored. 
Moreover, a non-insecticidal Bt strain isolated by Jung et al. (2006) showed spherical 
crystals that had cytolytic activities. The gene responsible was sequenced and was 
found to have homology with Cry31A toxin. This strain had specific cytotoxic effect 
on human cancer cells and no effect on the normal human cells. Guan et al. (2014) 
found that Bt sichuansis showed spherical crystals and had a novel δ- endotoxin gene 
cry69Aa1. This gene when isolated and cloned into acrystalliferous strain, formed 
crystals of δ- endotoxins and had high insecticidal activities against Culex 
quinquefaciatus.  
Some δ- endotoxins are toxic to more than one family of insects. One such 
example is Cry2 protein. Cry2 δ- endotoxin is toxic to Lepidopteran as well as Dipteran 
insects (Hofte & Whiteley, 1989). Cry2 is usually expressed by Bt strains like var. 
kurstaki, that acts against Lepidopteran insects. Cry2 protein is encoded by an ORF3 
gene that forms a part of a 3 ORF operon. The ORF2 is a regulatory gene that encodes 
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for a regulatory protein. This regulatory protein aids the translation of ORF3 gene to 
form the Cry2 protein. Also, once the Cry2 protein is translated, ORF2 protein helps 
the former to form the cuboidal crystal (Staples et al., 2001).  
In addition to the presence of novel δ- endotoxins, these non-Bti subspecies may 
also harbour other accessorial essential proteins. In 1977, a new subspecies Bt pakistani 
(Btp) expressed and released chitinase enzyme at a very high concentration. Although 
at that time, the importance was given only to the enzyme for industrial degradation, 
today we recognize the additive effect it has on the insecticidal activities (de Barjac et 
al., 1977).  
2.10 Current research on Bt 
As it is evident so far, the different ecologies and climatic conditions affect the 
diversity of the Bt strains. Different research groups in new ecologies continuously 
carry out large-scale screenings worldwide. Apart from these, mainly the research 
focuses on modification of the known and novel δ- endotoxin proteins at genetic and 
molecular levels to increase their insecticidal activities. Also, many groups are focusing 
on heterologous expression of these δ- endotoxin genes in other organisms. Different 
combinations of δ- endotoxin genes are cloned together in the carrier organisms to 
evaluate their efficiency.  
Sansinenea et al. (2015) isolated melanin producing local strain of Bt, which 
gives the δ- endotoxins protection against sunlight when applied on the fields. This will 
help resolve the issue of low persistence of δ- endotoxins in nature due to UV light 
degradation. Other factors that affect the persistence and recycling of the applications 
in the field are organic matter content and the presence of susceptible insects (Duchet 
et al., 2014; Tetreau et al., 2012).  
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The different types of formulations of Bti in different ecologies affect the 
efficiency of the applications. For example, it was found that the breeding grounds like 
tree holes would have better control of the mosquitoes if the formulations are in 
granular instead of liquid form (Harwood et al., 2015). Earlier, another group had 
reported the same by experimentally proving that the backpack application (granular 
form) was more effective than source reduction (surfactant in monolayer film) in urban 
areas. This was especially beneficial because the backpack applications were also more 
cost effective that the latter (Sun et al., 2014). The specific receptors on the gut epithelia 
that the Cry toxics bind to are fairly understood today. For instance, the Cry4Ba toxin 
has two specific isoforms of aminopeptidase N (Aroonkesorn et al., 2015). On the other 
hand, Farajollahi et al. (2013) validated the efficacy and persistence of both granulated 
and pellet formulations for up to 4 weeks.  
Large-scale screenings are being undertaken in new ecologies worldwide. In 
Saudi Arabia, out of 157 Bt strains isolated, one strain was found to have good protein 
production and an enhanced insecticidal activity when compared to the reference Bti 
H14 (El-kersh et al., 2014). Elleuch et al. (2014) isolated 10 Bt strains producing 
spherical crystals but had entirely different plasmid patterns compared to H14. They 
found that three of these strains produced novel δ- endotoxins that had moderate 
toxicity to C capitate, which till then was only susceptible to the exotoxins of Bt. As 
these exotoxins are toxic to vertebrates, they cannot be used for field applications. The 
mosquitocidal strains were also isolated from excreta of the birds and showed good 
insecticidal activities against Culex, Anopheles and Aedes species (Poopathi et al., 
2014). A soil isolate from China also showed comparable insecticidal activities that 
could be an alternative to the H14 reference strain (Zhang et al., 2012). 
Once efficient genes have been isolated, they are cloned. The next step is 
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heterologous expression of these genes in suitable organisms that can over-express 
particular toxin proteins. Many study groups have utilized different organisms and 
found good candidates for this purpose: aquatic bacterium Asticcacaulis excentricus 
(Armengol et al., 2005), E coli (Khasdan et al., 2001).  
Apart from the δ- endotoxins, Bt strains may produce many other proteins that 
have synergistic or additive effects on their insecticidal activities. The production of 
chitinase was found to enhance the insecticidal activity of Bt kurstaki (Driss et al., 
2011). The helper gene p20 from Bti was found to enhance the stability of the Cyt 
proteins as well as Cry4A and Cry11A proteins, thereby increasing their insecticidal 
activity (Elleuch et al., 2015).  The expression of other δ- endotoxins also enhances the 
insecticidal activity and prevents the development of resistance among the target insects 
(Park et al., 2005). On the other hand, mutagenesis is used to select new mutants that 
have high insecticidal activities or higher persistence. Ghribi et al. (2004) mutated the 
local strains randomly with UV and nitrous oxide. They could obtain new strains that 
had higher insecticidal activities. The same group (Ghribi et al.) in 2005 improved the 
Bt strains by heat and high concentration of NaCl. And, in 2006, they improved the 
strains by changing their growth conditions (aeration) to overcome catabolite repression 
(Ghribi et al., 2006). On molecular levels, DNA shuffling and in silico procedures are 
also being tested for increasing the activities (Lucena et al., 2014).  
Another major focus of research in this field depends on understanding the 
triggers and patterns of possible development of resistance. Despres et al. (2014) 
reported that the gene expressions triggered in the insects due to biological and 
chemical insecticides are exactly the opposite. Hence, they suggested an integrated 
method of management where the resistance development will be very difficult in such 
cases. Known Cry genes are usually amplified and cloned using specific primers by 
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PCR amplification. But, now mass spectroscopy has been found to be a better method 
to identify rare and novel toxins (Zhang et al., 2014).  
The commercial production of the bio-insecticides can replace the chemical 
alternatives only when the production is extremely economical. Apart from other 
limitations, it is essential to find good, cheap, highly productive media for the growth 
and sporulation of Bti. Different study groups have suggested such media: mushroom 
substrate by solid state fermentation (Wu et al., 2014), chicken feather-based media 
(Poopathi & Archana, 2012), pigeon pea and soya bean flour as carbon and nitrogen 
sources (Devidas et al., 2014), sugarcane processed bagasse (Poopathi et al., 2013), 
starch and soybean media (Khedher et al., 2011).  
2.11 Current market status of Bt insecticides 
For a long time, the biocontrol agents could not compete with the chemical 
pesticides because of its limitations. Growing evidences for harmful effects of the 
synthetic chemical control agents and the development of resistance among the insects 
have brought about a decline in the development of new chemical pesticides. Slowly, 
but steadily the scenario is changing in the market for insecticides. According to the 
BCC research LLC report (CHM029E, 2014), the market for insecticides will increase 
globally at a rate of 6.3% by 2019 and reach $ 80 billion. Out of this, the major 
contribution will be due to the bio-insecticides forming a 4% increment. This change 
in scenario can be witnessed in the form of the new mergers and acquisitions formed 
between the agricultural development and bio-insecticide production companies (Luca, 
2015). Currently, commercial products based on Bti insecticidal endotoxins are 
available; like mosquito dunks, Aquabac, Bonide, Microbe lift, etc. Bt continues to be 
the “star” of biopesticides and many formulations, needing the search for novel Bt 
toxins. Many research groups from different continents are in constant search for Bt 
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strain diversity and particularly δ- endotoxins with high insecticidal activities. In this 
PhD, we are contributing to the worldwide search by screening for novel biopesticides 
and other activities based on Bt strains isolated from Qatar.  
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CHAPTER 3: MATERIALS AND METHODS 
3.1. Materials 
3.1.1. Strains studied  
Table 1. List of important strains studied with reference strains  
[Non-Bti strains listed are only representatives of the group of strains in their class; 
number of strains represented by each representative is mentioned in brackets next to 
it] 
Bti strains 
(Jaoua et al., 
unpublished) 
Non-Bti 
representative strains 
(Jaoua et al., 
unpublished) 
Reference strains 
QBT205 QBT3 (4) Bacillus thuringiensis israelensis H14 
QBT213 QBT6 (7) Bacillus thuringiensis israelensis 4Q7 
QBT214 QBT34 (19) Bacillus thuringiensis kurstaki HD1 
QBT215 QBT39 (12) Bacillus cereus 
QBT216 QBT41 (29) Bacillus subtilis 
QBT217 QBT43 (33) Pseudomonas 
QBT218 QBT56 (28)  
QBT220 QBT81 (2)  
QBT221 QBT99 (2)  
QBT222 QBT212 (10)  
QBT223 QBT240 (48)  
QBT224 QBT320 (16)  
QBT225 QBT418 (9)  
QBT226 QBT555 (202)  
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Bti strains 
(Jaoua et al., 
unpublished) 
Non-Bti 
representative strains 
(Jaoua et al., 
unpublished) 
Reference strains 
QBT227 QBT674 (1)  
QBT228   
QBT229   
QBT230   
QBT608   
 
 
3.1.2. Insect larvae studied 
1. Culex pipiens 
2. Aedes aegypti Bora Bora  
3.1.3. Cell lines 
NCIH1975 [H1975, H1975] (ATCC® CRL5908TM) – Adherent lung cancer epithelial 
cell lines 
3.1.4. Media compositions 
1) Luria Bertini medium 
Tryptone – 10 g/l 
Yeast extract – 5 g/l 
Sodium Chloride (NaCl) – 5 g/l 
pH – 7  
Agar – 15 g/l 
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2) T3 medium 
Tryptone – 3 g/l 
Tryptose – 2 g/l 
Yeast extract – 1.5 g/l 
Sodium hydrogen phosphate (Na2HPO4) – 1.4 g/l 
Sodium dihydrogen phosphate (NaH2PO4) – 1.2 g/l 
Manganese sulphate (MnSO4.7H2O) – 0.002 g/l 
Magnesium sulphate (MgSO4.7H2O) – 0.02 g/l 
pH – 6.8  
Agar – 15 g/l 
 
3) Glucose based medium 
Glucose – 15 g/l 
Glycerol – 5 g/l 
Ammonium sulphate – 5.4 g/l 
Calcium carbonate – 20 g/l 
Monopotassium phosphate (KH2PO4) – 1 g/l 
Dipotassium phosphate (K2HPO4) – 1 g/l 
Manganese sulphate (MnSO4) – 0.01 g/l 
Magnesium sulphate (MgSO4) – 0.3 g/l 
Ferrous sulphate (FeSO4) – 0.01 g/l 
pH – 7 
 
4) Soya-meal starch based medium 
Starch – 15 g/l 
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Soyameal – 25 g/l 
Calcium carbonate – 20 g/l 
Monopotassium phosphate (KH2PO4) – 1 g/l 
Dipotassium phosphate (K2HPO4) – 1 g/l 
Manganese sulphate (MnSO4) – 0.01 g/l 
Magnesium sulphate (MgSO4) – 0.3 g/l 
Ferrous sulphate (FeSO4) – 0.01 g/l 
pH – 7 
 
5) Blood agar medium 
Peptone – 5 g/L 
Beef extract – 3 g/L 
Sodium chloride (NaCl) – 5 g/L 
Blood – 50 ml/L 
Agar – 15 g/L 
pH – 7  
 
6) Cell line medium 
RPMI-1640 
10% Fetal Bovine Serum  
100 µg/ml Streptomycin 
100 IU/ml Penicillin 
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3.1.5. Primers used 
Table 2. List of primers used in the study 
Gene Primers Sequence Reference 
16s rRNA Rib73 5′-AGAGTTTGATCCTGGCTCAG  
Rib74 5′-AGGAGGTGATCCAGCCGCA  
cry4A, 
cry4B 
Dip1A 5'CAAGCCGCAAATCTTGTGGA Carozzi et 
al., 1991 Dip1B 5'ATGGCTTGTTTCGCTACATC 
cry4B Dip2A 5'GGTGCTTCCTATTCTTTGG 
Dip2B 5'TGACCAGGTCCCTTGATTAC 
cry4 Cry4-1 5'GGTGCTTCCTATTCTTTGG Carozzi et 
al., 1991 Cry4-2 5'ATGGCTTGTTTCGCTACATC 
cyt1A Cyt1A1 5'GTTGTAAGCTTATGGAAAAT Zghal et al., 
2008 Cyt1A2 5'TTAGAAGCTTCCATTAATA 
cyt2 Cyt2-1 5'AATACATTTCAAGGAGCTA Guerchicoff 
et al., 1997 Cyt2-2 5'TTTCATTTTAACTTCATATC 
cry11 Cry11-1 5'TTAGAAGATACGCCAGATCAAGC Bravo et al., 
1998 Cry11-2 5'CATTTGTACTTGAAGTTGTAATCCC 
cry10 Cry10-1 5'ATATGAAATATTCAATGCTC Porcar et al., 
1999 Cry10-2 5'ATAAATTCAAGTGCCAAGTA 
cyt1C Cyt1c-1 5'CAAAATCTACGGGAGCAAGG Nair et al., 
2018 (a) Cyt1c-2 5'GGAAGGATCCCTTTGACTTTT 
cry2 Cry2A 5`GTTATTCTTAATGCAGATGAATGGG  Ben Dov et 
al., 1997 Cry2B 5`CGGATAAAATAATCTGGGAAATAGT  
cry2 Cry2-1 5’ACTATTTGTGATGCGTATAATGTA Ben Dov et 
al., 1997 Cry-2 5’AATTCCCCATTCATCTGC 
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Gene Primers Sequence Reference 
cry11 Cry11-1 5`CCGAACCTACTATTGCGCCA  Bravo et al., 
1998 Cry11-2 5`CTCCCTGCTAGGATTCCGTC  
p19 P19-1 5'GCAGGAGGAACATCACCATT Nair et al., 
2018b P19-2 5'GGATTTGCTGAGCAGGTCAT 
p20 P20-1 5'TGACGAGGAAACAGAGTATACGA 
P20-2 5' TGAAAGGTTAAACGTTCCGATT 
parasporin 
1 
PS1-1 5′ AGCACCTAATGATGATAGAGGAA Ammons et 
al., 2016 PS1-2 5′ CCCAGATTCAAATAATAACCAAGA 
parasporin 
2 
PS2-1 5′ 
GATGGTATTGCATTAAATAATGAAAC 
PS2-2 5′ TTCTCCACCAATTTCAAAGACT  
parasporin 
3 
PS3-1 5′ ATACAAGATGTGAGGAAATGATGA 
PS3-2 5′ GTATGGCTCAGCTCAATTTGA 
parasporin 
4 
PS4-1 5′ ACTAGTCAGCCTATAATCAGAACGA 
PS4-2 5′ ACTATTCCAGTACCAGTGTAACC  
parasporin 
5 
PS5-1 5′ TCAACGCCACAATTAACAAATA  
PS5-2 5′ TCCCTTGTATAGTTGCCTTTGT 
parasporin 
6 
PS6-1 5′ TGTTTACTATGTGAAAGGTGGAGA 
PS6-2 5′ CAATAGTGGTTCCTATTGGACC 
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Gene Primers Sequence Reference 
Plasmid 
mapping 
F1 5’GAAGAAGGGCCAATAGATGG 
Designed 
for the study 
R1 5’AATTTGATCCGTCCTGATGC 
F2 5’GGGAAAGAATATGCAGGGAAA 
R2 5’TCAAACGTCGGTTTGTGAAA 
F3 5’TCGGTTGTACCCCATACACA 
R3 5’CCATTCCACGAAAAAGGAGA 
F4 5’AAGTAAAGCTGGGGCCTTGT 
R4 5’GTCAGATCCTTGCCAAAAG 
F5 5’GCCAAATCAACCACTGAAAAA 
R5 5’CCTGTGTGACCAGGACCTTT 
F6 5’GGATAAACCAAGGGCGTTTT 
R6 5’TTTTCCATAGCGTGAAACCA 
 
 
3.1.6. Databases accessed: 
1) National Center for Biotechnology Information (NCBI) 
2) UniProt  
3.1.7. Softwares used: 
1) ImageJ 
2) Probit analysis 
3) Tree viewer 
4) MS Excel 
5) Spectrum Mill 
6) ExPasy tool 
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7) SWISS-MODEL 
8) Primer3 plus 
3.2. Methodology 
 3.2.1. Qatari Bt strains collection, culture conditions, revival and storage 
More than 700 Bt isolates collected from Qatar soil form the Bt collection. This PhD 
project is a part of this broader study of isolation and characterization of Qatari Bt 
isolates. This project concentrates on 441 Qatari Bt isolates that produce spherical 
crystals. The spherical crystal producing strains are known to be toxic to Dipteran 
insects, which are the target insects for this study. The collection is stored in the form 
of spore-crystal mixture in 25% glycerol at -800C.  
3.2.1.1. Revival of the strains 
Spore-crystal mixture of each strain was taken from -800C freezer, transferred on Luria 
Bertini (LB) agar plate by four quadrant streaking technique and incubated at 300C 
overnight. A pure isolated colony was then streaked on a new LB agar plate and 
incubated at 300C overnight to get a revived pure culture of each strain.  
3.2.1.2. Culture conditions and storage 
To obtain fresh culture of each strain, the latter was inoculated on LB agar plates by 
four-quadrant method of streaking and incubated at 300C overnight. For liquid cultures, 
a single isolated colony from the LB agar plate was inoculated into LB broth and 
incubated at 300C in a shaker overnight at 150 rpm. The strains that produced spherical 
crystals were stored again separately in the spore-crystal form. To obtain the spores and 
crystals, isolated colony of each strain from LB agar plate was transferred to the T3 
sporulation medium. The T3 agar plates were incubated at 300C for 96 hours to allow 
complete sporulation of the culture (Molina et al., 2010). The spore-crystal mixtures 
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were transferred with a loop from the plate to 30% glycerol prepared with LB broth and 
stored at -800C.  
3.2.2. Characterization of the Bt strains producing spherical crystals 
3.2.2.1. Based on Crystal morphology  
441 Bt isolates producing spherical crystals were studied first based on their crystal 
morphology. Completely sporulated cultures of each strain were used for the following 
staining and microscopy procedures.   
A. Wet mounting under light microscope: 
Sporulated cultures from T3 medium were used to study the crystal forms under the 
microscope. Wet mounts were performed at 1000x magnification under light 
microscope. The samples that show spherical crystals were tested for solubilisation test 
at high pH. To confirm that the spherical structures seen under light microscope are 
indeed protein crystals, 0.5 M NaOH was added to the sides of the slides, still under the 
microscope. The complete disappearance of the spherical forms after 3-4 minutes of 
incubation confirmed that the crystals were present before the alkaline solubilisation.  
B. Endospore staining and light microscopy: 
The spore-crystal mixture was stained by Schaeffer-Fulton method, one of the 
differential endospores staining techniques. By using steam treatment, the usually 
impermeable endospores were stained with malachite green. The crystals were counter-
stained with saffranine. The imaging was performed with light microscope at 1000x 
(oil immersion) (Gorashi et al., 2012; Kassogue et al., 2015).  
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C. Scanning electron microscopy: 
For better resolution and understanding of the crystal structures, the samples were 
imaged with scanning electron microscope. The samples were observed by FEI Nova 
NanoSem 450 Scanning Electron Microscope. The images obtained were then edited 
and further studied using the software ImageJ. The dimensions of each spore and crystal 
were measured using this software.  
3.2.2.2. Based on protein patterns of the solubilized δ- endotoxin crystals 
Protein patterns were studied for all 441 samples using denaturing SDS-PAGE 
technique (Laemmli, 1970). The protein patterns of each isolate were studied and were 
classified based on the similar patterns. A representative was chosen from each group.  
A. Preparation of SDS-PAGE gels:  
Upper and lower acrylamide gels were prepared as listed in the table 3 below. The 
upper stacking gel was a 3% gel and the lower resolving gel was a 10% gel (Guz et al., 
2005).  
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Table 3. Preparation of stacking and resolving gels for SDS-PAGE gels 
Components 
3% acrylamide gel 10% acrylamide gel 
30% Acrylamide and 
0.8% Bis-acrylamide 
3.46 ml 0.835 ml 
Tris-HCl 1.4 ml (3M, pH 8.8) 0.333 ml (1M, pH 6.8) 
20% SDS 0.05 ml 0.05 ml 
10% Ammonium 
persulphate 
0.05 ml 0.025 ml 
TEMED 0.006 ml 0.006 ml 
Water 5.4 ml 3.75 ml 
Total volume 10.366 ml 4.99 ml 
 
 
B. Preparation of sample: 
The spore-crystal mixture was obtained from the completely sporulated culture of each 
strain by centrifugation at 10000 rpm for 5 min. The pellets obtained were washed thrice 
in cold distilled water. The resuspended pellets were then mixed with half volume of 
the boiling buffer containing 1 M Tris-HCl, 20% SDS, β-mercaptoethanol, 60% 
glycerol and 1% bromophenol blue. This sample was then boiled for 5 min. After 
boiling, the samples were loaded in to the wells of the SDS-PAGE gels. A broad range 
protein marker was also loaded in the first well of each gel as ladder to identify the size 
of the protein bands obtained from the samples.  
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C. Electrophoresis: 
The gel was run in a tank buffer containing 0.025 M Tris-HCl (pH 8.5), 0.1 M Glycine 
and 0.1% SDS. The gel was run at 100 mA till the loading dye reaches the bottom of 
the gel (about 3 hours).  
D. Staining, de-staining and imaging:  
The gel was stained with a staining solution containing 0.25% Coomassie brilliant blue 
in ethanol, glacial acetic acid and water in 5:1:4 ratio. The gels were left on a shaker at 
low speed overnight. De-staining was performed with a de-staining solution of ethanol, 
glacial acetic acid and water in the ratio of 5:7:88 (Ammouneh et al., 2011). De-staining 
solution was changed after 2 hours and the gels were left in de-staining solution 
overnight at low speed on a shaker. The next day, de-staining solution was changed 
again, and the gels were imaged with a white background.  
3.2.2.3. Based on plasmid patterns by gel electrophoresis 
The plasmid patterns of the 441 Bt strains were studied and the isolates were classified 
based on their patterns. A representative strain was chosen from each group.  
A. Plasmid isolation: 
The total plasmid DNA from each of the 441 isolates was obtained by alkaline lysis and 
alcohol precipitation method. A pure isolated colony was spread on a fresh LB agar 
plate and incubated overnight at 300C. The cells were harvested from 1/4th part of the 
plate into 1 ml distilled water. The cells were then separated by centrifugation at 5000 
rpm for 3 min. The pellet was resuspended in Solution AL containing Tris-HCl, 
Glucose, EDTA-Na2 and 4 mg/ml lysozyme (added just before use). The mixture was 
then incubated at 370C for half hour so that lysozyme can lyse the cell membrane. 
Solution B containing potassium acetate and glacial acetic acid is added and the samples 
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are transferred to ice. A freshly prepared alkaline solution C containing NaOH and SDS 
was added to the samples before incubating them back on ice for 5 min. After separating 
the cell debris by centrifugation, the supernatant containing nucleic acids and some 
proteins was added to an equal volume of phenol/chloroform/isoamyl alcohol (25/24/1) 
buffer. This separates the proteins from the desired nucleic acids. After centrifugation, 
the upper phase containing the nucleic acids was transferred to 2.5 V absolute ethanol 
and incubated at -200C overnight. After precipitating by ethanol, the nucleic acids were 
washed with 70% ethanol to discard any salts. Pure nucleic acids were then treated with 
RNase to remove the RNA molecules from the plasmids. The pellets containing pure 
plasmids were re-suspended in Tris-EDTA solution of 8 pH and stored at -200C 
(Faguntes et al., 2011; Sambrook et al., 1989).  
B. Gel preparation and tank buffer: 
For the study of plasmid patterns, an agarose gel of 1% was prepared with 0.5% TAE 
buffer containing 0.4 mM tris-acetate and 0.01 mM EDTA-Na2. The gel was stained 
using 0.5 µg/ml Ethidium bromide. 0.5% TAE buffer was used as tank buffer as well.  
C. Electrophoresis and imaging: 
5 µl of the plasmid sample, mixed with 2 µl of 6x loading dye and 5 µl of distilled 
water, was loaded in each well. A 1 kb plus DNA ladder was always loaded in the first 
well of each gel. The gel was run at 25 V for 10 min and then 50V till the tracking dye 
reaches near the bottom of the gel (about one and half hour). The gels were studied and 
imaged under Ultra-violet light (Reyes-Ramirez & Ibarra, 2008).  
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3.2.2.4. Phylogenetic studies 
16s rRNA sequences were analysed by amplification of conserved regions using 
Polymerase Chain Reaction (PCR) technique. The PCR amplifications were performed 
with Universal primers Rib73 and Rib74.  
A. DNA isolation: 
The total DNA was isolated using the heat shock method. Single isolated colony of the 
Bt strain from a fresh overnight LB agar plate was resuspended in 250 µl of sterile 
distilled water. The resuspended cells are then incubated at -800C for 20 min and then 
immediately boiled for 10 min. The cell debris was separated from the nucleic acids by 
centrifugation at 10000 rpm for 45 seconds. The nucleic acids in the supernatant was 
transferred to a sterile Eppendorf for further use.  
B. Polymerase chain reaction: 
The PCR was run with total DNA isolated and universal primers (Lane et al., 1991) 
used for the amplification of a (~) 1.5 kb conserved region of 16s rRNA gene. The PCR 
was performed with a 25 µl reaction mixture containing 2.5 µl of 13 µM forward 
(Rib73) and reverse (Rib74) primers each, 12.5 µl 2x Thermo fisher PCR master Mix, 
5 µl of molecular water and 2.5 µl of isolated total DNA. The PCR cycle consisted of 
one 5 min step of denaturation (at 950C), which was followed by 35 cycles involving 
denaturation for five min (at 950C), annealing for one min (at 500C) and polymerization 
of one and half minutes (at 720C) (Awad et al., 2007, Punina et al., 2013).  
C. Electrophoresis and gel purification of DNA: 
The PCR products were loaded on 1.2% agarose gel (prepared as discussed in section 
3.2.3). The gel was run for 30 min at 25 V and at 50V for one hour. The gel was 
observed and imaged under the UV light. The bands of interest were cut from the gel. 
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The desired PCR product of about 1.5 kb was purified from the gel using a gel 
purification kit from Qiagen, Germany. The eluted PCR product was used for DNA 
sequencing.  
D. DNA sequencing and phylogenetic studies: 
PCR amplified products were sequenced with 3700 DNA sequencer and Taq 
DyeDeoxy Terminator cycle sequencing kit (Elleuch et al., 2015). PCR amplified 
products were sequenced with 3700 DNA sequencer and Taq DyeDeoxy Terminator 
cycle sequencing kit (Elleuch et al., 2015).  Tree viewer program was used to form a 
dendrogram based on the sequences (Thompson et al., 1997; Felsenstein, 1993; Elleuch 
et al., 2015). 
3.2.3 Study of insecticidal activity 
3.2.3.1. Qualitative insecticidal bioassay 
The 19 Bti strains and the 14 Non-Bti like strains were tested for their insecticidal 
activity along with Bti H14 strain as positive control and a crystalliferous Bti 4Q7 strain 
as negative control. 
A. Insect rearing: 
For the qualitative study, the eggs of Culex pipiens complex were collected locally in 
water with organic matter stored outdoors. The eggs collected were then transferred to 
distilled water and allowed to transform to larval stages till 3rd instar. The 3rd instar 
larvae were then used for the bioassay.  
B. Isolation and purification of spore-crystal mixture: 
The Bt strains were inoculated on LB plates and incubated overnight at 300C. Single 
isolated colony from each agar plate was transferred to a pre-culture of 3 ml LB broth 
and incubated overnight at 300C with 150 rpm. After 16 hours, 500 µl of preculture was 
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transferred to a second pre-culture of 50 ml LB broth and incubated overnight at the 
same conditions as above. The O D of the second preculture was taken at 600 nm of the 
light spectrometer. Accordingly, the amount of pre-culture to be added to sporulation 
media was calculated such that the sporulation media starts at an O D of 0.1. The 
sporulation culture was incubated at the same conditions as above for 96 hours, until 
complete sporulation. The spore-crystal mixture was obtained by centrifugation. The 
pellet of spores, crystal and cell debris was washed thrice with sterile cold 1 M NaCl 
solution and thrice with sterile cold distilled water. The washed pellets were 
resuspended in 10 ml cold sterile distilled water. This purified spore-crystal mixture 
was then used for qualitative bioassay.  
C. Experimental design of the insecticidal bioassay: 
For each of the Bt strains tested, three 50 ml centrifuge tubes were filled with 10 ml 
water and five 3rd instar larvae. From the resuspended spore-crystal mixture, 500 µl was 
added to each of the centrifuge tubes. The test tubes were incubated at 260C with 12:12 
light and dark photoperiod. As negative control, three replicates were left untreated. 
After 24 hours, the number of live and dead larvae were counted for each of the strains 
(WHO, 2005; Tetreau et al., 2013).   
3.2.3.2. Quantitative insecticidal bioassay 
The 19 Bti strains were tested for their insecticidal activity along with Bti H14 strain as 
positive control and a crystalliferous Bti 4Q7 strain as negative control. 
A. Insect rearing: 
In this study, the Dipteran insect Aedes aegypti Bora Bora was used for the insecticidal 
bioassay. The eggs of A aegypti were obtained from Laboratoire de Lutte contre les 
Insectes Nuisibles (LIN), Montpellier, France on filter papers. These eggs were then 
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transferred to water and allowed to develop into 3rd instar larvae by incubation at 260C 
(± 2) with a 12:12 hours light & dark photoperiod.  
B. Isolation and purification of spore-crystal mixture: 
The procedure was as mentioned in section 3.2.3.1.B 
C. Quantification of protein content: 
Protein concentration of spore-crystal mixture of each strain was estimated by 
Bradford’s method (Bradford, 1976). 100 µl of spore crystal mixture was incubated in 
sterile NaOH solution with the final concentration of 50 mM for 2 hours. Once the 
crystals were completely dissolved, the spores were separated from the solution by 
centrifugation. The solubilized protein for each sample was then used for calculating 
the optical density (O D) by spectrophotometer. The protein concentration was then 
extrapolated on a standard graph of O D versus protein concentration of Bovine serum 
albumin (BSA). The non-crystal producing strain 4Q7 was used as a control for all the 
proteins that could be present in the solution, other than the δ- endotoxins. The protein 
concentration obtained from 4Q7 was subtracted from the concentrations of all strains 
to obtain the actual δ- endotoxin protein concentrations for each strain.  
D. Experimental design of insecticidal bioassay: 
The quantitative bioassays were performed by the standard protocols of WHO (WHO, 
2005). The 3rd instar larvae were added to 100 ml water in plastic cups. Each 
concentration was triplicated, and the larvae were exposed to the spore-crystal mixture 
at 27 (± 2) oC with 12:12 light and dark photoperiod. As negative control, three 
replicates were left untreated. The number of dead and live larvae were counted after 
24 hours. The bioassay was first performed with different concentrations of δ- 
endotoxins from reference H14 and 4Q7. The probable LC50 concentration for H14 
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strain was estimated. The 19 Bti strains were tested at this concentration to investigate 
their efficiency against Aedes larvae. The Bti strains were then grouped into three 
classes based on the following categories: efficiency lower than H14, efficiency 
resembling H14 and efficiency higher than H14. The third group with higher efficiency 
were tested for more concentrations to calculate their actual LC50 values.  
E. Statistical analysis: 
The values from Bioassay were used to calculate the LC50 values of each Bt strain tested 
along with H14 using Probit analysis software. The 95% fiducial limit range was also 
calculated for each. This range was used to draw graphs to compare the efficiency of 
local strains with each other and the reference.  
3.2.3.3. Histological studies 
After performing the bioassay, the live and dead larvae were collected separately and 
observed under the light microscope by wet mounting to understand the probable cause 
of death (Knaak & Fiuza, 2005). The live larvae from the negative control were also 
checked under the microscope.  
3.2.4. Exploration of insecticidal proteins in Bti strains  
3.2.4.1. Identification of insecticidal protein genes and helper genes by PCR  
A. Plasmid isolation: 
The total plasmid DNA from each of the 19 Bti isolates was obtained by alkaline lysis 
and alcohol precipitation method. A pure isolated colony was spread on a fresh LB agar 
plate and incubated overnight at 300C. The cells were harvested from 1/4th part of the 
plate into 1 ml distilled water. The cells were then separated by centrifugation at 5000 
rpm for 3 min. The pellet was resuspended in Solution AL containing Tris-HCl, 
Glucose, EDTA-Na2 and 4 mg/ml lysozyme (added just before use). The mixture was 
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then incubated at 370C for half hour so that lysozyme can lyse the cell membrane. 
Solution B containing potassium acetate and glacial acetic acid is added and the samples 
are transferred to ice. A freshly prepared alkaline solution C containing NaOH and SDS 
was added to the samples before incubating them back on ice for 5 min. After separating 
the cell debris by centrifugation, the supernatant containing nucleic acids and some 
proteins was added to an equal volume of phenol:chloroform:isoamyl alcohol (25:24:1) 
solution. This separates the proteins from the desired nucleic acids. After 
centrifugation, the upper phase containing the nucleic acids was transferred to 2.5 V 
absolute ethanol and incubated at -200C overnight. After precipitating by ethanol, the 
nucleic acids were washed with 70% ethanol to remove any salts. The pure nucleic 
acids were then treated with RNase to remove the RNA molecules from the plasmids. 
The pellets containing pure plasmids were re-suspended in Tris-EDTA solution of 8 pH 
and stored at -200C (Faguntes et al., 2011; Sambrook et al., 1989).  
B. Polymerase chain reaction: 
The PCR was run with plasmid DNA isolated. The primers used for the detection of 
each of the genes encoding insecticidal proteins and helper proteins were either adopted 
from published articles or designed specifically for this study. The list of primers and 
the associated details are given in the table 2. The PCR was performed with a 25 µl 
reaction mixture containing 2.5 µl of 13 µM forward and reverse primers each, 12.5 µl 
2x Thermo fisher PCR master Mix, 5 µl of molecular water and 2.5 µl of isolated total 
DNA. The PCR cycle consisted of one 5 min step of denaturation (at 950C), which was 
followed by 35 cycles involving denaturation for five min (at 950C), annealing for time 
depending on expected PCR product (at temperatures appropriate for each primer set) 
and polymerization of one and half minutes (at 720C) (Awad et al., 2007, Punina et al., 
2013). All PCRs were performed with Bti H14 as positive control for Bti genes and Bti 
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4Q7 as negative control for Bti genes. Btk HD1 was used as positive control for Btk 
genes and negative control for Bti genes.  
C. Electrophoresis and gel imaging: 
The PCR products were loaded on 1.2% agarose gel (prepared as discussed in section 
3.2.3). Every gel had one kb plus ladder in the first well. The gel was run for 30 min at 
25 V and at 50V for one hour. The gel was observed and imaged under the UV light. 
3.2.4.2. Exploration of insecticidal proteins in Non-Bti representatives 
A. Plasmid isolation: 
The total plasmid DNA from each of the 14 Non Bti representative isolates was 
obtained by alkaline lysis and alcohol precipitation method. A pure isolated colony was 
spread on a fresh LB agar plate and incubated overnight at 300C. The cells were 
harvested from 1/4th part of the plate into 1 ml distilled water. The cells were then 
separated by centrifugation at 5000 rpm for 3 min. The pellet was resuspended in 
Solution AL containing Tris-HCl, Glucose, EDTA-Na2 and 4 mg/ml lysozyme (added 
just before use). The mixture was then incubated at 370C for half hour so that lysozyme 
can lyse the cell membrane. Solution B containing potassium acetate and glacial acetic 
acid is added and the samples are transferred to ice. A freshly prepared alkaline solution 
C containing NaOH and SDS was added to the samples before incubating them back 
on ice for 5 min. After separating the cell debris by centrifugation, the supernatant 
containing nucleic acids and some proteins was added to an equal volume of 
phenol:chloroform:isoamyl alcohol (25:24:1) solution. This separates the proteins from 
the desired nucleic acids. After centrifugation, the upper phase containing the nucleic 
acids was transferred to 2.5 V absolute ethanol and incubated at -200C overnight. After 
precipitating by ethanol, the nucleic acids were washed with 70% ethanol to remove 
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any salts. The pure nucleic acids were then treated with RNase to remove the RNA 
molecules from the plasmids. The pellets containing pure plasmids were re-suspended 
in Tris-EDTA solution of 8 pH and stored at -200C (Faguntes et al., 2011; Sambrook et 
al., 1989).  
B. Polymerase chain reaction: 
The PCR was run with plasmid DNA isolated for all 14 Non Bti representative isolates. 
The primers used for the detection of each of the genes encoding insecticidal proteins 
and helper proteins were either adopted from published articles or designed specifically 
for this study. The list of primers and the associated details are given in the table 2. The 
PCR was performed with a 25 µl reaction mixture containing 2.5 µl of 13 µM forward 
and reverse primers each, 12.5 µl 2x Thermo fisher PCR master Mix, 5 µl of molecular 
water and 2.5 µl of isolated total DNA. The PCR cycle consisted of one 5 min step of 
denaturation (at 950C), which was followed by 35 cycles involving denaturation for five 
min (at 950C), annealing for time depending on expected PCR product (at temperatures 
appropriate for each primer set) and polymerization of one and half minutes (at 720C) 
(Awad et al., 2007, Punina et al., 2013). All PCRs were performed with Bti H14 as 
positive control for Bti genes and Bti 4Q7 as negative control for Bti genes. Btk HD1 
was used as positive control for Btk genes and negative control for Bti genes.  
C. Electrophoresis and gel imaging: 
The PCR products were loaded on 1.2% agarose gel (prepared as discussed in section 
3.2.3). Every gel had one kb plus ladder in the first well. The gel was run for 30 min at 
25 V and at 50V for one hour. The gel was observed and imaged under the UV light. 
 
 
  
81 
 
D. Sequencing of novel genes: 
The novel genes were amplified and purified from the gel using techniques discussed 
in section 3.2.4. Full δ- endotoxin genes amplified using PCR were sequenced by 
Sanger sequencing. The gene sequences were then compared to the other similar δ- 
endotoxin protein gene sequences on the NCBI database.  
3.2.4.3. Protein profiling to identify insecticidal proteins 
A. Purification of crystal proteins: 
The Bt strains were inoculated on LB plates and incubated overnight at 300C. Single 
isolated colony from each agar plate was transferred to a pre-culture of 3 ml LB broth 
and incubated overnight at 300C with 150 rpm. After 16 hours, 500 ul of preculture was 
transferred to a second pre-culture of 50 ml LB broth and incubated overnight at the 
same conditions as above. After 16 hours, 1 ml of this pre-culture was added to 49 ml 
of T3 sporulation broth. The sporulation culture was incubated at the same conditions 
as above for 96 hours, until complete sporulation. The spore-crystal mixture was 
obtained by centrifugation. The pellet of spores, crystal and cell debris was washed 
thrive with sterile cold 1 M NaCl solution and thrice with sterile cold distilled water. 
The washed pellets were resuspended in 10 ml cold sterile 50 mM Na2CO3 to solubilize 
the crystal proteins. After complete solubilization, the spores were removed by 
centrifugation at 10,000 rpm for 10 minutes.  
B. Trypsin activation: 
The proteins were digested as per the protocol described by Huang et al. (2012), with 
slight modifications. The total proteins were reduced to 3 µg/µl by added 1 µl of 1 M 
DTT and incubating at 370C for two and half hours. The solution was alkylated by 5 µl 
of 1 M iodoactamide and incubating at room temperature in dark for 40 minutes. The 
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proteins were then precipitated using six volumes of cold acetonitrile-Acetone-Acetic 
acid in the ratio of 50:50:0.1 (V/V/V). The precipitation process took 12 hours. The 
pellets obtained were washed thrice with cold 100% alcohol and resuspended in 50 mM 
NH4HCO3 along with trypsin in the ratio trypsin:protein of 1:100 (Wt/Wt). After four 
hours of incubation in a shaker, trypsin was added again in the ration trypsin:protein of 
1:50. This activation process was continued overnight. Formic acid was then added the 
next day to quench trypsin activity. The entire mixture was then filtered to remove 
unwanted larger molecules. Then the filtrate was lyophilized. Each sample was 
triplicated.  
C. Protein profiling: 
Mass spectrometry for the samples were performed using LTQ XL Mass spectrometer 
couple to nano-ionization source and an autosampler. To trap the peptides, two parallel 
enrichment columns were used. A total of 50 µg sample was introduced into the SCX 
colum on the HPLC system. A reverse column was also applied in the HPLC system. 
A series of increasing concentrations of NH4HCO3 solutions were used for the first 
dimension of separation in Liquid chromatography. These solutions eluted the 
remaining peptides in a gradual manner from SCX column. Once the peptides were 
trapped and desalted completely using the exchanged enrichment columns, secondary 
separation commenced using RP column. The peptides that eluted from RP column then 
moved to MS online. The buffers used were Elution buffer A containing 0.1% FA in 
molecular water and Elution buffer B containing 1% FA in acetonitrile. The elution 
buffers used in the first 5 minutes contained 98% A and 2% B, followed by only 40% 
of B for 45 minutes, followed by 90% B for 30 minutes and going back to 98% A and 
2% B for last 20 minutes. The data collected during the scan used a full range of 300 to 
2000 m/z. This was followed by a positive mode of MS/MS analysis and intervening 
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scans of the strongest ions from the earlier scan.  
D. Data analysis: 
The raw files were checked against the databases downloaded from UniProt Protein 
Knowledgebase (https://www.uniprot.org/; accessed on 19th January 2019) in the form 
of FASTA files. The software Spectrum Mill was used to check and analyse the data. 
For the search parameter: the mass tolerance was set to 1.5 Da and the fragmentations 
ions were set at 1.0 Da; only y and b fragments were used; The target false discovery 
rate was adjusted to 1% by using a target and decoy database. When three or more 
unique peptides were recognized, the protein was “identified”.  
3.2.5. Evaluation of cytolytic activities 
3.2.5.1. Evaluation of haemolytic activity 
A. Sample preparation: 
The 19 Bti strains and 14 Non-Bti representatives were inoculated on a fresh LB plates 
and incubated overnight at 300C. the well isolated colony from each strain was picked 
by a sterile toothpick and was used as sample for haemolytic assay.  
B. Media composition: 
Blood agar was used for this assay. Nutrient rich LB agar was prepared as discussed 
before. The temperature of the melted agar medium was maintained at around 500C. To 
this media, fresh human blood water added to get a final 5% blood in the media. The 
Blood agar was then poured in petri plates and allowed to solidify for use.  
C. Experimental design: 
The Blood agar plates were divided into grids and each box was assigned to a single 
strain. The strains were transferred from the fresh LB plate to Blood agar plate using 
sterile toothpick. Once inoculated, the blood agar plates were incubated at 300C 
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overnight. The next day, the plates were checked for zone of clearance around the Bt 
strain colonies.  
3.2.5.2. Evaluation of anticancer activity 
A. Isolation and activation of protein: 
The proteins were isolated using the same protocol discussed in the section 3.5.2. The 
proteins were activated using 15µg/µl Trypsin by adding 15 µl to 500 µl of purified and 
solubilized crystal proteins (Vilchez et al., 2004).  The activation procedure was done 
after quantifying the protein content as discussed below.  
B. Quantification of proteins: 
Protein concentration of each strain was estimated by Bradford’s method (Bradford, 
1976). The solubilized protein for each sample was used for calculating the optical 
density (O D) by spectrophotometer. The protein concentration was then extrapolated 
on a standard graph of O D versus protein concentration of Bovine serum albumin 
(BSA). 
C. Cell lines and experimental conditions: 
For the cytolytic assay, NCIH1975 [H1975, H1975] (ATCC® CRL5908™) was used; 
which is an adherent lung epithelial cancer cell line. The cell lines were obtained from 
ATCC in RPMI-1640 medium. The cells were maintained in the same media 
supplemented with 10% Fetal Bovine serum (FBS), 100 µg/ml of Streptomycin and 
100 IU/ml of Penicillin. The cells were grown and maintained at 370C with 5% 
humidity in a CO2 incubator. The experiments were also conducted in the same media 
and conditions.  
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D. Experimental design: 
The cytotoxicity assay was performed by the MTT protocol, also called as cell 
proliferation assay (Heiss et al, 1997). 5000 cells were added to each of the 96 wells of 
microtiter plate. The cells were allowed to attach overnight and then the media was 
replaced with fresh media containing appropriate concentrations of Bt crystal proteins.  
The Bt crystal proteins from each strain was diluted to get three different 
concentrations: 0.15 µg/ml, 0.35 µg/ml and 0.5 µg/ml. Along with these a 0.0 µg/ml 
concentration (untreated) was also used for each strain. Each of these concentrations 
were triplicated. And each concentration was tested for 24 hrs, 48 hrs and 72 hrs.  
After the treatment, 100 µl MTT reagent was added to each well and incubated again 
for three hours. Then 20 µl of DMSO reagent was added to each well and incubated for 
20 minutes. The purple formazan dye formed and solubilized in DMSO was quantified 
using spectrophotometer (Correa et al., 2012).   
E. Statistical analysis: 
The viability was estimated by comparing the O D of the untreated wells to that of the 
treated wells (Correa et al., 2012). The three readings were considered for each 
concentration and the standard errors and deviations were calculated using MS excel.  
3.2.5.3. Investigation of anticancer Parasporin protein genes  
The strains showing anticancer activity were tested for the presence of Parasporin 
protein genes. The plasmid DNA was isolated by alkaline lysis and alcohol precipitation 
method. The PCR amplifications were performed using the primers listed below in table 
2. The presence of all six families of Parasporins were checked.  
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3.2.5.4. Investigation of novel Cyt protein 
The Bti strain showing the highest activity was investigated further on molecular level 
by comparing its Cyt protein with that of the reference H14.  
A. Amplification and sequencing of cyt1A gene: 
The whole cyt1A gene was amplified by PCR as discussed in section 3.4.1. The whole 
gene was sequenced by Sangers sequencing method. The gene sequence was compared 
to the cyt1A gene of Bti H14, as available on the NCBI database.  
B. Prediction of amino acid sequence: 
The gene sequence was translated into amino acid sequence using the ExPasy tool 
provided by the website of Swiss Institute of Bioinformatics.  The amino acid sequence 
of Cyt1A protein of Qatari Bti was compared to the amino acid sequence of the Cyt1A 
protein of reference H14, as available on NCBI database.  
C. Protein modelling and structural homology studies: 
To understand the consequences of differences of amino acids between the local Bti 
and reference Bti, the amino acid sequences were used to model the protein. The 
software used for the same was SWISS-MODEL. The structures deduced from the 
software were checked for differences in conformation. SWISS-MODEL was also used 
to check the changes in the polarity and charges due to changes in amino acids.  
3.2.6. Evaluation of protein production capacity 
The four strains, showing higher insecticidal activity than the reference, were analysed 
for their protein production capacity.  
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3.2.6.1. Study of protein production using glucose-based media 
A. Media composition and culture conditions: 
The protein production was tested in a new sporulation medium called Glucose based 
medium as it is known to increase the level of crystal protein production. The glucose-
based medium composition was as mentioned in Materials section 3.1. The glucose, 
glycerol and calcium carbonate were autoclaved separately and added to autoclaved 
media later. The four strains along with the references H14 and 4Q7 were inoculated 
on LB plates and incubated overnight at 300C. Single isolated colony from each agar 
plate was transferred to a pre-culture of 3 ml LB broth and incubated overnight at 300C 
with 150 rpm. After 16 hours, 500 ul of preculture was transferred to a second pre-
culture of 50 ml LB broth in 500 ml Erlenmayer’s flask and incubated overnight at the 
same conditions as above. The O D of the second preculture was taken at 600 nm of the 
light spectrometer. Accordingly, the amount of pre-culture to be added to sporulation 
media (50 ml in 500 ml Erlenmayer’s flask) was calculated such that the sporulation 
media starts at an O D of 0.1. The sporulation culture was incubated at the same 
conditions as above for 120 hours, until complete sporulation. 1 ml of completely 
sporulated culture was transferred to four eppendorfs, each. One tube was used for 
estimation of cell biomass and the remaining three were used for estimation of protein 
production per ml (Ghribi et al., 2007). 
B. Estimation of protein production: 
The three eppendorfs with sporulated culture was centrifuged at 10000 rpm for 10 min 
to obtain the pellet of spore-crystal mixture. The pellet was washed thrice with sterile 
cold 1 M NaCl and thrice with sterile cold distilled water. The washed pellet was then 
resuspended in 1 ml of 50 mM NaOH incubated at room temperature for 2 hours till the 
crystals are completely solubilized. Once the crystals were completely dissolved, the 
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spores were separated from the solution by centrifugation. The solubilized protein for 
each sample was then used for calculating the optical density (O D) by 
spectrophotometer. The protein concentration was then extrapolated on a standard 
graph of O D versus protein concentration of Bovine serum albumin (BSA). 
C. Estimation of cell biomass: 
One remaining Eppendorf from above was used for the estimation of cell biomass by 
serial dilution and cfu count method. The culture was serially diluted till 10-7. The last 
four dilutions were used for the cfu count. 100 µl from each dilution was spread on LB 
agar plate and incubated at 300C overnight. Each dilution was also triplicated. The 
colony forming units were counted for each plate after 16 hours of incubation.  
D. Estimation of protein yield: 
The protein yield per spore was calculated by dividing the protein production values by 
the cell biomass values for each strain. To obtain the real value of δ- endotoxins 
produced by each spore, the value obtained for the reference 4Q7 was subtracted from 
them. This ensured that the readings due to other spore associated proteins were 
removed and the values represented the true concentration of δ- endotoxin proteins.  
E. Statistical analysis: 
All the tests were replicated thrice, and the values were used to calculate the standard 
error. Histograms were drawn using Tree viewer software for each to compare the 
protein yield of the local strains and that of the reference H14.  
3.2.6.2. Study of protein production using soya meal starch based media 
A. Media composition and culture conditions: 
The protein production was tested in an alternative sporulation media called Soya bean 
and starch-based media as it has cheaper and complex sources of carbon and nitrogen. 
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The Soya bean and starch-based media composition was as mentioned in Materials 
section 3.1. The four strains along with the references H14 and 4Q7 were inoculated on 
LB plates and incubated overnight at 300C. Single isolated colony from each agar plate 
was transferred to a pre-culture of 3 ml LB broth and incubated overnight at 300C with 
150 rpm. After 16 hours, 500 ul of preculture was transferred to a second pre-culture of 
50 ml LB broth and incubated overnight at the same conditions as above. The O D of 
the second preculture was taken at 600 nm of the light spectrometer. Accordingly, the 
amount of pre-culture to be added to sporulation media was calculated such that the 
sporulation media starts at an O D of 0.1. The sporulation culture was incubated at the 
same conditions as above for 120 hours, until complete sporulation. 1 ml of completely 
sporulated culture was transferred to four eppendorfs, each. One tube was used for 
estimation of cell biomass and the remaining three were used for estimation of protein 
production per ml. 
B. Estimation of protein production per millilitre: 
As discussed in section 3.8.1 
C. Estimation of cell biomass: 
 As discussed in section 3.8.1 
D. Estimation of protein yield per spore: 
As discussed in section 3.8.1 
E. Statistical analysis: 
As discussed in section 3.8.1.  
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3.2.7. Investigation of plasmid structural stability 
3.2.7.1. Study of possible deletion of plasmid in Bti strains by mapping 
A. Designing overlapping primers: 
Published pBtoxis plasmid sequence was used to design the primers that can amplify 
regions that overlap each other along the plasmid. The region under study extended 
from cry4 gene to cyt1C gene. The primers studied are listed in Table 2. The reference 
strain H14 was also tested along with the 19 local Bti strains.  
B. Polymerase chain reactions: 
The PCR cycles were run as per the conditions mentioned in section 3.2.4. Different 
combinations of forward and reverse primers were used, and amplifications of various 
regions were carried out. This was necessary to find exactly which part of the plasmid 
was missing.  
C. Gel electrophoresis and mapping: 
The PCR products were run on a 1.2% agarose gel stained with Ethidium bromide and 
imaged under Ultra violet light. The mapping was done by analysing the PCR product 
obtained using each set of primers and “walking” through the region of interest on the 
pBtoxis plasmid (Figure 7).  
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Figure 8. A representation of the section of pBtoxis plasmid that was studied. The 
position of each primer designed and the expected PCR products are represented by 
arrows and dotted lines, respectively. 
 
 
3.2.7.2. Study of effect of plasmid curing on protein production capacity 
A. Plasmid curing: 
The plasmid curing was performed with two local Bti strains QBT217 and QBT220. A 
single isolated colony of these two strains were inoculated in 2 ml of LB broth and 
incubated at 420C overnight at a rpm of 200. After 24 hours, 100 µl of this culture was 
transferred to 2 ml of fresh LB broth. These steps were continued for 7 days.  
B. Isolation of new clones: 
On the 8th day, the culture was serially diluted till 10-5 and the last dilution was spread 
on LB agar plates. After overnight incubation of these plates at 300C, each of the 
colonies obtained were transferred to a separate LB agar plate. These were considered 
the new clones of the original Bti strains.  
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C. Investigation of retaining pBtoxis after curing by PCR: 
Each clone was tested for the presence of pBtoxis plasmid by amplifying the cry4 gene 
by PCR and running gels to check the results. The clones that gave positive expected 
PCR products for this amplification were considered for protein production 
experiments.  
D. Evaluating the change in protein production capacity: 
The protein production experiments were performed with clones of interest using the 
methodology discussed in section 3.8.1. The controls used in the experiments were Bti 
H14, 4Q7, original QBT217, original QBT220, acrystalliferous clones of QBT217 and 
QBT220 obtained by plasmid curing. The change in protein production was calculated 
by comparing the production capacities of original Bti strains and the newly obtained 
clones. 
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CHAPTER 4.1 RESULTS: CHARACTERIZATION OF QATARI BT STRAINS 
PRODUCING SPHERICAL CRYSTALS 
4.1.1. Introduction 
In this PhD project, 441 Bt strains producing spherical crystals were explored. The first 
part of the characterization included morphological studies of the parasporal crystals 
produced by the Bacillus thuringiensis israelensis (Bti) strains. This was performed 
using three approaches: Wet mounting to ensure the crystal shape, Endospore staining 
to differentiate between crystals and spores and scanning electron microscopy at higher 
magnification to identify the different morphologies observed among the strains 
producing spherical crystals. Once the different crystal morphologies of the parasporal 
crystals were identified, the crystal proteins were analysed by SDS-PAGE. The 
different protein sizes observed were used to group the strains with similar crystal 
content into classes. Similarly, the plasmid DNA was isolated from each strain and the 
plasmid patterns were also used to group the strains into classes with similar plasmid 
patterns. This is a novel approach of characterization of such big collections of Bt. 
Instead of relying on one category to characterize the Bt strains, all three categories 
mentioned above were taken into consideration to achieve an efficient classification 
system. This efficiency of classification ensures that the representatives taken from 
each class would truly represent the whole. A true representative will be a good 
candidate to investigate at molecular levels as done in next chapters. All the Bacillus 
thuringiensis israelensis (Bti) strains and one representative from each class of Non Bti 
spherical crystal producing strains were hence selected and used for other studies 
described in the next chapters. The strains that showed interesting results were used for 
ribotyping and phylogenetic studies. We have published parts of the results from this 
chapter as an original article in Frontiers in Microbiology journal: Nair et al., 2018 (b). 
Article is attached as Appendix B.  
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4.1.2. Results 
A. Evaluation of morphology of parasporal crystals 
Wet mounting 
Wet mounting was performed for all 441 strains to ensure that the strains analysed are 
producing spherical crystals. As reference, Bti strain H14 was used alongside. The 
strains when observed after 48 hours of culturing in sporulation medium, showed spores 
and crystals still encapsulated in vegetative cells. After 72 hours, the cultures showed 
spores and crystals released and absence of any vegetative cells (complete sporulation). 
A completely sporulated culture of each strain was mounted on a slide with a drop of 
water and observed under oil immersion lens of the light microscope with a coverslip. 
The elliptical shaped spores and spherical crystals could be seen under the microscope 
(figure 9). Compared to the reference, Non-Bti strains showed the presence of larger 
crystals (figure 9c). To ensure that the spherical structures are protein crystals and the 
elliptical structures are spores, the endospore staining was performed.  
 
 
 
Figure 9.  Microscopical images of spores and crystals observed under light microscope 
[(a): spores and crystals of reference strain Bti H14; (b): spores and crystals of QBT225 
(resembled that of reference); (c): spores and crystals of QBT446 (with larger crystals); 
s: elliptical spore; c: spherical crystal] 
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Endospore staining 
Endospore staining was performed for the Bt strains to confirm that the elliptical 
structures were spores and the spherical structures were protein crystals. The malachite 
green dye under steam used for endospore staining gave the spores and crystals, a green 
colour. And the destaining step removed the green colour from crystals while the 
malachite green got trapped under the spore; allowing the spore only to retain the green 
colour. A counter stain of safranin coloured the crystals pink while the endospores 
green (figure 10). It was clear once again that the Non-Bti strain had crystals that were 
larger and not exactly smooth and round (figure 10c). To understand the different 
morphologies, it was essential to check the crystals at higher magnification.  
 
 
 
Figure 10. Microscopical images of spores and crystals of Bt strains stained with 
endospore staining technique 
[(a): spores and crystals of QBT446 (with larger crystals); (b): spores and crystals of 
reference strain Bti H14; (c): spores and crystals of QBT225 (resembled that of 
reference); s: elliptical spore; c: spherical crystal] 
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Scanning Electron Microscopy 
The Scanning Electron Microscopy (SEM) of the completely sporulated cultures of the 
Bt strains was performed by mounting the spore-crystal mixture on aluminium stubs 
and coating it with gold. The surface and shape of the spores and crystals could be seen 
in the two-dimensional pictures taken on the SEM. Among the 441 strains, five different 
morphologies were observed: smooth spherical (figure 11b), spherical with undulated 
surface (figure 11c), spherical but deflated balloon (figure 11d), spherical concave 
(figure 11e) and spherical pointy edged (figure 11f). The smooth spherical crystals were 
observed for 19 Bt strains and they resembled that of the reference strain H14. Bt strains 
producing spherical crystals with undulated surface were the maximum among the 
collection of Bt (table 4). The rare morphologies observed were the ones with spherical 
concave and spherical with pointy edge. Only two strains showed the presence of 
crystals with each of these two morphologies (table 4).  
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Figure 11. Crystal morphologies observed among the Bt strains studied (Nair et al., 
2018b) 
[Scanning electron microscopy images of the crystal morphologies; S: spores; ss: 
smooth spherical; us: spherical undulated; cs: spherical concave; db: spherical deflated 
balloon; pe: spherical pointy edged] 
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Table 4. Distribution of Bt strains based on parasporal crystal morphologies (Nair et 
al., 2018b) 
Crystal morphologies Number of Bt strains 
Smooth spherical 19 
Spherical undulated  326 
Spherical deflated balloon 92 
Spherical concave 2 
Spherical pointy edged 2 
Total strains 441 
 
 
B. Analysis of protein patterns of parasporal crystal proteins 
The parasporal crystal proteins from each Bt strain were solubilized and run on SDS-
PAGE gels to separate the different δ- endotoxins based on their sizes. Based on the 
content of crystals and the type of patterns formed as per the different sized proteins, 
the strains were grouped into classes. Among the 441 Bt strains studied, 15 different 
protein patterns were seen (figure 12). They were named Prot1 to Prot15. Prot1 
consisted of 19 Bt strains that had similar protein patterns like the reference H14. The 
19 strains were considered as Bti strains. The main protein sizes seen in this Bti pattern 
included 130 kD, 65 kD, 45 kD and 27 kD. The different protein sizes forming the 
remaining 14 patterns are listed in the table 5. The Prot10 pattern was seen the most 
among the Bt strains analysed. Prot14 and Prot15 patterns were the rarest; seen among 
only two strains each. The distribution of different protein patterns seen among the 441 
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strains tested are listed in the table 5.  
 
 
 
Figure 12. Crystal protein patterns observed among the Bt strains analysed in the study 
(Nair et al, 2018b) 
[M: broad range protein marker; H14: the crystal protein pattern for reference strains 
H14; Lanes 1 to 15: crystal protein patterns Prot1 to Prot15] 
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Table 5. Distribution of Bt strains based on its δ- endotoxin content of the parasporal 
crystals  
Protein pattern Number of Bt strains Protein sizes (kD) 
Prot1 19 130, 65, 45, 27 
Prot2 4 130, 90, 75, 65, 50, 40, 25 
Prot3 7 100, 65, 40 
Prot4 19 180, 140, 90, 80, 60, 45, 25 
Prot5 12 140, 90, 80, 60, 45, 25 
Prot6 10 130, 90, 60, 40, 22 
Prot7 48 100, 80, 60, 45, 40 
Prot8 16 80, 60, 45, 40, 35 
Prot9 9 150, 80, 60, 45, 40, 27 
Prot10 203 180, 150, 80, 60, 45, 40, 27 
Prot11 29 130, 90, 75, 55, 40, 27, 22 
Prot12 33 85, 65, 55, 45, 30, 27, 22 
Prot13 28 130, 100, 65, 45, 27, 22 
Prot14 2 65, 45, 35, 27 
Prot15 2 230, 150, 85, 70, 40, 27, 25 
Total strains 441  
 
 
C. Analysis of plasmid patterns of the Bt strains 
The plasmid samples for all the 441 strains were run. The different plasmids of each 
strains separated on the gel forming unique patterns. These patterns were used to group 
the strains with similar plasmid contents into one class. Among the Bt strains tested, six 
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patterns were observed (figure 13). They were named Plas1 to Plas6. Most common 
plasmid pattern observed among the Bt strains was Plas4 with 286 strains showing 
similar plasmid content. Plas5 was the rarest pattern seen, with only two strains showing 
this plasmid pattern (table 6). All the plasmid patterns observed and the number of 
strains showing these patterns are listed in table 6. The Plas1 pattern observed for 19 
strains resembled that of the reference H14. Hence, these 19 strains were considered as 
Bti strains.  
 
 
 
Figure 13. Plasmid patterns observed among the Bt strains analyzed 
[L: 1 kb plus linar DNA marker; H14: the plasmid pattern for the reference strains H14; 
Lanes 1 to 6: Plasmid patterns Plas1 to Plas6] 
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Table 6. Distribution of plasmid patterns observed among the Bt strains analyzed 
Plasmid patterns Number of Bt strains 
Plas1 19 
Plas2 7 
Plas3 33 
Plas4 286 
Plas5 2 
Plas6 94 
Total Bt strains 441 
 
 
D. Phylogenetic analysis of the Bt strains 
Analysis by sequencing and dendrogram study 
After characterizing the Bt strains based on their crystal morphology, δ- endotoxin 
content and plasmid patterns, phylogenetic studies were performed for a few strains for 
two reasons: confirming their identity as Bt and check their relationship with other Bt 
strains from the NCBI database. It was seen that the Non Bti strains also are very close 
to the references Bti and Bacillus thuringiensis kurstaki (Btk). But the dendrogram 
showed that the Non Bti strains are very close to other Bacillus species like anthracis 
and subtilis also. This is common as phylogenetically thuringiensis, anthracis, subtilis 
and cereus are very closely related (figure 14). The main characteristic that 
differentiates thuringiensis is the presence of parasporal crystals during sporulation. 
The Dendrogram confirmed that the Non-Bti strains do belong to the Bt group despite 
having different plasmid and protein patterns.  
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Figure 14. Dendrogram showing the phylogenetic relationship between the Qatari Bt 
strains and references  
[Nucleotide sequence of 1.5 kb region of the 16s rRNA gene from Qatari Non-Bti 
strains compared with that of reference strains from NCBI database; reference strains 
selected include Bt, Btk, cereus, subtilis and anthracis] 
 
 
Analysis by Amplified ribosomal DNA restriction analysis (ARDRA) 
A second method of phylogenetic analysis was performed using the ARDRA technique. 
The 16s rRNA gene was amplified and cut using a restriction enzyme Sau3A. The 
Sau3A restriction enzyme has a four-nucleotide target sequence: GATC. Small targets 
ensure that more fragments are formed when cut. For references, Bacillus cereus, 
Bacillus subtilis, Pseudomonas, Bacillus thuringiensis israelensis and Bacillus 
thuringiensis kurstaki. When the patterns were compared, it was clear that the Bti and 
Non Bti strains resembled that of the Bti and Btk and cereus (figure 15). It confirmed 
that despite the differences seen, the strains are Bt.  
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Figure 15. Patterns of DNA fragments formed by ARDRA 
[Ladder: 1 kb plus linear DNA marker; QBT3, QBT34, QBT35, QBT39, QBT41, 
QBT56, QBT96, QBT240, QBT320, QBT466, QBT555: Qatari Non Bti strains; 
QBT608: Qatari Bti strain] 
 
 
4.1.3. Discussion 
Isolation and characterization of Bt strains was done for the first time in Qatar and a 
huge collection of diverse Bt strains has formed a part of this study. Huge collections 
like this needs an efficient system of characterization as it is not possible to analyse 
each of the 700 Bt strains from Qatar for every property. Hence, it is necessary to 
classify the collection into groups that can be truly represented by a representative 
strain. The goal of this PhD work was to identify Bt strains with insecticidal activity 
towards Dipteran insects, and it is known that Bt strains with spherical parasporal 
crystals are normally insecticidal to Dipteran insects. Hence, this study focused on 441 
Bt strains that showed the production of spherical crystals during sporulation. A 
collection of 441 Bt strains with spherical crystals is still huge when the objectives of 
this project included many detailed molecular analyses. Hence, it was essential to 
classify the collection further into groups and choose true representatives for the 
molecular analyses. Crystal morphologies and plasmid patterns are usually used for 
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classification, but the protein pattern of the parasporal δ- endotoxins were included in 
this objective to see the actual variety among the collection. The classification based on 
crystal morphology only divided the collection into five groups (table 4) and that for 
the plasmid patterns divided the collection into six groups (table 6). On the other hand, 
when the protein patterns were considered, the collection was divided into 15 groups 
(table 5). A representative was chosen from each of these 15 groups considering the 
crystal morphology and the plasmid patterns also. The classification has been 
summarized in the table 7. 
The first group of strains represented by QBT229 had one crystal morphology with 
smooth spherical shape (figure 11b) and one plasmid pattern Plas1 (figure 12) and all 
had one protein pattern Prot1 (figure 13). These characteristics resemble that of the 
reference Bti strain H14. It was concluded that these 19 strains are Qatari Bti strains. 
The second crystal morphology observed was spherical crystal with undulated surface. 
This is the most common morphology found. This group of strains have three different 
plasmid patterns among them and seven different protein patterns among them. The 
third type of crystal morphology observed was deflated balloon shaped. This group of 
strains had just one plasmid pattern but five protein patterns among them. The fourth 
type of crystal morphology observed was the spherical with one concave face. This type 
of strains had one protein pattern and one plasmid pattern among them. The last type 
of crystal morphology observed was the pointy edged crystals. Like the last group, these 
strains also displayed just one protein and one plasmid pattern among them. It is 
interesting to note that Plas6 plasmid pattern was seen among two strains with two 
different crystal shapes: spherical deflated balloon and spherical concave. This proves 
that the plasmid pattern, which is usually considered a representative of the crystal 
morphology, is not always so. Once again, it justifies the use of protein pattern for the 
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right classification of huge collections of Bt.  
Some of the Non-Bti strains were used for amplifying the 1.5 kb region of their 16s 
rRNA gene. The sequence, of which, was compared with that of the references. Despite 
the novel plasmid patterns and crystal morphologies observed, the collection of Bt 
strains producing the spherical crystals truly belong to the parent group of Bacillus 
cereus. The crystals they produce during the sporulation stage distinguishes them as 
thuringiensis from the other species like anthracis, subtilis and cereus.  
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Table 7. Summary of the classification & distribution of Qatari Bt strains producing 
spherical crystals 
[Family representatives and their respective plasmid patterns, protein patterns and 
crystal morphology has been listed; Plas1 to Plas6 plasmid patterns are shown in figure 
13; Prot1 to Prot15 protein patterns are shown in figure 12; the SEM images of the 
crystal morphologies mentioned are shown in figure 11] 
Family 
representative 
Crystal 
morphology 
Plasmid 
pattern 
Protein 
pattern 
Number of Bt 
strains 
QBT229 
Smooth 
spherical 
Plas1 Prot1 19 
QBT6 
Spherical 
undulated 
Plas2 Prot3 7 
QBT43 Plas3 Prot12 33 
QBT212 Plas4 Prot6 10 
QBT240 Plas4 Prot7 48 
QBT320 Plas4 Prot8 16 
QBT418 Plas4 Prot9 9 
QBT555 Plas4 Prot10 203 
QBT3 
Spherical 
deflated 
balloon 
Plas6 Prot2 4 
QBT34 Plas6 Prot4 19 
QBT39 Plas6 Prot5 12 
QBT41 Plas6 Prot11 29 
QBT56 Plas6 Prot13 28 
QBT81 
Spherical 
concave 
Plas6 Prot14 2 
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Family 
representative 
Crystal 
morphology 
Plasmid 
pattern 
Protein 
pattern 
Number of Bt 
strains 
QBT99 
Spherical 
pointy edged 
Plas5 Prot15 2 
Total Bt strains 441 
 
 
4.1.4. Conclusion 
The characterization and classification of the Bt strains producing spherical crystals 
were completed in this part of the project. The categories used for classification of the 
441 spherical crystal producing Bt strains were crystal morphology, plasmid patterns 
and crystal protein patterns (Nair et al., 2018b). The Bt strains were divided into 15 
groups based on protein patterns, with 1st group of 19 Bti strains and 14 groups of Non-
Bti strains. A true representative was chosen from each of these 14 groups, considering 
their plasmid patterns and crystal morphologies. Phylogenetic studies by 16s rRNA 
sequencing and ARDRA confirmed the identity novel Bt profiles as belonging to the 
Bacillus thuringiensis species.  All the analyses performed hereafter in this study were 
done with 19 Bti strains and 14 Non Bti representative strains.  
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CHAPTER 4.2 RESULTS: EXPLORATION OF THE INSECTICIDAL 
ACTIVITIES OF QATARI BTI STRAINS AGAINST AEDES AEGYPTI AND 
CULEX PIPIENS LARVAE 
4.2.1. Introduction 
In this part of the study, the insecticidal activities of the Qatari Bt strains producing 
spherical crystals were studied against the 3rd instar larvae of Dipteran insects like Culex 
pipiens and Aedes aegypti. Two groups of Bt strains were tested for their insecticidal 
activity. The first group consisted of 19 Qatari Bti strains (QBti); characterized as such 
based on their crystal morphology, plasmid and protein patterns, insecticidal protein 
genes content, etc (Refer Chapter 4.1). Based on these characteristics, the 19 Bti are the 
most important strains which were expected to be possible candidates for bio-pesticide 
production. The second group consisted of 14 Non Bti representatives that were also 
chosen based on the aforementioned characteristics (refer Chapter 4.1). As reference, 
the Bti strain H14 was used as positive control as it has been widely studied and 
characterized by many research groups. Bti H14 is also considered one of the best Bti 
available today in the market to produce bio-pesticides. As negative control, Bti 4Q7 
strain was used. This is an acrystalliferous clone of Bti H14. In the qualitative bioassay 
experiments, the Dipteran larvae were exposed to high concentrations of the crystal 
proteins from each strain of the two groups. This was carried out in order to screen the 
strains in terms of their insecticidal potentials. In the quantitative bioassay, the LC50 of 
QBti strains were determined using H14 as positive control strain. For the histological 
studies, the live and dead larvae were collected after the bioassay experiments and 
observed by wet mounting to identify the possible tissues affected by the Bt insecticidal 
proteins.  
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4.2.2. Results 
A. Qualitative insecticidal bioassay 
After treating the 3rd instar larvae of the Culex pipiens for 24 hours with high doses of 
insecticidal spore-crystal mixture of Bt strains, it was found that some strains killed all 
five larvae while some couldn’t kill any. Then there were some strains that could kill 1 
or 2 or 3 larva(e). The QBti strains and the positive reference H14 killed all five strains 
as expected (table 8). None of the Non Bti strains could kill all five larvae. Among the 
Non Bti strains, QBT3, QBT39, QBT43, QBT81, QBT240 and QBT418 could kill none 
of the larvae; like the negative control reference strain 4Q7. QBT34 and QBT56 could 
kill 2 and 3 larvae, respectively. Other Non-Bti strains including QBT6, QBT41, QBT99, 
QBT212, QBT320 and QBT555 could kill only one larva out of the five (table 9).  
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Table 8. Qualitative bioassay to screen QBti strains for their insecticidal activities 
[Each test performed with five larvae] 
 
Insecticidal activity (No. of dead and viable larvae) 
Bti Strains Dead Viable 
H14 5 0 
QBT205 5 0 
QBT213 5 0 
QBT214 5 0 
QBT215 5 0 
QBT216 5 0 
QBT217 5 0 
QBT218 5 0 
QBT220 5 0 
QBT221 5 0 
QBT222 5 0 
QBT223 5 0 
QBT224 5 0 
QBT225 5 0 
QBT226 5 0 
QBT227 5 0 
QBT228 5 0 
QBT229 5 0 
QBT230 5 0 
QBT608 5 0 
4Q7 0 5 
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Table 9. Qualitative bioassay to screen Non-Bti strains for their insecticidal activities 
[Each test performed with five larvae; Dead and viable larvae numbers mentioned for 
each strain tested] 
 
Insecticidal activity (No. of dead 
and viable larvae) 
Non Bti Strains Dead Alive 
H14 5 0 
QBT3 0 5 
QBT6 1 4 
QBT34 2 3 
QBT39 0 5 
QBT41 1 4 
QBT43 0 5 
QBT56 3 2 
QBT81 0 5 
QBT99 1 4 
QBT212 1 4 
QBT240 0 5 
QBT320 1 4 
QBT418 0 5 
QBT555 1 4 
4Q7 0 5 
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B. Quantitative insecticidal bioassay 
Determination of protein concentrations of each strain for Bioassay against 
Aedes Aegypti 
In order to assess the larvicidal properties of the studied strains, crystal protein 
concentrations were determined by calculating the protein concentration of a sample 
from the spore crystal mixture. The sample was solubilized completely, spores 
separated by centrifugation, and the protein concentration was determined by 
Bradford’s method. The estimated protein concentrations of each strain are listed in the 
table 10. The spore-crystal mixture of each strain was diluted as per requirements of 
the bioassay experiments.   
 
 
Table 10. Estimation of protein concentration in spore-crystal mixture of Bt strains 
[δ- endotoxin protein concentrations in µg/l; the estimated value was calculated by 
Bradford’s method and subtracting the value obtained for negative control reference 
strain 4Q7] 
Strains Actual δ-endotoxin content (µg/l) 
4Q7 0 
QBT215 996246.663 
QBT224 996246.663 
QBT227 1058746.66 
QBT213 1162916.66 
QBT222 1204580 
QBT230 1204580 
QBT205 1246250 
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Strains Actual δ-endotoxin content (µg/l) 
QBT229 1350413.33 
QBT214 1392080 
QBT220 1496246.66 
QBT225 1517080 
QBT223 1579580 
QBT221 1600413.33 
QBT228 1662913.33 
H14 1700416.66 
QBT226 1808746.66 
QBT218 1829580 
QBT216 2121246.66 
QBT217 2767080 
QBT608 2850413.33 
 
 
Determination of the lethal concentration (50) of reference Bti H14 
Among the different concentrations of - δ- endotoxin tested for the reference H14, all 
concentrations below 0.01 µg/l could not kill any larvae and all concentrations above 
0.25 µg/l killed all the larvae. The concentration of 0.1 µg/l of - δ- endotoxin proteins 
from H14 could kill about 50% of the larvae (figure 16).  The concentration of 0.1 µg/l 
was considered as the estimated LC50 value for the reference H14.  
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Figure 16. Determination of LC50 value of the δ- endotoxins of reference strain H14 
against Aedes aegypti 
[The graph represents the concentrations of δ- endotoxins tested against the percentage 
of larvae killed by respective concentrations of δ- endotoxins; the red dot represents the 
~50% larvae killed at the concentration of 0.1 µg/l of δ- endotoxins]  
 
 
Evaluation of efficiency of local strains against Aedes aegypti larvae 
When tested at a - δ- endotoxin concentration of 0.1 µg/l, QBti strains showed different 
insecticidal activities against Aedes aegypti larvae. Based on their efficiency, the QBti 
strains were divided into three groups. The first group consisted of QBT205, QBT222, 
QBT224, QBT227, QBT226, QBT213 and QBT214. The strains belonging to this group 
could kill only less than 40% larvae. The second group consisted of QBT223, QBT230, 
QBT215, QBT229, QBT216, QBT225, QBT228 and QBT608. The insecticidal activities 
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of the strains of this group are similar to that of H14, killing 50% of the larvae. The 
third group consisted of QBT221, QBT217, QBT218 and QBT220; able to kill more 
than 60% of the larvae. The three different groups, thus formed, are shown in the figure 
17.  
 
 
 
Figure 17. Study of the toxicity efficiencies of QBti strains against Aedes aegypti larvae 
[The graph represents the percentage of larvae killed by the reference and the QBti 
strains at the δ- endotoxin concentration of 0.1 µg/l; error bars are plotted with the 
standard errors calculated based on three readings for each strain; Group 1 (red box) 
consists of QBti strains that could kill only 40% or less larvae; Group 2 (blue box) 
consists of QBti strains and reference that could kill 50% of larvae; Group 3 (green box) 
consists of QBti strains that could kill more than 60% of larvae] 
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Determination of LC50 of the most insecticidal QBti strains  
When tested at more concentrations of - δ- endotoxins, the Group 3 strains could not 
kill as larvae at or below 0.005 µg/l and killed all the larvae at or above 0.25 µg/l. These 
strains killed about 50% of larvae at a concentration of 0.075 µg/l of - δ- endotoxins. 
At other concentrations of 0.03 µg/l, 0.05 µg/l, 0.1 µg/l and 0.125 µg/l, they killed about 
19%, 38%, 66% and 86%, respectively. Among these Group 3 strains, the percentage 
of larvae killed by QBT220 was slightly higher as shown in the table 11.    
 
 
Table 11. Study of toxicity of Group 3 QBti strains against Aedes aegypti larvae 
Strains 
Concentrations 
(µg/l) 
Larvae killed (%) 
Average larvae 
killed % (+/- 
Error) 
  I II III  
QBT217 0.005 0 0 0 0 +/- 0 
 0.03 14 19 19 18 +/- 1.59 
 0.05 33 33 38 35 +/- 1.59 
 0.075 52 57 52 54 +/- 1.59 
 0.1 67 62 67 65 +/- 1.59 
 0.125 86 86 86 88 +/- 0 
 0.25 100 100 100 100 +/- 0 
QBT218 0.005 0 0 0 0 +/- 0 
 0.03 19 19 19 19 +/- 0 
 0.05 38 38 38 38 +/- 0 
 0.075 57 52 52 54 +/- 1.59 
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Strains 
Concentrations 
(µg/l) 
Larvae killed (%) 
Average larvae 
killed % (+/- 
Error) 
I II III 
QBT218 0.1 62 67 67 65 +/- 1.59 
 0.125 81 86 81 83 +/- 1.59 
 0.25 100 100 100 100 +/- 0 
QBT220 0.005 0 0 0 0 +/- 0 
 0.03 19 19 24 21 +/- 1.59 
 0.05 43 43 38 41 +/- 1.59 
 0.075 57 57 67 60 +/- 3.17 
 0.1 62 81 71 71 +/-5.5 
 0.125 86 95 86 89 +/- 3.17 
 0.25 100 100 100 100 +/- 0 
QBT221 0.005 0 0 0 0 +/- 0 
 0.03 14 19 19 18 +/- 1.59 
 0.05 29 33 38 33 +/- 2.75 
 0.075 52 48 48 49 +/- 1.59 
 0.1 67 67 57 64 +/-3.17 
 0.125 81 81 86 83 +/-1.59 
 0.25 100 100 100 100 +/- 0 
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Statistical analysis 
The actual LC50 value was calculated for the reference and the group 3 strains with the 
data from table 11. Probit analysis software showed that the LC50 value of the reference 
H14 was 0.095 µg/l. The LC50 value for the group 3 strains were: 0.065 µg/l for 
QBT217, 0.066 µg/l for QBT218, 0.06 µg/l for QBT220 and 0.068 µg/l for QBT221 
(table 12). The fiducial limit at 95% confidence was calculated and the same has been 
shown in the figure 18.  
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Table 12. Probit analysis of the insecticidal activities of Group 3 QBti strains and 
reference H14 against Aedes aegypti larvae 
[The output for the LC50 calculated for Group 3 QBti strains and reference from Probit 
analysis software; lower and upper values represent the fiducial range for each strain at 
95% confidence level] 
STRAINS PROBIT ANALYSIS OUTPUT 
H14 LD/LC LD/LC 95% Fiducial CI 
(%) ug/l Lower Upper 
LD50 0.094797 0.0675826 0.1329701 
QBT217 LD/LC LD/LC 95% Fiducial CI 
(%) ug/l Lower Upper 
LD50 0.065119 0.0492225 0.0861484 
QBT218 LD/LC LD/LC 95% Fiducial CI 
(%) ug/l Lower Upper 
LD50 0.065488 0.0484001 0.088608 
QBT220 LD/LC LD/LC 95% Fiducial CI 
(%) ug/l Lower Upper 
LD50 0.060121 0.0452774 0.0798318 
QBT221 LD/LC LD/LC 95% Fiducial CI 
(%) ug/l Lower Upper 
LD50 0.068275 0.0507161 0.091914 
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Figure 18. Comparison between the insecticidal activities of QBti strains and reference 
H14 based on probit analysis 
[The LC50 values of the Group 3 QBti strains and reference H14; the bars represent the 
range of LC50 values for each strain, the black line and the associates values show the 
calculated LC50 values] 
 
 
C. Histological study of larvae exposed to QBti insecticidal proteins 
In this study, the effect of QBti insecticidal proteins on larvae were analysed. It was 
seen that the dead larvae had shrunk in size and that all the dead larvae had a broken 
gut, compared to the intact structure found in untreated larvae. The break was always 
found to be between the anterior and posterior midgut in dead larvae. It shows that the 
insecticidal δ- endotoxins do bind to the larval midgut causing a disruption in its 
membrane. The loss of integrity of the midgut membrane wall causes starvation and 
eventual death of the larvae treated with Bti crystals.  
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Figure 19. Microscopic observation of the effect of QBti δ- endotoxins on the 
morphology of larval midgut 
[The microscopical observation of dead and live larvae after treating with the - δ- 
endotoxin and spore mixture of Bt; (a) shows the dead larvae and (b) shows the 
untreated larvae collected after 24 hours of treatment with δ- endotoxins; AM is the 
anterior midgut and PM is the posterior midgut of the larvae; the red arrow represents 
the region where all the dead larvae showed a break in their midgut tube]  
 
 
4.2.3. Discussion 
The two groups of Bt strains tested for qualitative bioassay were the Qatari Bacillus 
thuringiensis israelensis strains (QBti) and the Qatar Non-Bti strains. This selective 
bioassay had three goals: (1) main aim was to select the strains that have insecticidal 
activity against Dipteran insects, (2) consequently also to confirm the characterization 
of 19 strains as Bti based on their protein and gene content and (3) compare the LC50 of 
the different strains. To see the slightest insecticidal activity that the strains could 
possess, very high concentrations of δ- endotoxins were used for the treatment (40 
µg/ml to 150 µg/ml). Like the reference strain, the QBti killed all the larvae tested. This 
was expected as the QBti strains had the molecular characteristics of the reference Bti 
and carried genes encoding insecticidal proteins (Chapter 4.1). The Non-Bti strains, on 
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the other hand, could not kill all the larvae even at high concentrations of their 
insecticidal proteins confirming that the δ- endotoxin forming crystals do not belong to 
the same family as the QBti strains. Therefore, the target of these Non-Bti strains could 
be other insect families. The quantitative bioassay was carried out with the QBti strains 
only as they showed promising results in the selective qualitative bioassay.  
The quantitative bioassay is usually carried out with all the tested strains at different 
concentrations and then narrowed down to the LC50 concentration. As a huge number 
of strains were to be tested, a new approach was used to group the strains based on their 
efficiency. From research articles a rough range of LC50 value of the reference strains 
H14 is available (Elleuch et al., 2015). But, the culture conditions and the instruments 
used may give us varied results in our lab. So, to standardize the results, the bioassay 
was first carried out with different concentrations of δ- endotoxins produced by H14 
alone. The concentration that killed almost 50% of the tested larvae was considered as 
the estimated LC50 value for H14. As the reference could kill 50% of larvae at 0.1 µg/l, 
a strain that is as efficient as H14 should be able to kill 50% of the larvae as well. On 
the other hand, a strain more efficient than H14 should be able to kill more than 50% 
of the larvae. Similarly, a strain less efficient than H14 will not be able to kill 50% of 
the larvae. As the goal of the study is to find the strains that are more efficient than 
H14, this strategy could narrow down the number of strains to be studied further. As 
shown in the figure 18, the strains were grouped into 3 groups. The Group 3 strains 
were of interest as they proved to be more efficient than H14; killing more than 60% of 
the larvae tested. The four strains QBT217, QBT218, QBT220 and QBT221 were chosen 
as candidate strains for further studies. To calculate the LC50 value of these strains, it 
was essential to repeat bioassays for them at more concentrations above and below 0.1 
µg/l. From the second set of bioassays, it was found that the Group 3 strains had their 
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LC50 values below 0.075 µg/l, as they killed 50% of the larvae at this concentration. 
Probit analysis software was used to calculate the exact LC50 values for the reference 
as well as Group 3 strains. The results from the software showed that the LC50 value for 
H14 was 0.095 µg/l (~ estimated was 0.1 µg/l) and that for Group 3 strains were 
between 0.06 µg/l to 0.068 µg/l. Lower LC50 values among the QBti strains confirmed 
once again that they were more efficient as insecticidal Bt against Aedes aegypti larvae.  
There are still controversies regarding which pathway fits the best to explain the mode 
of action of the Cry proteins (Adang et al., 2014; Vachon et al., 2012). Two different 
models have been suggested: pore-formation model and cell signal transduction model. 
But it is accepted that Cry proteins recognize the proteins on the brush border of the 
midgut of larvae. The larval midgut epithelial layers loose integrity due to either of the 
two models that leads to insect death (Soberon et al., 2009; Adang et al, 2014).  The 
break in the midgut is expected after the treatment with insecticidal - δ- endotoxin. 
When the treated live and dead larvae were observed under the microscope, the 
expected break in the larval midgut were visible for all the dead larvae. On the contrary, 
the live larvae had intact alimentary tract.  
4.2.4. Conclusion 
In this study, 441 Bt strains that produce spherical crystals were characterized to 
identify 19 Bti strains that were expected to have insecticidal activity against the 3rd 
instar larvae of Dipteran insects. Out of these 19 Bti strains, it was shown that four Bti 
strains were more efficient against Aedes aegypti larvae compared to the reference H14. 
Their efficiency was confirmed when they displayed low LC50 values, much lower than 
that of H14. These QBti strains were hence recognized as candidate strains for bio-
insecticide production against Aedes aegypti mosquitoes but most probably against 
other Dipteran insects as well. These strains were then tested for their δ- endotoxin 
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production capacity, which is discussed in Chapter 4.5. Ultimately, the aim is to not 
only find a highly insecticidal strain, but also to find one that can produce the efficient 
insecticidal proteins at a much higher rate than the reference strain H14.  
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CHAPTER 4.3 RESULTS: EXPLORATION OF THE δ ENDOTOXINS OF 
QATARI BACILLUS THURINGIENSIS STRAINS  
4.3.1. Introduction 
The objective of this part of the work was to identify -endotoxins synthesized by the 
Bt strains isolated from Qatar. The first method used for the identification of -
endotoxins was to amplify whole or part of the -endotoxins coding genes by PCR. As 
the goal of the project was to identify the Bt strains having insecticidal activities against 
Dipteran insects, the PCR amplifications were done first using primers specific to genes 
encoding -endotoxins targeting Dipteran larvae, like cry4, cry2, cry11, cyt1A, cry10, 
cyt2A, cyt1C. The other important accessory protein genes were screened in a second 
phase, including p19 and p20. The PCR screenings were performed with 19 Bti strains 
and 14 Non Bti representative strains. In the second part, a different strategy was used 
for identifying the possible -endotoxins: protein profiling. Here the crystal proteins 
from Non Bti strains were solubilized, digested and run on liquid chromatography 
coupled with mass spectrometer (LC-MS). The data from these profiling was compared 
to Bt database on UniProt and similar proteins were identified. The protein profiling 
was performed for Non Bti strains, as they failed to amplify most of the Bti -endotoxins 
coding genes. Protein profiling was added to the project to analyse Non Bti to overcome 
the main limitation of the PCR screenings: the inability to distinguish between the 
absence of gene and differences in the gene sequences. In both cases, PCR gives a 
negative result with no amplification. This chapter is hence divided into two sections: 
PCR screenings and Protein profiling.  
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 4.3.2. Results 
A. Prediction of δ- endotoxin proteins by PCR 
Screening of Bti strains 
The 19 Bti strains were screened for the presence of Dipteran specific δ endotoxin genes 
and accessory protein genes. The Bti strains H14 and acrystalliferous strains 4Q7 were 
used as positive and negative controls, respectively. It was found that the Qatari Bti 
strains gave the expected amplifications for PCRs run with primers specific to genes 
like cry4, cry11, cyt1A, cyt2A, p19 and p20. The amplifications obtained for these genes 
were the same as the ones obtained with reference strain H14. Unlike H14, Qatari Bti 
strains failed to give any amplifications for the two genes cry10 and cyt1C. Also, as 
expected Qatari Bti strains did not give any amplifications for PCRs run with primers 
specific to cry2 gene.  
 
 
Table 13. Primers and expected PCR products 
Gene Primer 
pairs 
Sequences Tm Expected 
product 
size 
cry4A, 
cry4B 
Dip1A 5' CAAGCCGCAAATCTTGTGGA 60 800 bp 
 
Dip1B 5' ATGGCTTGTTTCGCTACATC 58 
 
cry4B Dip2A 5' GGTGCTTCCTATTCTTTGG 56 1293 bp 
 
Dip2B 5' TGACCAGGTCCCTTGATTAC 60 
 
cry4 Dip2A 5' GGTGCTTCCTATTCTTTGG 56 2609 bp 
 
Dip1B 5' ATGGCTTGTTTCGCTACATC 58 
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Gene Primer 
pairs 
Sequences Tm Expected 
product 
size 
cyt1A Cyt1A1 5' GTTGTAAGCTTATGGAAAAT 52 701 bp 
 
Cyt1A2 5' TTAGAAGCTTCCATTAATA 48 
 
cyt2 Cyt2-1 5' AATACATTTCAAGGAGCTA 50 471 bp 
 
Cyt2-2 5' TTTCATTTTAACTTCATATC 48 
 
cry11 Cry11-1 5' TTAGAAGATACGCCAGATCAAGC 66 304 bp 
 
Cry11-2 5' CATTTGTACTTGAAGTTGTAATCCC 68 
 
cry10 Cry10-1 5' ATATGAAATATTCAATGCTC 50 614 bp 
 
Cry10-2 5' ATAAATTCAAGTGCCAAGTA 50 
 
cyt1C Cyt1C1 5' CAAAATCTACGGGAGCAAGG 60 1320 bp 
 
Cyt1C2 5' GGAAGGATCCCTTTGACTTTT 60 
 
cry2 Cry2-1 5`GTTATTCTTAATGCAGATGAATGGG  68 701 bp 
 
Cry2-2 5`CGGATAAAATAATCTGGGAAATAGT  66 
 
p19 P19-1 5’GCAGGAGGAACATCACCATT 60 291 bp 
 
P19-2 5’GGATTTGCTGAGCAGGTCAT 60 
 
p20 P20-1 5’TGACGAGGAAACAGAGTATACGA 66 704 bp 
 
P20-2 5’TGAAAGGTTAAACGTTCCGATT 60 
 
cry2A Cry2A-1 5' ACTATTTGTGATGCGTATAATGTA 62 600 bp 
 
Cry2A-2 5' ACTATTTGTGATGCGTATAATGTA 52 
 
cry2 KNCry2F 5’ATGAATAATGTATTGAATAGTGGAAGAA  70 1902 bp 
 
KNCry2R 5’TTAATAAAGTGGTGGAAGATTAGTTGG 72 
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Gene Primer 
pairs 
Sequences Tm Expected 
product 
size 
ORF2 KNORF2-
1 
5’TGCTAAAATATCATTTTCC 50 758 bp 
 
KNORF2-
2 
5’CTACTTACAACCACAATCAC 56 
 
 
 
Screening of Non-Bti strains 
Among the Non-Bti strains, all the Non- Bti failed to amplify any of the Bti δ- 
endotoxins and accessory proteins coding genes. Interestingly, one Non Bti strains 
QBT674 gave the expected amplification for primers specific to cry2 gene. The Bacillus 
thuringiensis kurstaki HD1 (Btk HD1) producing Dipteran specific Cry2 protein was 
used as reference. QBT674 was further analysed as this was a novel finding.  
QBT674 is a spherical crystal forming Non-Bti strain. It has an undulated surface on its 
crystal (figure 20). When compared to the references Bti and Btk, it has protein (figure 
21a) and plasmid profiles which were very different (figure 21b). The primers used for 
amplifying the whole gene of cry2 was used for PCR amplifications. QBT674 and 
reference strain HD1 gave the correct expected amplification. The ORF2 gene 
associated with cry2 function was analysed with the primers amplifying the complete 
gene of ORF2. Reference strain HD1 gave the correct expected amplification but not 
in case of QBT674.  
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Figure 20. Micrographs of crystals and spores produced by Qatari Bt strain QBT674 
[SEM images of crystal morphology of (a): Btk HD1; (b): QBT674; (c): Bti H14; Cc: 
cuboidal; Bc: bipyramidal; SUc: spherical undulated; SSc: Spherical smooth; S: spore] 
 
 
Figure 21. Comparison between QBT674 and reference strains on molecular level 
[(a): protein pattern formed by SDS-PAGE of parasporal crystals; (b): plasmid pattern 
on agarose gel; M: broad range protein marker; L: 1 kb plus linear DNA marker; H14: 
reference strain Bti H14; HD1: reference strain Btk HD1; QBT674: Qatari Non Bti 
strains QBT674] 
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Table 14. Identification of Bt strains cry genes by PCR 
Genes  cry4 cry2 cry11 cry10 cyt1A cyt1C cyt2A p19 p20 
Bti Strains 
H14          
HD1          
4Q7          
QBT205          
QBT213          
QBT214          
QBT215          
QBT216          
QBT217          
QBT218          
QBT220          
QBT221          
QBT222          
QBT223          
QBT224          
QBT225          
QBT226          
QBT227          
QBT228          
QBT229          
QBT230          
QBT608          
Non Bti strains 
QBT3          
QBT6          
QBT34          
QBT39          
QBT41          
QBT43          
QBT56          
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Genes  cry4 cry2 cry11 cry10 cyt1A cyt1C cyt2A p19 p20 
QBT81          
QBT99          
QBT212          
QBT240          
QBT320          
QBT418          
QBT555          
QBT674          
 
 
B. Prediction of δ- endotoxin proteins by protein profiling 
The spectral data for each sample was obtained from the nano-liquid chromatography 
coupled to tandem mass spectrometer. The protein identification was done from the 
spectral data using the software Spectrum Mill. Checking against the UniProt database 
for Bti, all the Bti proteins that Non Bti strains could have, were identified. The list of 
proteins identified for each of the strains tested are attached in Appendix. The relevant 
proteins identified are listed in the table 15 for the reference strains H14. Among the 
Non Bti strains tested, QBT555 showed the presence of Bti proteins.  
QBT555 is a spherical crystal producing Non Bti strain isolated from Qatar. It does not 
have a smooth spherical crystal like the reference Bti H14. Although spherical, the 
surface of the crystal is undulated (figure 22). Compared to H14, it has different 
proteins and plasmid pattern (Chapter 4.1). The PCR amplifications for the Bti strains 
gave negative results (table 14).  
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Figure 22. Micrographs of crystals and spores produced by Qatari Bt strain QBT555 
[Scanning electron microscopy images showing crystal morphology of (a): crystal and 
spore of QBT555; (b): crystal and spore of reference strain Bti H14; SUc: spherical 
undulated crystal; SSc: spherical smooth crystal; S: spore] 
 
 
The protein profile for the crystals of QBT555 showed many common proteins when 
compared to the database for reference strains H14 on UniProt. Most of the proteins in 
the list of identified protein entries included the sporulation associated proteins and 
enzymes like Spore coat protein GerQ, Stage 0 sporulation protein A, etc. When 
screened for insecticidal proteins, it was found that QBT555 had Cry11A protein. 
Among the peptides inserted to mass spectrometer, 25 peptides matched with Cry11 
protein from the database with 16 peptides that were unique to Cry11A protein. It 
showed a high coverage of 28% to 31%. As control, the reference strains H14 was also 
run along with QBT555. H14 samples gave 56 peptides matching Cry11A protein with 
35 unique peptides. H14 sample gave a coverage of 55% to 56%. In case of Cyt1A 
protein, H14 had 10 unique peptides out of 45 that matched, giving a coverage of 74%. 
On the other hand, QBT555 had six unique peptides out of 11, giving a coverage of 
55%. Cry10Aa is another protein that was identified in QBT555 with three unique 
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peptides out of three and a coverage of 6%.  H14 sample had 11 unique peptides out of 
13 and a coverage of 21% for Cry10Aa protein. Apart from these insecticidal proteins, 
an accessory protein was also identified in QBT555: pBt152. QBT555 had one unique 
peptide out of just one peptide that matched this protein with a coverage of 3% (table 
15). On the other hand, H14 had 8 unique peptides out of 9 that matched and a coverage 
of 25% (table 14).  
 
 
Table 15. List of identified proteins from Protein profile data for reference strain H14 
[No. Spectra: Number of spectra for peptides that matched with the protein; No. Unique 
peptides: Number of unique peptides out of all the spectra that matched with the protein; 
Percent coverage: The percentage of the amino acids of the whole protein that matched 
with all the peptides combined; Accession number: the ID for the protein from the 
database on UniProt; Identified protein: the list of relevant proteins that were screened] 
No. 
Spectra 
No.  Unique 
Peptides 
Percent 
Coverage 
Accession 
number 
Identified protein 
42 25 55.5 P21256 Cry11Aa 
14 10 56.3 A0A141DWM3 Cry11 
45 10 74.2 P0A382 Cyt1Aa  
13 11 21.7 P09662 Cry10Aa 
9 8 25.2 Q8KNP4 pBt152 
19 16 18.1 P05519 Cry4Ba 
19 16 16.8 Q1RN84 Cry4BLB 
4 3 24.3 O30895 Cyt2B 
6 6 10 Q8KNV1 Cyt1C 
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Table 16. List of identified proteins from Protein profile data for Qatari strains QBT555 
[No. Spectra: Number of spectra for peptides that matched with the protein; No. Unique 
peptides: Number of unique peptides out of all the spectra that matched with the protein; 
Percent coverage: The percentage of the amino acids of the whole protein that matched 
with all the peptides combined; Accession number: the ID for the protein from the 
database on UniProt; Identified protein: the list of relevant proteins that were screened] 
No. 
Spectra 
No.  
Unique 
Peptides 
Percent 
Coverage 
Accession 
number 
Identified protein 
18 11 28.6 P21256 Cry11Aa 
7 5 31.7 A0A141DWM3 Cry11 
11 6 55.4 P0A382 Cyt1Aa 
3 3 6.6 P09662 Cry10Aa 
1 1 2.9 Q8KNP4 pBt152 
 
 
4.3.3. Discussion 
The screening for δ endotoxin proteins and accessory proteins were conducted using 
two different techniques: PCR amplifications of the encoding genes and protein 
profiling of the parasporal crystals by LC/MS. Different primers that can amplify part 
or whole of the genes were used to screen the Bt strains for the presence of the encoding 
genes. Among the Qatari Bti strains, all the important Dipteran specific δ endotoxin 
coding genes were present including the cry4A/4B, cry11, cyt1A and cyt2B.  They also 
showed the presence of accessory protein coding genes like p19 and p20. Despite 
resembling the reference strain in every way, Qatari Bti strains lacked the cry10 and 
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cyt1C genes. This showed the possible gene instability among the Bti strains from 
Qatar. This instability was studied further, and the details are described in Chapter 4.6.  
Among the Non Bti strains, PCR screenings showed that they probably do not have the 
Dipteran specific insecticidal protein encoding genes. This was expected as the Non Bti 
groups of strains were very different compared to the reference H14, in every aspect 
tested. But, it was interesting to see that one Non Bti strain QBT674 gave expected 
amplification of cry2 gene. Cry2 protein is expressed by Btk strains that produce 
cuboidal crystals along with bipyramidal crystals during sporulation. Cry2 protein, that 
has insecticidal activity against Dipteran insects, is known to be responsible for the 
crystallization of itself and other proteins into cuboidal shape. Cry2 protein is part of 
an operon of three ORFs and the protein itself is encoded by the ORF3. The ORF2 of 
this operon encodes for a protein that is essential for the cuboidal crystal formation. 
When checked for the presence of this ORF2 in QBT674, it gave negative results. In 
summary, QBT674 has the ORF3 gene encoding Cry2 protein but not ORF2 encoding 
the regulatory protein for cuboidal crystal formation. Because of this, QBT674 produces 
only spherical crystals with undulated surface, but no cuboidal crystal. This is the first 
report of a spherical crystal producing strain to show the presence of cry2 gene.  
Apart from QBT674, the possible presence of any δ endotoxins could not be detected 
in any other Non Bti strains. Hence, a new approach was tested in the form of LC/MS 
protein profiling. In these screenings, it was found that a Non Bti strain QBT555, with 
all the characteristics very different than H14, showed the presence of Bti δ endotoxin 
proteins and accessory proteins. To evaluate the data for QBT555, the reference H14 
was also tested and compared to its own database of proteins on UniProt. In this 
technique, the parasporal crystals were solubilized and digested with Trypsin to get 
many peptides of all the proteins that are present in the crystals. The peptides were 
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separated by size and then charge, and they were sent into mass spectrometer. Each 
peptide was given a spectrum by the spectrometer. At the end, each sample for each 
strain had data in the form of 1000s of spectra. These spectra were then compared to 
the database of spectra of the proteins from the reference strain Bti on UniProt website. 
The software Spectrum Mill then gave out the data in the form of excel sheets where 
the list of protein identified were given. Along with the list, it showed the number of 
peptides from the samples that matched a protein of Bti and the percentage of the amino 
acid sequence of the identified protein that was covered by the amino acids from the 
peptides. For QBT555, three δ- endotoxins and one accessory protein were identified: 
Cry11, Cry10, Cyt1A and pBt152.  
The absence of Cry4A/4B protein could explain its lack of insecticidal activity against 
Dipteran larvae (Chapter 4.2). Cry4A/4B is one of the biggest and most toxic δ- 
endotoxins that act against the Dipteran larvae. Also, Cry4A/4B is responsible for the 
crystallization of itself and other proteins into spherical shape. Possible absence of this 
protein could mean that QBT555 possesses some other crystallization protein that forms 
the spherical crystal.  
pBt152 is a hemagglutinin protein that is also essential for the spherical crystal 
formation. Only the Cry4A/4B protein is not enough to form the spherical crystals 
among the Bti strains. It can be postulated that the accessory protein pBt152 is present 
to help the other crystallization protein that QBT555 possesses.  
4.3.4. Conclusion 
The Qatari Bt strains producing spherical crystals were screened for the Dipteran 
specific δ endotoxin proteins and the associated accessory proteins. It was found that 
the Qatari Bti strains have the essential insecticidal proteins and accessory protein, 
except Cry10 and Cyt1C. The absence of these proteins in all the Qatari Bti strains 
shows that this a signature plasmid instability among the Qatari Bti strains. Among the 
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Non Bti strains, a novel Bt strain QBT674 was found that produces spherical crystals 
only during the sporulation stage but does have the cry2 gene and the regulatory gene 
ORF2 that is necessary for the formation of cuboidal crystal. As no other Dipteran 
specific δ- endotoxins could be detected by PCR screenings, protein profiling was 
conducted for the Non Bti strains. It was found that QBT555, which did not give any 
amplifications for the PCRs used to screen all the Bti δ- endotoxin genes, showed the 
presence of the Bti δ- endotoxins and accessory proteins in its parasporal crystals.   
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CHAPTER 4.4 RESULTS: INVESTIGATION OF HAEMOLYTIC & CYTOLYTIC 
ACTIVITY OF BT STRAINS 
4.4.1. Introduction 
Apart from its insecticidal activities, Bt is also known for its cytolytic activity; which 
is explored in this part of the study. The 19 Bti strains and the 14 Non Bti representatives 
were tested for their cytolytic and hemolytic activities along with the references H14 
and 4Q7. This part of the study had three sections. In the first section, all the strains 
were tested for their hemolytic activity by analyzing their ability to break down red 
blood cells (RBC) on Blood agar. The hemolytic activity was evaluated based on the 
zone of clearance seen around the colony of the Bt strain due to the breakdown of RBCs. 
In the second section, all the strains were tested for their cytolytic activity by MTT 
assay against cancer cell line. The MTT assay was carried out for each strain at five 
different concentrations of their parasporal crystal proteins. Each test was conducted 
thrice for 24 hours, 48 hours and 72 hours, each. The anticancer property is attributed 
to Parasporins and/or Cyt1A proteins. Hence, the strains showing anticancer property 
were analyzed further to check the presence of parasporin genes and cyt1A gene and 
encoded proteins. In the third section, the strain showing the highest anticancer activity 
was studied intrinsically to understand the molecular and biochemical reasons for the 
higher activity. Along with the gene sequence, amino acid sequences were compared 
and then a 3D model was prepared using bioinformatic tools. The different protein 
moieties from the model were studied and their possible function in cytolytic activity 
was deduced based on the understanding from published research works. The results of 
this chapter have been published as part of two research articles: Nair et al., 2018(a) 
and Nair et al., 2018(b). Articles are attached as Appendix A and Appendix B.  
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4.4.2. Results 
A. Hemolytic activity of Bt strains 
When the strains were grown on Blood agar overnight, three different types of 
hemolytic activities were observed among the local strains. Some strains showed no 
hemolytic activity (figure 23c), while the others showed slight (figure 23b) or high 
hemolytic activity (figure 23a). All the Qatari Bti strains had high hemolytic activity 
along with three Non Bti strain representatives, viz., QBT6, QBT81 and QBT99. Among 
the other Non Bti strains, QBT43, QBT240, QBT320 and QBT418 showed slight 
hemolytic activities around their respective colonies. Other Non Bti strain 
representatives like QBT212, QBT555, QBT3, QBT34, QBT39, QBT41 and QBT56 
showed no hemolytic activities (table 17).  
 
 
(a) 
 
(b) 
 
(c) 
 
Figure 23. Types of hemolysis observed among the Bt strains studied for the hemolytic 
activity 
[a: The zone of clearance observed around the highly hemolytic Bt strains; b: the slight 
zone of clearance observed around the Bt strains with lower hemolytic activities; c: the 
absence of any zone of clearance observed around the Bt strains with no hemolytic 
activities] 
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Table 17. Hemolytic activities of Bti strains, Non Bti representative strains and the 
reference strain H14 
[++: indicates the high hemolytic activities (figure 23a); +: indicates the slight 
hemolytic activities (figure 23b); -: the absence of hemolytic activities (figure 23c)] 
Bti strains  Non-Bti strains 
Strains Hemolytic activity  Strains Hemolytic activity 
QBT205 ++  QBT3 - 
QBT213 ++  QBT6 ++ 
QBT214 ++  QBT34 - 
QBT215 ++  QBT39 - 
QBT216 ++  QBT41 - 
QBT217 ++  QBT43 + 
QBT218 ++  QBT56 - 
QBT220 ++  QBT81 ++ 
QBT221 ++  QBT99 ++ 
QBT222 ++  QBT212 - 
QBT223 ++  QBT240 + 
QBT224 ++  QBT320 + 
QBT225 ++  QBT418 + 
QBT226 ++  QBT555 - 
QBT227 ++  Reference 
QBT228 ++  Strains Hemolytic activity 
QBT229 ++  H14 ++ 
QBT230 ++    
QBT608 ++    
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B. Cytolytic activity of Bt strains 
The MTT assay for each of the strains was carried out in triplicate for 24 hours, 48 
hours and 72 hours, each (results for 72 hours listed in table 18, full results attached as 
Appendix E). The cytotoxic activity of the strains was analyzed for anticancer activity 
for two of the properties: (1) the ability of the lung cancer cell lines to recover after the 
treatment for 24 hrs, 48 hrs and 72 hrs, and (2) the smallest concentration of the Bt δ- 
endotoxins that can inhibit the growth of maximum cancer cells. Although, the actual 
cytolytic assay for Bt is carried out only for 72 hours, in this study, 24 hours and 48 
hours were also included to understand the recovery of the growing cancer cells after 
treatment. Among the Bti strains, when analyzed for cytolytic activities, four strains 
QBT205, QBT216, QBT229 and QBT230 showed the highest activities (figure 24). In 
other words, even after 72 hours of treatment, the number of viable cells kept on 
declining without recovery. Seven other Bti strains QBT213, QBT221, QBT222, 
QBT223, QBT224, QBT225 and QBT608 showed cytotoxic activities till 48 hours and 
then recovered by 72 hours (figure 25). The reference strain H14 and eight other Bti 
strains including QBT214, QBT215, QBT217, QBT218, QBT220, QBT226, QBT227 
and QBT228 showed cytotoxic activities only for 24 hours and recovered by 48 hours 
(figure 26).  
On the other hand, only two of the Bti strains could inhibit the growth of more than 
50% of the cancer cells. At the end of 72 hours of treatment, only 49.62% of the cancer 
cells survived when treated with 0.5 µg/ml of δ- endotoxins from QBT229 (figure 24c). 
In case of QBT230, only 40.75% cancer cell lines survived when treated with 0.5 µg/ml 
of δ- endotoxins (figure 25d). QBT229 showed higher cytotoxic activities as its δ- 
endotoxins could inhibit about 50% of the cancer cells even at the lowest concentration 
tested; 0.15 µg/ml (figure 24c). QBT230, on the other hand could inhibit 50% of the 
cancer cells only at a concentration of 0.35 µg/ml (figure 24d).  
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Figure 24. Cytolytic activities of Bti strains where lung cancer epithelial cell lines could 
not recover even after 72 hours of treatment 
[the graph plotted with concentration of δ- endotoxins used for each treatment versus 
the percentage of viable cells quantified after treatment for 24 hours or 48 hours or 72 
hours; blue lines indicate the cytolytic activities seen for each concentration tested after 
72 hours, grey and orange dotted lines indicate the cytolytic activities of Bt strains after 
24 and 48 hours respectively; error bars have been plotted for results obtained after 72 
hours and indicate the standard errors] 
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Figure 25. Cytolytic activities of Bti strains where lung cancer epithelial cells recovered 
after 48 hours of treatment 
[the graph plotted with concentration of δ- endotoxins used for each treatment versus 
the percentage of viable cells quantified after treatment for 24 hours or 48 hours or 72 
hours; blue lines indicate the cytolytic activities seen for each concentration tested after 
72 hours, grey and orange dotted lines indicate the cytolytic activities of Bt strains after 
24 and 48 hours respectively; error bars have been plotted for results obtained after 72 
hours and indicate the standard errors] 
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Figure 26. Cytolytic activities of reference H14 and Bti strains where lung cancer 
epithelial cells recovered after 24 hours of treatment 
[the graph plotted with concentration of δ- endotoxins used for each treatment versus 
the percentage of viable cells quantified after treatment for 24 hours or 48 hours or 72 
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hours; blue lines indicate the cytolytic activities seen for each concentration tested after 
72 hours, grey and orange dotted lines indicate the cytolytic activities of Bt strains after 
24 and 48 hours respectively; error bars have been plotted for results obtained after 72 
hours and indicate the standard errors] 
 
 
Table 18. Cytotoxic activities shown by Bti strains and reference straisn Bti H14 after 
72 hours 
[Average of three percentage values of viable cells that were estimated for each Bti 
strain δ- endotoxin proteins at their five different concentrations; 0 µg/ml concentration 
represents untreated wells] 
Strains Concentrations of δ- endotoxin proteins tested (µg/ml)  
  0 0.15 0.25 0.35 0.5 
P
ercen
ta
g
e o
f v
ia
b
le ca
n
cer cells (%
)  
H14 100 99.33 91.89 76.73 61.28 
QBT205 100 85.03 74.07 72.46 58.27 
QBT213 100 103.56 109.15 92.86 65.61 
QBT214 100 86.56 82.98 87.91 76.64 
QBT215 100 88.90 92.96 98.31 77.79 
QBT216 100 90.58 72.15 59.81 56.34 
QBT217 100 74.40 66.04 60.88 58.16 
QBT218 100 101.37 75.44 76.27 71.39 
QBT220 100 76.08 73.49 61.01 70.54 
QBT221 100 98.38 91.92 71.98 61.04 
QBT222 100 77.27 82.98 75.04 66.36 
QBT223 100 82.72 80.49 75.74 67.96 
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Strains Concentrations of δ- endotoxin proteins tested (µg/ml) 
 0 0.15 0.25 0.35 0.5 
QBT225 100 101.07 74.09 83.73 85.32 
QBT226 100 85.28 79.27 76.64 79.47 
QBT227 100 81.51 73.76 75.38 73.20 
QBT228 100 89.95 83.39 81.21 75.34 
QBT229 100 51.30 47.98 52.44 49.62 
QBT230 100 92.25 54.98 51.43 40.75 
QBT608 100 96.209 87.878 80.028 75.747 
 
 
Among the Non-Bti strains, none could inhibit more than 50% of the cancer cells even 
at the highest concentration tested for 24 hours, 48 hours or 72 hours (results for 72 
hours listed in table 19, full results attached as Appendix). Among the Non Bti strains, 
QBT41 and QBT320 showed comparatively higher toxicity as the cancer cells could not 
recover after 72 hours of treatment (figure 27). In other words, the number of viable 
cancer cells kept on declining with time as the toxins were active even after 72 hours 
of treatment. Cancer cells recovered even after 24 hours when treated with δ- 
endotoxins from QBT6, QBT99, QBT212 and QBT555 (Figure 28). In case of QBT3, 
QBT34, QBT39, QBT43, QBT56, QBT81, QBT240 and QBT418, cancer cells recovered 
after 48 hours of treatment (figure 29).  
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Figure 27. Cytolytic activities of Non Bti strains where lung cancer epithelial cells did 
not recover even after 72 hours of treatment 
[the graph plotted with concentration of δ- endotoxins used for each treatment versus 
the percentage of viable cells quantified after treatment for 24 hours or 48 hours or 72 
hours; grey lines indicate the cytolytic activities seen for each concentration tested after 
72 hours, blue and orange dotted lines indicate the cytolytic activities of Bt strains after 
24 and 48 hours respectively; error bars have been plotted for results obtained after 72 
hours and indicate the standard errors] 
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Figure 28. Cytolytic activities of Non Bti strains where lung cancer epithelial cells 
recovered after 24 hours of treatment 
[the graph plotted with concentration of δ- endotoxins used for each treatment versus 
the percentage of viable cells quantified after treatment for 24 hours or 48 hours or 72 
hours; grey lines indicate the cytolytic activities seen for each concentration tested after 
72 hours, blue and orange dotted lines indicate the cytolytic activities of Bt strains after 
24 and 48 hours respectively; error bars have been plotted for results oBtained after 72 
hours and indicate the standard errors] 
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Figure 29. Cytolytic activities of reference H14 and Bti strains where lung cancer 
epithelial cells recovered after 48 hours of treatment 
[the graph plotted with concentration of δ- endotoxins used for each treatment versus 
the percentage of viable cells quantified after treatment for 24 hours or 48 hours or 72 
hours; grey lines indicate the cytolytic activities seen for each concentration tested after 
72 hours, blue and orange dotted lines indicate the cytolytic activities of Bt strains after 
24 and 48 hours respectively; error bars have been plotted for results obtained after 72 
hours and indicate the standard errors] 
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Table 19. Cytotoxic activities shown by Non Bti representative strains after 72 hours 
[Average of three percentage values of viable cells that were estimated for each Non 
Bti strain δ- endotoxin proteins at their five different concentrations; 0 µg/ml 
concentration represents untreated wells] 
Strains Concentrations of δ- endotoxin proteins tested 
(µg/ml) 
 
  0 0.15 0.25 0.35 0.5 
P
ercen
ta
g
e o
f v
ia
b
le ca
n
cer cells (%
)  
QBT3 100 85.93 91.99 76.11 72.16 
QBT6 100 97.58 89.56 89.27 78.40 
QBT34 100 84.24 81.53 72.05 72.67 
QBT39 100 77.38 73.04 87.30 70.78 
QBT41 100 80.57 85.71 83.84 78.45 
QBT43 100 92.12 90.57 89.76 82.04 
QBT56 100 84.66 91.98 88.93 100.3 
QBT81 100 92.99 87.77 88.90 89.92 
QBT99 100 80.75 74.68 74.66 76.04 
QBT212 100 88.93 84.73 86.60 92.64 
QBT240 100 82.38 100.3 83.82 79.16 
QBT320 100 72.63 71.84 69.60 63.01 
QBT418 100 99.71 92.53 88.23 105.1 
QBT555 100 74.29 78.37 74.05 70.11 
 
 
C. Parasporin genes of Bt strains 
The PCR amplification experiments using primers specific to the Parasporin encoding 
genes gave negative results for all the Bti and Non Bti strains. It was deduced that the 
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cytotoxicity of the Bti strains cannot be attributed to known Parasporins. It was essential 
to check the Cyt1A protein.  
D. Nucleotide sequence of cyt1A gene 
To analyze the high cytotoxicity and anticancer activity shown by QBT229, primers 
were used to amplify the full-length gene of cyt1A by PCR.  When sequenced, it was 
found that the nucleotide sequence of cyt1A gene from QBT229 had at least five 
nucleotide differences, when compared to that of cyt1A gene from the reference strain 
H14 (figure 30).  
 
 
1 
61 
121 
181 
241 
301 
361 
421 
481 
541 
ATTGGATGTTAACATTGTAGCTCGCAGAATCTTGAATTGTGAAAAATAAAACTTGTTCCT 
TTACTGCTGATACTTTAATTTCAAAACCAACTGGTACACAATACATAACGCCACCAGTTT 
GGGCATTTTGGATTGCAAACAGGACATTGTATGTGTAATTTGTTTGATTAGCAGTTTCCT 
TGCCCCAGAAAATCCATGCTTCATTTTTTTGAGTATTTAAATTTGTAAACGTATTTGTAA 
CTGCTGCAGTTAATTGATCTATTACAGATCCACTTAATGCAACTCCTAATACAGTTTTTA 
ACACTTCTAAGACTTTATTAATCATAACACTTACTTGGTTATTCTTTTGAGTTACATTTT 
GATCAACATAACTCACTACAGCACCCATCGGTGTAATTGTGTTTGCGATTTCTAAACCTT 
TTGCCATACTAAAGCGTAGGGCATCACCAAAATGTGTAGAAGTGGTAACTAATGTATTTT 
GAAATGCATTTGCTAACATAATTGCTTGCAATATATAATTCGGATTATCAATTTCGTTAA 
TAGAAAGAAGATTATTGATTTCATTTGGATCCTCAACACGTAATGTAATAACCCTTG 
Figure 30. Nucelotide sequence of cyt1A full gene 
[Submitted to NCBI database with accession number: MG708177] 
 
 
 
 
 
  
153 
 
E. Protein sequence of Cyt1A protein 
The nucleotide sequence of cyt1A gene from QBT229 was translated to amino acid 
sequence using the ExPasy tool available on Swiss Institute of Bioinformatics website. 
When compared to the amino acid sequence of Cyt1A protein of the reference strain 
H14, five consecutive amino acid replacements were observed (figure 31). From the 
amino acid positions 225 to 229, Lysine (K) was replaced by Asparagine (N), 
Phenylalanine (F) by Leucine (L), Alanine (A) by Histidine (H), Glutamine (Q) by 
Asparagine (N) and Proline (P) by another Histidine (H).  
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Figure 31. Amino acid sequence alignment of Cyt1A protein from QBT229 and 
reference Bti (Tron.3) 
[Amino acid sequence of QBT229 Cyt1A protein aligned with the amino acid sequence 
of Cyt1A protein from the reference Bti H14; Tron.3 is the name of the reference protein 
submitted to SWISS model software; red box indicates the five amino acid 
replacements seen in Cyt1A protein of QBT229 compared to H14; each set of 
underlined amino acids form alpha, beta or nu sheets of the protein as indicated below 
the underline; amino acids in blue indicate positive charge and the ones in red indicate 
negative charge]  
 
 
F. 3D protein modeling of Cyt1A protein 
A 3D model of the Cyt1A protein was drawn from the amino acid sequence using the 
software SWISS MODEL. Its structural homology was compared with that of the 
reference H14. No structural differences were noted among the two (figure 32). In 
silico, it was predicted that the amino acid replacements were not enough to bring about 
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any structural differences in the Cyt1A protein but might have changed the chemical 
property of the region. 
 
 
 
Figure 32. In silico 3D model of the Cyt1A protein and the region with amino acid 
replacements 
[a: 3D model of the Cyt1A protein of reference strain H14; b: 3D model of the Cyt1A 
protein of local strain QBT229; the dotted black box indicates the section of β sheet 
where the amino acids have been replaced; the amino acids in this section are indicated 
below the section in each model] 
 
 
G. Chemical homology of the novel Cyt1A protein
The chemical homology of the β8 sheet of the Cyt1A proteins from QBT229 and 
reference strain H14 was analyzed and compared. It was found that the β8 of QBT229 
had four polar amino acids between position 225 and 229 instead of just one polar 
amino acid in the respective region of Cyt1A protein from the reference H14. Also, the 
same region of Cyt1A protein of QBT229 had lost two hydrophobic amino acids that 
were present in case of H14 (table 20). Biochemically, this β8 sheet of QBT229 had 
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become much more positively charged than that of the reference strain H14 (figure 33).  
 
 
Table 20. Amino acids replacements observed in QBT229 and the consequent 
biochemical changes observed 
[charge, polarity and hydrophobicity of each amino acid are indicated below them] 
Amino 
Acid 
Positions 
Bt subsp. israelensis H14 Qatari Bt 
subsp. israelensis QBT229 
225 Lysine (+) 
(Charged) 
Asparagine (+) 
(Polar) 
226 Phenylalanine 
(Hydrophobic) 
Leucine 
(Hydrophobic) 
227 Alanine 
(Hydrophobic) 
Histidine (+) 
(Polar) 
228 Glutamine 
(Polar) 
Asparagine (+) 
(Polar) 
229 Proline 
(Hydrophobic) 
Histidine (+) 
(Polar) 
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Figure 33. Chemical changes in the β-sheet of Cyt1A protein of QBT229 due to amino 
acid replacements 
[green dotted box indicates the region of β sheet with the amino acid replacements; the 
blue color indicates positively charged regions and red color indicates negatively 
charged regions of the Cyt1A protein] 
 
 
4.4.3. Discussion 
In this part of the study, hemolytic and cytolytic activities of the Bt strains were studied. 
Analyzing the hemolytic activity, it was found that all the Bti strains have high 
hemolytic activities. In fact they gave big and clear zones around their colonies in Blood 
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agar; showing high breakdown of red blood cells (table 17). It was reported that Bt 
strains that have insecticidal activity and hemolytic activity do not possess anticancer 
cytolytic properties (Ohba et al., 2009). So, the Bti strains with high insecticidal 
(Chapter 4.2) and hemolytic activities, were expected to have almost no cytolytic 
activities. On the other hand, the Non-Bti representative strains showed varying degrees 
of hemolytic activities (table 17). Three strains QBT6, QBT81 and QBT99 showed 
similar degrees of hemolytic activities as the Bti strains. Like Bti, they were expected 
to have no cytolytic activities. QBT43, QBT240, QBT320 and QBT418 showed slightly 
less hemolytic activity. Other Non Bti representative strains showed no hemolytic 
activity at all. This last group of strains including QBT3, QBT34, QBT39, QBT41, 
QBT56, QBT212 and QBT555 with no hemolytic activity and no insecticidal activity 
(Chapter 4.2) were expected to have cytolytic activities.  
All the Bti strains and the Non Bti representative strains were tested for their cytolytic 
anti-cancer activities against lung cancer epithelial cells. Among the Bti strains, 
QBT205, QBT216, QBT229 and QBT230 were found to have comparatively high 
cytolytic activities (figure 24). Among the Non Bti strains, QBT41 and QBT320 had 
comparatively high cytolytic activities (figure 27). They continued to inhibit the growth 
of cancer cells even after 72 hours of treatment. Considering the hemolytic activities, 
cytolytic activities and insecticidal activities, the hemolytic insecticidal Bti strains were 
expected to have no cytolytic activities. In this study, novel Bti strains (QBT205, 
QBT216, QBT229 and QBT230) were identified as having all the three properties. The 
Non Bti representative QBT41 was expected to have cytolytic properties (figure 27a) as 
it had neither hemolytic activities nor insecticidal activities against at least Dipteran 
insects. This strain would be a good candidate for anticancer trials.  
Among the Bt strains tested, QBT229 showed the lowest LC50 as it could kill about 50% 
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of the cancer cells after 72 hours (figure 24 c) at the lowest concentration tested (0.15 
µg/ml). On molecular level when compared to the reference H14, QBT229 had similar 
plasmid content, similar δ- endotoxin protein profile and showed the presence of 
important δ- endotoxin coding genes like cry4 and cyt1A but lacked the genes cry10 
and cyt1C (Chapter 4.1 & 4.3). But, it had much higher cytolytic activities than H14. 
The anticancer parasporin encoding genes were absent in both QBT229 and H14. The 
other protein responsible for cytolytic activity is Cyt1A. The full gene nucleotide 
sequence was compared and there were at least five nucleotide differences among the 
cyt1A gene of QBT229 and H14. The translated amino acid sequences showed that there 
were five consecutive amino acid replacements in QBT229 on the β8 sheet (figure 31). 
A 3D model was drawn in silico using the amino acid sequences and structural 
homologies were analyzed. No structural differences were observed (figure 32). The 
chemical changes in this region was studied and it was found that the amino acid 
replacements in the β8 sheet of Cyt1A protein from QBT229 makes the β8 sheet more 
polar and positively charged; compared to that of H14 (figure 33). The β8 sheet of 
Cyt1A protein has two known functions: (1) interaction with the membrane to form 
pores to lyse the cell and (2) synergizing with other δ- endotoxins like Cry11.  
The increased polarity in the β8 sheet of Cyt1A protein from QBT229 enhances its 
cytolytic activities in terms of both its functions. The overall increase in polarity 
enhances its ability to interact with the polar heads of the lipid molecules in the cell 
membrane. The increased interaction between Cyt1A protein and the cell membrane 
will in turn increase its pore forming and consequent cell lysis abilities.  
On the other hand, the synergism between Cyt1A protein and Cry11 protein depends 
on the interaction between following amino acids: Lysine (+), Glutamate (+) and Lysine 
(+) at the positions 198, 204 and 225 of the Cyt1A protein and Serine (polar) and 
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Glutamate (+) at position 259 and 266 of Cry11 protein. Cry11 protein requires specific 
receptors for its insecticidal activities; which are absent on cancer cell lines. Hence, 
Cry11 protein doesn’t affect the cancer cell lines unless there is Cyt1A protein to 
synergize the Cry11 proteins and make it bind to the membrane (Perez et al., 2005). 
The replacement of Lysine at position 225 of β8 sheet of Cyt1A protein from QBT229 
with an Asparagine molecule makes it more polar and hence increases its interaction 
with the polar Serine molecule at position 266 of Cry11 molecule. To summarize, the 
five amino acids that are replaced in the β8 sheet of Cyt1A protein from QBT229 
enhances its ability to form pores in the cell membrane and its ability to recruit Cry11 
protein to the membrane. Overall, this novel Cyt1A protein of QBT229 gives it a much 
higher anti-cancer property towards lung cancer epithelial cell lines.  
4.4.4. Conclusion 
Among the Bt strains studied in this project, all Bti strains are highly hemolytic strains 
like the reference strain H14. Among the Non-Bti representative strains, QBT6, QBT81 
and QBT99 were also highly hemolytic, QBT43, QBT240 and QBT320 were slightly 
hemolytic and the remaining were not hemolytic at all. When tested for anticancer 
property, Bti strain QBT229 had the highest cytolytic activity. On molecular analyses, 
it was found that Cyt1A protein of QBT229 had five consecutive amino acids replaced 
in its β8 sheet. These replacements gave the β8 sheet more polarity; enhancing the 
ability of Cyt1A protein to form pores in the cell membrane and recruit Cry11 protein 
to the membrane. The presence of novel Cyt1A protein explains the high anti-cancer 
property of QBT229 when compared to the reference strains H14. These findings are 
very important and might have many applications in the treatment of lung cancer.  
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CHAPTER 4.5 RESULTS: EVALUATION OF PROTEIN YIELD OF HIGHLY 
INSECTICIDAL BTI STRAINS 
4.5.1. Introduction 
In this part of the study, four Qatari Bti strains were chosen from the collection of Bt 
strains: QBT217, QBT218, QBT220 and QBT221. These strains were chosen based on 
their high insecticidal activity against Aedes aegypti Bora Bora larvae (Chapter 4.2). 
The reference Bti strain H14 was used as positive control as it has been widely studied 
and characterized by many study groups. Bti H14 is also considered as one of the best 
Bti available today in the market to produce bio-pesticide. As negative control, Bti 4Q7 
strain was used. This is an acrystalliferous clone of Bti H14 having lost its insecticidal 
activities. In the first part of the study, the strains were grown in glucose-based medium 
that is known to be appropriate for δ- endotoxin production. The objective of the study 
was to estimate the production of δ- endotoxin per millilitre and per spore, at the end 
of complete sporulation. In the second part of the study, the glucose-based medium was 
modified, and alternate cheap and complex sources of nitrogen and carbon were 
provided. This was done to estimate the yield of δ- endotoxins in other sources that can 
be used for possible scale-up in the future and to compare between the local Bti and 
reference, the stability of crystal production in alternative media. 
4.5.2. Results 
A. Protein yield in Glucose based media 
Standard curve of Bovine Serum Albumin 
The concentrations of Bovine Serum Albumin (BSA) used and the associated O D 
obtained for each of the concentrations are listed in the table 21. A standard curve for 
BSA protein was obtained as shown in figure34. The linear slope trendline for the 
values were drawn using MS excel as shown in the figure 34. The regression (r2) value 
obtained for the slope was 0.9914 (very close to 1), showing that the standard curve for 
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the BSA was statistically accurate to be used for Bradford’s method. The slope equation 
obtained for this curve was y = 0.0089x + 0.0107. Where, x represents the concentration 
of protein and the y represents the O D. This equation was used to extrapolate the 
protein content for each strain based on their O D values.  
 
 
Table 21. Calibration of concentrations of standard protein Bovine Serum Albumin 
(BSA) using a spectrophotometer at 595 nm 
Concentration of BSA (ug/ml) O D at 595 
nm 
3 0.028 
5 0.055 
10 0.102 
15 0.157 
30 0.27 
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Figure 34. The standard curve for Bovine Serum Albumin  protein  
 
 
Estimation of protein production capacity  
The reference strain H14 produced about 35.56 µg of protein per ml. This was the 
highest amount of protein production seen among the strains tested (figure 35). The 
Group 3 strains produced lesser proteins per ml. QBT217 produced 26.76 µg/ml, 
QBT218 produced 23.39 µg/ml, QBT220 produced 20.58 µg/ml and QBT221 produced 
19.46 µg/ml of proteins. The negative control strain 4Q7 produced 3.17 µg/ml of 
proteins (table 22).  
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Table 22. Determination and statistical analysis of the protein production capacity in 
glucose based medium 
[Positive control is Bti strain H14; Negative control is Bti strain 4Q7; standard error for 
each value mentioned with +/- in brackets]  
Strains Protein concentration (µg/ml) Average protein 
concentration (µg/ml) 
 
I II III 
 
H14 33.315 35.562 37.809 35.562 +/- 1.3 
4Q7 1.854 3.539 4.101 3.165 +/- 0.7 
QBT217 23.764 27.697 28.820 26.760 +/- 1.5 
QBT218 20.393 22.640 27.135 23.390 +/- 2 
QBT220 18.146 20.955 22.640 20.581 +/- 1.3 
QBT221 18.146 19.831 20.393 19.457 +/- 0.7 
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Figure 35. Comparing the protein production capacity (µg/ml) of Qatari Bti strains with 
references 
[Bti H14 is the positive control; Bti 4Q7 is the negative control; Qatari Bti strains: 
QBT217, QBT218, QBT220, QBT221; error bars are standard error values plotted for 
positive and negative values]  
 
 
Estimation of cell biomass of Bti strains 
Contrary to the protein production per ml, the same strains showed a different trend 
when compared for their cell biomass. The reference H14 had 166.7 x 105 cfu/ml and 
the negative control 4Q7 had 536.7 x 105 cfu/ml. Among the QBti strains, QBT217 had 
the lowest cell biomass with 100 x 105 cfu/ml, followed by QBT220 with 176.7 x 105 
cfu/ml, QBT218 with 636.7 x 105 cfu/ml and QBT221 with 860 x 105 cfu/ml (figure 
36).  
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Table 23. Determination and statistical analysis of the cell biomass of Bti strains in 
glucose based medium 
[Positive control is Bti strain H14; Negative control is Bti strain 4Q7; standard error for 
each value mentioned with +/- in brackets] 
Strains Cell biomass (105 cfu/ml) Average 105 cfu/ml 
 
I II III 
 
H14 150 160 190 166.67 +/- 12.02 
4Q7 530 590 490 536.67 +/-29.06 
QBT217 80 100 120 100 +/- 11.6 
QBT218 600 6500 660 636.67 +/- 18.6 
QBT220 150 170 210 176.67 +/- 17.6 
QBT221 820 880 880 860 +/- 20 
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Figure 36. Comparing the cell biomass (105 cfu/ml) of Qatari Bti strains with references 
in glucose based medium 
[Bti H14 is the positive control; Bti 4Q7 is the negative control; Qatari Bti strains: 
QBT217, QBT218, QBT220, QBT221; error bars are standard error values plotted for 
positive and negative values]  
 
 
Estimation of protein yield of Bti strains per spore 
The highest yield of δ- endotoxins was seen with QBT217 producing 265.4 ng δ- 
endotoxin proteins per 105 cells (figure 37). Comparatively, the reference had a lower 
protein yield. H14 could only produce 208.5 ng per 105 cells. Other local strains gave 
very low protein yield with QBT218 giving only 36.6 ng per 105 cells and QBT221 
giving only 22.6 ng per 105 cells. Even though not as good as QBT217, QBT220 had 
comparatively good yield with 111 ng per 105 cells (table 24). 
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Table 24. Determination and statistical analysis of protein yield for Qatari Bti strains 
with references in glucose-based medium 
[Positive control is Bti strain H14; Negative control is Bti strain 4Q7; standard error for 
each value mentioned with +/- in brackets] 
Strains Protein 
production 
(µg/ml) 
Cell biomass 
(105 cfu/ml) 
δ endotoxin content 
(ng/105 cfu) 
H14 35.562 +/- 1.3 166.67 +/- 12.02 208.50 +/- 7.73 
4Q7 3.165 +/- 0.7 536.67 +/-29.06 0.00 +/- 1.41 
QBT217 26.760 +/- 1.5 100 +/- 11.6 265.44 +/- 16.66 
QBT218 23.390 +/- 2 636.67 +/- 18.6 30.69 +/- 2.25 
QBT220 20.581 +/- 1.3 176.67 +/- 17.6 111.40 +/- 4.81 
QBT221 19.457 +/- 0.7 860 +/- 20 16.66 +/- 0.3 
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Figure 37. Comparing the protein yield per spore (ng/105 cfu) of Qatari Bti strains with 
references in glucose based medium 
[Bti H14 is the positive control; Bti 4Q7 is the negative control; Qatari Bti strains: 
QBT217, QBT218, QBT220, QBT221; error bars are standard error values plotted for 
positive and negative values] 
 
 
B. Protein yield in Soyameal starch based medium 
Estimation of protein production capacity per 
 In the alternative media, the protein production per ml was the highest for the reference 
H14 (figure 38). H14 could produce 147.3 µg/ml proteins. For the negative control 
4Q7, the protein production was the lowest at 7.9 µg/ml. QBT217 strain produced 111.9 
µg protein per ml and QBT220 produced 101.9 µg protein per ml (table 25).  
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Table 25. Determination and statistical analysis of the protein production capacity in 
soya meal starch based medium 
[Positive control is Bti strain H14; Negative control is Bti strain 4Q7; standard error for 
each value mentioned with +/- in brackets]  
Strains Protein concentration (µg/ml) 
Average protein 
concentration 
(µg/ml) 
 I II III  
4Q7 7.775 6.427 9.573 7.925 +/- 0.91 
H14 149.798 143.955 148.000 147.251 +/- 1.73 
QBT217 97.663 127.775 110.247 111.895 +/- 8.73 
QBT220 100.809 110.247 94.517 101.858 +/- 4.57 
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Figure 38. Comparing the protein production capacity (µg/ml) of Qatari Bti strains with 
references in soya meal starch based medium 
[Bti H14 is the positive control; Bti 4Q7 is the negative control; Qatari Bti strains: 
QBT217, QBT220; error bars are standard error values plotted for positive and negative 
values] 
 
 
Estimation of cell biomass of Bti strains 
The cell biomass seen for H14 was the highest at 1883.3 x 105 cfu/ml (figure 39). The 
second highest cell biomass was seen in the negative control 4Q7 where there were 
1476.7 x 105 cfu/ml. The QBT217 and QBT220 had 1370 x 105 cfu/ml and 1013.3 x 105 
cfu/ml, respectively (table 26).  
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Figure 39. Comparing the cell biomass (105 cfu/ml) of Qatari Bti strains with references 
in soya meal starch based medium 
[Bti H14 is the positive control; Bti 4Q7 is the negative control; Qatari Bti strains: 
QBT217, QBT220; error bars are standard error values plotted for positive and negative 
values]  
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Table 26. Determination and statistical analysis of the cell biomass of Bti strains in 
soyameal starch based medium 
[Positive control is Bti strain H14; Negative control is Bti strain 4Q7; standard error for 
each value mentioned with +/- in brackets] 
Strains Actual cell biomass (cfu/ml) Average 105 
cfu/ml 
 
I II III 
 
4Q7 1.44 x 108 1.52 x 108 1.47 x 108 1476.67 +/- 23.33 
H14 2.06 x 108 1.74 x 108 1.85 x 108 1883.33 +/- 93.86 
QBT217 1.48 x 108 1.18 x 108 1.45 x 108 1370 +/- 95.39 
QBT220 0.91 x 108 0. 97 x 108 1.16 x 108 1013.33 +/- 75.35 
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Estimation of protein yield of Bti strains per spore 
In the alternative media, the protein yield was the highest in QBT220 with the yield of 
95.59 ng/105 cfu (figure 40). The reference H14 and QBT217 had almost the same yield 
of 73.13 ng/105 cfu and 76.36 ng/105 cfu, respectively (table 27).  
 
 
  
Figure 40. Comparing the protein yield per spore (ng/105 cfu) of Qatari Bti strains with 
references in soyameal starch based medium 
[Bti H14 is the positive control; Bti 4Q7 is the negative control; Qatari Bti strains: 
QBT217, QBT220; error bars are standard error values plotted for positive and negative 
values] 
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Table 27. Determination and statistical analysis of protein yield for Qatari Bti strains 
with references in soya meal starch based 
[Positive control is Bti strain H14; Negative control is Bti strain 4Q7; standard error for 
each value mentioned with +/-] 
Strains Protein 
production 
(µg/ml) 
Cell biomass (105 
cfu/ml) 
Protein 
yield 
(ng/105 cfu) 
δ endotoxin 
content (ng/105 
cfu) 
4Q7 7.925 +/- 0.91 1476.67 +/- 23.33 5.35 0.00 +/- 0.53 
H14 147.251 +/- 1.73 1883.33 +/- 93.86 78.48 73.13 +/- 2.99 
QBT217 111.895 +/- 8.73 1370 +/- 95.39 81.71 76.36 +/- 3.02 
QBT220 101.858 +/- 4.57 1013.33 +/- 75.35 100.94 95.59 +/- 2.95 
 
 
4.5.3. Discussion 
The main goal of this study was to evaluate the four highly insecticidal Bti strains 
(Chapter 4.2) based on their ability to produce δ- endotoxins (quantitative analysis). 
The strains tested for their protein production per cell were QBT217, QBT218, QBT220 
and QBT221. The study included two sections: testing the four strains in glucose-based 
medium and testing the important strains in alternative medium. All the strains were 
first grown in a glucose-based media that is known to enhance the sporulation and δ- 
endotoxin production in Bt (Ghribi et al., 2005). First the concentration of protein 
produced per ml was calculated and it was found that the reference H14 had produced 
the highest protein quantity per ml (figure 35). This was followed by QBT217, QBT218, 
QBT220 and QBT221. On the contrary, when the cell biomass of these strains were 
compared, the trend seen was very different. The reference H14, QBT217 and QBT220 
had a much lower cell biomass compared to QBT218, QBT221 and 4Q7 (figure 36). 
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The cultures for all the strains began with approximately equal number of cells. So, 
after culturing for same time, the huge differences in their cell counts show the 
differences in their cell biomass. It is even more interesting to note that the protein 
produced per ml do not correspond to the cell biomass. This means that the higher 
amount of protein produced could be due to either of the two reasons: the higher number 
of cells or the higher capacity to produce - δ- endotoxins. When the protein yield per 
cell was calculated, it was seen that local strain QBT217 has the highest protein yield 
per cell followed by the reference H14 and then the local strain QBT220. The protein 
yield per cell for other two local strains (QBT218 and QBT221) were much lower 
(figure 37). QBT217 and QBT220 were hence chosen as candidate strains.  
In the second part of this study, the protein yields were evaluated for the strains 
QBT217, QBT220 and the references H14 and 4Q7 in soyameal-starch-based medium. 
This alternative medium enhanced the protein production for all strains. Like glucose-
based media, in the alternative media also the protein production per ml was the highest 
in case of the reference H14 followed by QBT217 and then QBT220 (figure 38). H14 
had the highest cell biomass followed by QBT217 and then QBT220 (figure 39). When 
the protein yield was calculated, it was seen that the QBT220 had the highest yield 
followed by QBT217 and then H14 (figure 40). This was an interesting result as the 
local strains had much higher yield of δ- endotoxins than the reference in the presence 
of complex sources of carbon and nitrogen.  
4.5.4. Conclusion 
From the Bt collection, four Bti strains were chosen for the evaluation of their δ- 
endotoxin production capacity based on their high insecticidal properties against Aedes 
aegypti larvae. QBT217, QBT218, QBT220 and QBT221 showed different protein 
yields. Among them, QBT217 and QBT220 had high protein yield per cell compared to 
the Bti strain H14 available today in the market for bio-insecticide production. They 
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were hence considered as possible candidates for bio-insecticide production. An 
alternative medium was adopted to check the ability of the strains to grow and produce 
- δ- endotoxins in the presence of cheap yet complex sources of carbon and nitrogen. 
QBT220 was found to be the best candidate closely followed by QBT217 for local bio-
insecticide production.  
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CHAPTER 4.6 RESULTS: INVESTIGATION OF QATARI BT STRAINS 
PLASMID STABILITY AND EFFECT ON δ-ENDOTOXIN PRODUCTION 
4.6.1. Introduction 
Bt -endotoxins, the important components of the crystals formed during sporulation, 
are encoded by cry genes carried by one or more high molecular weight 
extrachromosomal plasmids. When a Bt strain is isolated from the environment and 
chosen for industrial bio-insecticide production, one of the main concerns is the stability 
of these plasmids and cry genes to ensure the highest -endotoxin yields. Bti carries its 
-endotoxins coding genes on a mega plasmid called pBtoxis. In this study, Qatari Bti 
strains were screened for the Bti  -endotoxin coding genes by PCR amplifications. The 
Qatari Bti strains showed the presence of all -endotoxins genes except the two genes 
cry10A and cyt1C. The first part of this study is about the analysis of the study o the 
stability of pBtoxis plasmid of Qatari Bti to monitor any segregational and structural 
instability that could lead to a loss of or change in the regions carrying the genes. The 
second objective of this study deals with choosing the best insecticidal strains among 
the Qatari Bti and submit them to plasmid curing conditions to select clones that have 
high structural stability, retaining the essential - endotoxin genes. The clones obtained 
after plasmid curing, were analysed based on their colony characteristics, the presence 
of cry4 - endotoxin genes and the presence or absence of insecticidal parasporal 
crystals. The clones, thus selected, were then tested for their - endotoxin yield per 
spore. The strategy was to compare the - endotoxin yields of the clones to that of the 
original strains and select the clones that show highest yield per spore. The Bt clones 
that show the highest yields would be considered as good candidates for bio-pesticide 
production, not only based on the yield for production, but also in terms of long-term 
stability of the genes encoding the -endotoxins.  
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4.6.2. Results 
A. Exploration of pBtoxis plasmid stability in Qatari Bti strains 
The 19 Bti strains isolated from Qatar showed the presence of all -endotoxin coding 
genes except cry10 and cyt1C (Chapter 4.3). When we analysed the positions of - 
endotoxin genes on the pBtoxis, it was identified that these two genes are located next 
to each other between positions 30 kb to 50 kb from the origin; in the order cry4B – 
cry10A – cyt1C. Mapping was done along this region with primers designed to amplify 
overlapping fragments (figure 41). The figure depicts the amplifications that gave the 
expected PCR products in green colour and the ones that did not work in red colour.  
 
 
 
Figure 41. Mapping of part of pBtoxis plasmid in Qatari Bti 
[The region between 30 kb and 50 kb from the origin of the pBtoxis plasmid is depicted 
by the black lines; forward primers designed depicted by green arrows; reverse primers 
designed depicted by the orange arrows; names of the primers listed in black; positions 
of genes depicted by the respective names and blue arrows; green lines: PCR 
amplifications that gave the expected product; red lines: PCR amplifications that did 
not give any amplifications.] 
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B. Evaluation of the effect of plasmid loss on - endotoxin production 
Induction of Bti plasmid curing 
Plasmid curing was conducted for two Qatari Bti strains QBT217 and QBT220. After 
seven overnight culturing at 420C, each culture was diluted till 10-5. The diluted culture 
was spread on a LB plate to obtain isolated colonies, which were analysed after 
overnight incubation. For QBT220, 75 clones were isolated and transferred to fresh 
plate, each. For QBT217, 43 clones were isolated and transferred to a fresh plate, each. 
Among the QBT220 clones, only one type of colony was observed: white (figure 42b). 
On the other hand, for QBT217, two types of colonies were observed: 26% white and 
74% yellow (figure 42a).  
 
 
 
Figure 42. Morphology of colonies among the clones obtained after plasmid curing 
[(a): LB Agar for QBT217 showing two types of colonies; (b): LB Agar for QBT220 
showing the single type of colonies; yellow circle: the yellow colored colonies obtained 
for clones of QBT217; red circle: the white colored colonies obtained for clones of 
QBT217] 
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Loss of genetic material among the obtained new clones  
The white colony colour is a new characteristic, as the original QBT220 and QBT217 
have yellow colony colour. It can be concluded that the culturing of these 2 strains at 
high temperature might have affected their genetic material giving this white colony 
colour to QBT220 and QBT217. In fact, these strains have many extrachromosomal 
high molecular plasmids among which the pBtoxis plasmid carrying the - δ- endotoxin 
coding genes. 
Investigation of the presence of pBtoxis plasmid in the Bt heat treated strains 
The interest in these clones resides in the possible importance of the clones that might 
have lost part of their plamids while managing to retain pBtoxis and the insecticidal δ- 
endotoxin genes. To check whether the new clones retain the pBtoxis plasmid, their 
total DNA was isolated and used to amplify cry4 gene (figure 43, figure 44). For 
QBT220, out of 75 clones, only two clones gave the expected amplification: 220KN65 
and 220KN66 (figure 46). In case of QBT217, only three clones out of the white 
colonies gave the expected PCR amplification: 217KN33, 217KN35 and 217KN39 
(figure 45). Among the yellow colony clones of QBT217, 75% of the clones gave the 
expected amplification and the other 25% did not (figure 45).  
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Figure 43. Exploration of the presence of cry4 gene in the QBT217 mutants by PCR  
[(a): PCR products obtained for clones that show yellow colonies; (b) PCR products 
obtained for clones that show white colonies; H: positive control Bti H14; L: 1 kb plus 
linear DNA ladder; N: negative control with no DNA template added for PCR; Lane 1 
to Lane 43: PCR products using DNA template from clones 217KN1 to 217KN43]  
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Figure 44. Agarose gel showing the PCR amplifications for cry4 gene in clones of 
QBT220 
[H: PCR positive control Bti H14; L: 1 kb plus linear DNA ladder; Lane 1 to Lane 75: 
PCR products using DNA template from clones 220KN1 to 220KN75]  
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Figure 45. Distribution of QBT217clones : colony characteristics & presence of cry4 
gene 
[middle disc depicts the distribution of clones obtained based on their colony color; pie-
chart on right depicts the distribution of clones forming yellow colonies based on the 
presence of cry4 gene; pie-chart on left depicts the distribution of clones forming white 
colonies based on the presence of cry4 gene; Lost: No amplification obtained for cry4 
specific primers; Retained: expected PCR product obtained for cry4 specific primers] 
 
 
 
Figure 46. Distribution of clones oBtained for QBT217: colony characteristics & 
presence of cry4 gene 
[Lost: No amplification obtained for cry4 specific primers; Retained: expected PCR 
product obtained for cry4 specific primers; only white colonies obtained for clones from 
QBT220]  
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Effect of the loss of the genetic material on important functions.  
Among the clones forming white colonies, the ones that showed the presence of cry4 
gene are the clones that have undergone genomic instability while retaining the - 
endotoxin coding genes. We proposed to explore the effect of this genomic instability 
on -endotoxin production in these obtained clones. The clones forming white colonies 
and lost the cry4 gene were used as negative control for - endotoxin production. The 
clones forming yellow colonies and have retained the cry4 gene are the true positive 
control apart from the original strain itself. After culturing the three groups of interest 
in Glucose based sporulation media, it was found that the clones forming white colonies 
with cry4 gene form normal spores and crystals; like the original strain. While the 
clones forming white colonies and lost cry4 gene showed the presence of normal spores 
but lacked crystals. The third group of clones, forming yellow colonies and having cry4 
gene failed to sporulate even after five days of incubation in sporulation media. Hence, 
three clones of QBT217 and two clones of QBT220 were chosen for δ- endotoxin 
production: 217KN33, 217KN35, 217KN39 (figure 47), 220KN65 and 220KN66 
(figure 48). For negative control, 217KN42 and 220KN9 were chosen. Positive controls 
were the original strains of QBT217 and QBT220.  
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Figure 47. Characteristics of QBT217 clones chosen for estimation of δ- endotoxin yield 
 
 
 
Figure 48. Characteristics of QBT220 clones chosen for estimation of - endotoxin yield 
production 
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Estimation of the - endotoxin yields of new clones 
- endotoxin yield of the new clones was estimated by the same methodology used in 
Chapter 4.5. The colonies forming white colonies and retaining the cyt4 gene were 
selected for the - endotoxin production studies. As negative control, the 
acrystalliferous clones forming white colonies and lacking the cry4 gene was used. As 
positive control the original strains QBT217 and QBT220 were used.  
A. Comparison of cell biomass:  
For QBT217 and QBT220, it was observed that the new clones had much higher cell 
biomass than the original strains. Among the new clones, the acrystalliferous strains (in 
red, table 28) had higher cell biomass then the other strains (in green, table 28) with 
normal spores and crystals.  
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Table 28. Determination and statistical analysis of cell biomass of plasmid cured clones 
[217KN33, 217KN35, 217KN39, 220KN65 and 220KN66: the clones with normal 
spore and crystal; 217KN42 and 220KN9: acrystalliferous clones used as negative 
control; QBT217 and QBT220: original strains used as positive control] 
Strains Growth (cfu/ml) x 106 
Average growth 
(cfu/ml) x 10
6 
 
I II III 
 
217KN33 32 31 34 32.33 (+/- 0.88)   
217KN35 98 100 98 98.67 (+/- 0.67)   
217KN39 49 55  50  51.33 (+/- 1.86)   
217KN42 220 215  229  221.33 (+/- 4.1)   
QBT217 
8  10  12  10 (+/-1.16)   
220KN9 130  137  141  136 (+/- 3.22)   
220KN65 40   43   43  42 (+/- 1)   
220KN66 36  34  38  36 (+/- 1.16)   
QBT220 
15  21  17  17.67 (+/- 1.77)   
 
 
B. Comparison of total protein production:  
Like the cell biomass, the amount of - endotoxin produced by the strains was the 
lowest among the original strains. Among the new clones, the acrystalliferous strains 
(in red, table 29) produced the lowest amount of proteins, compared to the other clones 
  
189 
 
(in green, table 29) with normal spores and crystals.  
 
 
Table 29. Determination and statistical analysis of crystal protein production of plasmid 
cured clones 
[217KN33, 217KN35, 217KN39, 220KN65 and 220KN66: the clones with normal 
spore and crystal; 217KN42 and 220KN9: acrystalliferous clones used as negative 
control; QBT217 and QBT220: original strains used as positive control] 
Strains Protein production (ng/ml) 
Average protein 
production  
(ng/ml) 
 
I II III 
 
217KN33 
10.08 x 104 10.53 x 104 10.13 x 104 10.25 (+/- 0.14) x 10
4
 
217KN35 
19.07 x 104 18.94 x 104 17.27 x 104 18.43 (+/- 0.58) x 10
4
 
217KN39 
10.58 x 104 9.77 x 104 10.26 x 104 10.2 (+/- 0.24) x 10
4
 
217KN42 
5.32 x 104 5.09 x 104 4.78 x 104 5.06 (+/- 0.16) x 10
4
 
QBT217 
2.77 x 104 2.89 x 104 2.38 x 104 2.67 (+/- 0.15) x 10
4
 
220KN9 
2.67 x 104 2.62 x 104 2.44 x 104 2.58 (+/- 0.07) x 10
4
 
220KN65 
7.65 x 104 8.06 x 104 7.7 x 104 7.8 (+/- 0.13) x 10
4
 
220KN66 
8.37 x 104 8.42 x 104 8.15 x 104 8.31 (+/- 0.08) x 10
4
 
QBT220 
2.1 x 104 2.26 x 104 1.82 x 104 2.06 (+/- 0.13) x 10
4
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C. Comparison of δ- endotoxin yield:  
The determination of δ- endotoxin yield was calculated by subtracting the protein yield 
of the negative control clones (in red, table 30) from each of the studied clones (in 
green, table 30). The yield of total protein per cell was calculated by dividing the values 
of total protein production by the growth obtained each millilitre. Among the clones for 
QBT217, 217KN33 showed a higher -endotoxin yield per spore compared to the 
original strain. The other two clones 217KN35 and 217KN39 showed a lower -
endotoxin yield per spore compared to the original strain QBT217. In case of clones for 
QBT220, both the clones showed much higher -endotoxin yield per spore compared 
to that of the original strain QBT220.  
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Table 30. Determination and statistical analysis of - endotoxin yield of plasmid cured 
clones 
[217KN33, 217KN35, 217KN39, 220KN65 and 220KN66: the clones with normal 
spore and crystal; 217KN42 and 220KN9: acrystalliferous clones used as negative 
control; QBT217 and QBT220: original strains used as positive control] 
Strains 
Protein 
production 
(ng/ml) x 10
4
 
Growth 
(cfu/ml) x 10
6
 
Protein yield 
(ng/10
5
cfu) 
δ- endotoxin 
yield 
(ng/10
5
cfu) 
217KN33 
10.25  
(+/- 0.14)  
32.33  
(+/- 0.88) 
317.14  
(+/- 4.47)  
294.27  
(+/- 4.79)  
217KN35 
18.43  
(+/- 0.58)  
98.67  
(+/- 0.67) 
186.73  
(+/- 5.30) 
163.86  
(+/- 5.62)  
217KN39 
10.2  
(+/- 0.24) 
51.33  
(+/- 1.86) 
198.98  
(+/- 3.71) 
176.11 
 (+/- 4.03)  
217KN42 
5.06  
(+/- 0.16) 
221.33 
 (+/- 4.1) 
22.87  
(+/- 0.32) 
0 
QBT217 
2.67  
(+/- 0.15) 
10  
(+/-1.16) 
271.5  
(+/- 16.82) 
248.63  
(+/- 17.14)  
220KN9 
2.58  
(+/- 0.07) 
136  
(+/- 3.22) 
18.94  
(+/- 0.10) 
0 
220KN65 
7.8  
(+/- 0.13) 
42  
(+/- 1) 
185.84  
(+/- 3.67) 
166.90  
(+/- 3.77)  
220KN66 
8.31  
(+/- 0.08) 
36  
(+/- 1.16) 
231.26  
(+/- 5.27) 
212.32  
(+/- 5.37)  
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Strains 
Protein 
production 
(ng/ml) x 10
4
 
Growth (cfu/ml) 
x 10
6
 
Protein yield 
(ng/10
5
cfu) 
δ- endotoxin yield 
(ng/10
5
cfu) 
QBT220 
2.06  
(+/- 0.13) 
17.67  
(+/- 1.77) 
117.27  
(+/- 4.9) 
98.33  
(+/- 5)  
 
 
D. Evaluation of the effect of plasmid curing on -endotoxin production 
Among the clones of QBT217, clones 217KN35 and 217KN39 had significantly lower 
δ- endotoxin yield compared to the original strains QBT217. They showed a decrease 
of about 29% to 34% in their δ- endotoxin yield. The clone 217KN33 showed an 
increase in its -endotoxin yield but, but statistically not significant as shown by the 
error value (table 31). In the case QBT220, both the clones 220KN65 and 220KN66 
showed a significant increase in their δ- endotoxin yield. 220KN65 showed an increase 
of about 68% and 220KN66 showed an increase of about 116%. As indicated by their 
error values, they are statistically significant (table 31).  
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Table 31. Estimation of the increase/decrease of the -endotoxin production in the Bti 
cured clones  
[Changes depicted as positive percentage indicates an increase and in negative indicates 
a decrease in the δ- endotoxin yield of clones per spore compared to the original strains; 
underlined values for the clones of QBT220 show statistically significant increase in 
their δ- endotoxin yield] 
Strains 
Change in δ- endotoxin 
yield (%) 
217KN33 +18.36 (+/- 20.27) 
217KN35 -34.1 (+/- 13.67) 
217KN39 -29.14 (+/- 13.07) 
220KN65 +69.74 (+/- 17.68) 
220KN66 +115.93 (+/- 32.94) 
 
 
4.6.3. Discussion 
The plasmid instability was analysed among the Qatari Bti strains from the collection 
in two different sections. The first study involved identifying the reason why Qatari Bti 
strains failed to give expected PCR amplifications with primers specific for two Bti 
gene: cry10A and cyt1C. The second study involved choosing the highly insecticidal 
Bti strains and obtain clones from them by plasmid curing process and analyse the effect 
on their -endotoxin yield per spore.  
In the first study, it was found that all 19 Qatari Bti strains lost part or all of each of the 
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two genes, cry10A and cyt1C. The absence of the amplification could be explained by: 
a change in the gene sequence, or a plasmid structural instability and gene loss. When 
analysing the positions of the two genes, it was found that they are next to each other 
on the mega plasmid pBtoxis of Bti. On further analysis it was found that they are 
present next to cry4 gene between the positions 30 kb and 50 kb from the origin. Primers 
were designed to map this region starting from cry4 gene that was found to be present 
in Qatari Bti. Mapping revealed that the region of pBtoxis with cry4 gene was intact, 
but the region from about 38 kb from the origin is lost. This structural instability is a 
signature of Qatari Bti strains as they all give the same results. This instability is not 
just associated with the lost genes, but the entire region of pBtoxis after cry4 gene.  
In the second study of plasmid stability, the two strains QBT217 and QBT220 were 
chosen because of their high insecticidal property compared to the reference Bti and 
other Qatari Bti. They were both individually used for plasmid curing experiment over 
a seven-day period. After seven days, QBT217 gave 43 clones and QBT220 gave 75 
clones. QBT217 clones showed two different types of colony colours: yellow colour 
like the original strain of QBT217 and white colour. QBT220 had all white coloured 
colonies. The white coloured clones were of interest as the new characteristic means 
loss of part of genome. For the interest of this study, it was essential to choose clones 
that have lost a part of the genome but retained essential - endotoxin genes. Hence the 
DNA from clones obtained were used as template to amplify part of the cry4 gene. On 
checking the PCR products on agarose gels, it was found that some clones had lost the 
cry4 gene. In the case of QBT217 clones three of the clones forming white colonies 
retained the cry4 gene and other had lost it. The three that retained the cry4 gene were 
the candidate clones for -endotoxin production experiments. The others that lost cry4 
gene were considered as negative control. Among the QBT217 clones forming yellow 
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colonies, the ones that retained the cry4 gene were to be used as positive control along 
with the original strain for -endotoxin production experiments. It was found that they 
did not sporulate even after 5 days. They had lost some part of their sporulation 
machinery but retained the -endotoxin genes. Hence it was decided to use only original 
strains as positive control. In case of QBT220, only one type of colonies was obtained: 
white. Among them, only two clones retained the cry4 gene. These two were the 
candidate strains for the -endotoxin production experiments. The ones that had lost the 
cry4 gene were the negative control and the original strain was the positive control. 
Before using the clones of both strains that have lost cry4 gene as negative control, it 
was essential to check the presence of crystals. Absence of Cry4 protein should 
eliminate the crystal formation. On microscopic observation, it was found that the cry4- 
strains were acrystalliferous. They formed spores during sporulation with no parasporal 
crystals.  
δ- endotoxin yield per spore was estimated for each of the candidate clones of QBT217 
and QBT220 along with the negative control clones of QBT217 and QBT220 (figure 47 
& figure 48), and the original strains as positive control. It was found that the cell 
biomass of the clones were much higher than the original strains. This could be 
explained by the fact that loss of part of genome usually increases the cell division rate. 
When the δ- endotoxin yield per spore was estimated, it was found that both the clones 
of QBT220 had gained a significant δ- endotoxin yield per cell. They showed an 
increase in the yield by 69% to 115% compared to the original strain QBT220. In case 
of clones of QBT217, one clone showed an increase in -endotoxin production and the 
other two clones had significantly lost the δ- endotoxin yield per spore compared to 
QBT217.  
 
  
196 
 
4.6.4. Conclusion 
The plasmid stability of the Qatari Bti strains was explored. Among the Qatari Bti, it 
was found that they were subjected to pBtoxis plasmid structural instability and 
consequently lost two of the - endotoxin genes: cyt1C and Cry10A. This plasmid 
structural instability is a common signature among the Bti strains isolated from Qatar 
as they all have lost that region of their pBtoxis.  
The two Bti strains QBT217 and QBT220, having the highest insecticidal activity, were 
chosen for heat induced plasmid curing segregational instability experiments. The 
clones were characterized based on their colony characteristics, presence of cry4 gene 
and microscopic observation of sporulated culture. The clones were studied for their δ- 
endotoxin yield per spore. Two clones of QBT220 were identified that have about 69% 
to 115% increase in their δ- endotoxin yield per spore compared to the original strain 
QBT220. These clones have the most stable pBtoxis plasmid as they retained the 
essential genes even after plasmid curing and, in the process, lost other non-essential 
parts of their genome. Loss of part of genome helped them to increase the -endotoxin 
production capacity.  
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CHAPTER 5: CONCLUSION AND PERSPECTIVES 
The aim of this PhD research project was to characterize the 441 Qatari Bacillus 
thuringiensis (Bt) strains, isolated by our research group from Qatar, that produce 
spherical crystals and identify candidate strains for insecticidal activity against Dipteran 
insects like mosquitoes. This study focused on finding a sustainable solution to two of 
the huge health hazards faced by humans today: the diseases caused by the pathogen 
carrying vectors like mosquitoes and the health issues caused by the toxic chemical 
insecticides used to control these vectors. An efficient biological control of the disease 
vectors would solve both health hazards. Bacillus thuringiensis (Bt) has been 
recognized as the best biological control for this purpose and there is a need to screen 
many unexplored ecologies for Bt strains that are efficient enough to replace the 
chemical insecticides in the market.  
In this study, a collection of 441 Bt strains producing spherical crystals were 
characterized and classified based on crystal morphology, plasmid patterns, protein 
patterns of crystal -endotoxins and corresponding cry and cyt genes (Chapter 4.1). 
Crystal morphology divided the collection into five classes. One class of 19 Bti strains 
that resembled the reference strain H14 and four other morphologies that were Non-Bti 
like. The plasmid patterns divided the collection into six groups. One group of 19 Bti 
strains that resembled that of H14 and five groups of Non-Bti strains. Based on protein 
patterns, the collection was divided into 15 groups; one Bti pattern and 14 Non-Bti 
patterns. As the protein patterns gave the maximum number of classes among the 
collection, the true groups were made based on this category. The collection was 
broadly divided into two groups: 19 Bti strains and 422 Non Bti strains. The Non-Bti 
strains were further divided into 14 classes based on their protein patterns. A true 
representative was chosen for each class. All the other studies were performed with 19 
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Bti strains, 14 Non Bti representatives, positive control Bti H14 and negative control 
Bti 4Q7.  
In another part of the study, the insecticidal properties of the strains were investigated 
against Dipteran insect larvae of Culex pipiens and Aedes aegypti (Chapter 4.2). The 
qualitative studies showed that the Bti strains were all insecticidal, while the Non-Bti 
representatives were not insecticidal against Culex pipiens 3rd instar larvae. 
Quantitative insecticidal bioassays with 3rd instar larvae of Aedes aegypti Bora Bora 
showed that four Bti strains QBT217, QBT218, QBT220 and QBT221 had higher 
efficiency than the reference strain H14. By statistical analysis, it was found that 
although all four had similar insecticidal fiducial range for their LC50 values, QBT220 
was the most insecticidal among them.  
To understand the insecticidal activity, Bt strains were screened for the presence of 
Dipteran specific delta endotoxin proteins (Chapter 4.3). The first strategy was 
screening by amplifying part / whole of the endotoxin coding genes. This worked well 
for Bti strains. It was found that the Qatari Bti strains carried all the insecticidal 
endotoxin genes except cry10A and cyt1C. As all the Qatari Bti strains showed the 
absence of these two genes, further analyses were performed to explore this 
phenomenon. It was found that there is a structural instability in the region of pBtoxis 
plasmid between the positions 30 kb and 50 kb from the origin (Chapter 4.6). Plasmid 
mapping showed that the entire regions from 38 kb to 50 kb was missing in case of 
Qatari Bti. Among the Non-Bti strains, QBT674 was found to carry the gene for Cry2 
-endotoxin. This is the first report of a spherical crystal forming Bt strain that carries 
cry2 gene without the presence of cuboidal crystals. The second strategy used for 
screening for endotoxins was protein profiling using LC/MS for Non-Bti representative 
strains. It was found that a Non Bti strain QBT555 expresses Bti -endotoxins like 
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Cry10, Cry11 and Cyt1A. The absence of Cry4 protein in this Bt strain explains why 
its crystal proteins were ineffective against Dipteran insect larvae despite having the 
other endotoxins.  
The Bt strains were further characterized based on their haemolytic and cytolytic 
properties (Chapter 4.4). As expected, the Bti strains have high haemolytic activities, 
but the Non-Bti strains showed varying degrees of haemolytic activities. Normally, the 
Bt strains with no haemolytic and no insecticidal activities are the ones with cytolytic 
activities. But, this study found Bti strains having insecticidal and haemolytic activities, 
to also possess high cytolytic activities. QBT229 was the most effective against lung 
cancer epithelial cells. The anti-cancer parasporin protein coding genes were absent in 
the Qatari Bt strains. The other protein Cyt1A responsible for cytolytic activities was 
further explored at the molecular and biochemical levels. It was found that Cyt1A 
protein of highly cytolytic QBT229 had five consecutive amino acid replacements in its 
β sheet. These amino acid replacements make the β sheet highly positive and polar. The 
β sheet is involved in the direct binding of the Cyt1A protein to the lipid bipolar 
membrane and recruiting Cry11 to the membrane. The highly positive and polar β sheet 
enhances both the functions of Cyt1A; thereby increasing its total cytolytic property. 
Bti strains were selected for -endotoxin production experiments based on two 
conditions: high insecticidal activity and low cytolytic activity. The four strains 
QBT217, QBT218, QBT220 and QBT221 were tested for the -endotoxin 
(crystal/spore) production capacity. It was found that QBT217 and QBT220 had the 
highest -endotoxin yield per spore, compared to that of H14 and other Qatari Bti 
(Chapter 4.5). The two efficient strains were also tested in an alternative sporulation 
medium called Soya meal-starch based media. In the presence of complex sources of 
carbon and nitrogen, QBT220 showed the highest -endotoxin production compared to 
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the reference H14 and QBT217.  
The candidate strains for production of bioinsecticides against Dipteran insects were 
chosen as QBT217 and QBT220. In the scale-up process and industrial level production, 
there is always a chance of losing the insecticidal endotoxin coding genes due to 
plasmid instability. Hence, the plasmid curing technique was conducted with QBT217 
and QBT220 to isolate clones with highest plasmid stability (Chapter 4.6). In the 
process, the effect of plasmid curing on -endotoxin production was evaluated. The 
positive effect on -endotoxin production means choosing clones with higher -
endotoxin production properties. Two important mutant clones of QBT220 were 
isolated, 220KN65 and 220KN66, with an increase in their -endotoxin yield per spore 
of about 69% and 115%, respectively.  
In summary, from our Qatari Bt collection, the Bti strains QBT220 was recognized as 
the most efficient Bt strain to produce bio-insecticides against Dipteran insects. Two of 
its clones obtained by plasmid curing showed an increase of up to 115% in the -
endotoxin yield per spore, even higher than the original strain QBT220. Novel Bt strains 
were recognized among the collection. QBT674 is aspherical crystal producing strains 
with cry2 gene but does not produce cuboidal crystal. QBT555 is a Non Bti strain with 
molecular profile very different from Bti strains, but expresses Bti proteins like Cry11, 
Cry10, Cyt1A and pBt152. QBT229 is an insecticidal and haemolytic Bt strain that also 
showed high cytolytic activity. Novel proteins were identified, like Cyt1A protein of 
the Bti strain QBT229 that had five amino acid replacements in its β sheet that enhanced 
its cytolytic activity.  
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Perspectives:  
The candidate strains QBT220 and its isolated mutants in this project, should be used 
for scale-up experiments and optimize the growth conditions for production at 
fermenter level. QBT229 should be studied further for its anticancer property using 
more cancer and normal cell lines; adherent and suspension. QBT674 strains will have 
to be studied at molecular level to understand the reason why it fails to produce the 
cuboidal crystal despite the presence of cry2 structural gene and the regulatory ORF2. 
Induced plasmid cured mutants are excellent candidates to be explored further for the 
enhancement of the production and / or activity of Bt toxins other than -endotoxins. 
The plasmid cured clones that have lost the sporulation machinery and retained the delta 
endotoxin genes are also interesting as these cells could be used as good model for 
developing encapsulated crystals without spores. The protein profiling of the Non Bti 
strains can be continued for the screening of any other proteins that are produced by the 
Bt strains during vegetative or sporulation stage as the procedure has been standardized 
in this PhD project. The thorough characterization and true classification of these 441 
Bt strains producing spherical crystals, have been performed in this PhD project and 
hence it will be easy to screen this very precious gene bank for any interesting and high 
value molecule and activity in the future. 
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APPENDIX C: Positions of primers designed for Plasmid mapping of pBtoxis 
 
CAAGCCGCAAATCTTGTGGAATGTATTTCTGAAGAATTATATCCAAAAGAAAAAA 
     >>>>>>>(Dip1A)>>>>>> 
TGCTGTTATTAGATGAAGTTAAAAATGCGAAACAACTTAGTCAATCTCGAAATGT
ACTTCAAAACGGGGATTTTGAATCGGCTACGCTTGGTTGGACAACAAGTGATAAT
ATCACAATTCAAGAAGATGATCCTATTTTTAAAGGGCATTACCTTCATATGTCTG
GGGCGAGAGACATTGATGGTACGATATTTCCGACCTATATATTCCAAAAAATTGA
TGAATCAAAATTAAAACCGTATACACGTTACCTAGTAAGGGGATTTGTAGGAAGT
AGTAAAGATGTAGAACTAGTGGTTTCACGCTATGGGGAAGAAATTGATGCCATC
ATGAATGTTCCAGCTGATTTAAACTATCTGTATCCTTCTACCTTTGATTGTGAAGG
GTCTAATCGTTGTGAGACGTCCGCTGTGCCGGCTAACATTGGGAACACTTCTGAT
ATGTTGTATTCATGCCAATATGATACAGGGAAAAAGCATGTCGTATGTCAGGATT
CCCATCAATTTAGTTTCACTATTGATACAGGGGCATTAGATACAAATGAAAATAT
AGGGGTTTGGGTCATGTTTAAAATATCTTCTCCAGATGGATACGCATCATTAGAT
AATTTAGAAGTAATTGAAGAAGGGCCAATAGATGGGGAAGCACTGTCACGCGTG 
                                             >>>>>>>>(F1)>>>>>>>> 
AAACACATGGAGAAGAAATGGAACGATCAAATGGAAGCAAAACGTTCGGAAAC
ACAACAAGCATATGATGTAGCGAAACAAGCCATTGATGCTTTATTCACAAATGTA 
                                            <<<<<<<(Dip1B)<<<<<< 
CAAGATGAGGCTTTACAGTTTGATACGACACTCGCTCAAATTCAGTACGCTGAGT
ATTTGGTACAATCGATTCCATATGTGTACAATGATTGGTTGTCAGATGTTCCAGGT
ATGAATTATGATATCTATGTAGAGTTGGATGCACGAGTGGCACAAGCGCGTTATT
TGTATGATACAAGAAATATTATTAAAAATGGTGATTTTACACAAGGGGTAATGGG
GTGGCATGTAACTGGAAATGCAGACGTACAACAAATAGATGGTGTTTCTGTATTG
GTTCTATCTAATTGGAGTGCTGGCGTATCTCAAAATGTCCATCTCCAACATAATCA
TGGGTATGTCTTACGTGTTATTGCCAAAAAAGAAGGACCTGGAAATGGGTATGTC
ACGCTTATGGATTGTGAGGAGAATCAAGAAAAATTGACGTTTACGTCTTGT 
 
GAAGAAGGATATATTACGAAGACAGTAGATGTATTCCCAGATACAGATCGTGTA
CGAATTGAGATAGGCGAAACCGAAGGTTCGTTTTATATCGAAAGCATTGAATTAA
TTTGCATGAACGAGTGATTAATAAAAAATAACTAAAGCTTTAAAAACCATGGAG
AAAGTTTTCTCCATGGTTTTTAATTTCTGCATTTATTAATTCTGGTACAAAAAATA
TATAGAAAACATAAAAAATAGATATCTAGAGGACATAAAATTTATACAAATATC
AATTTCATTAGTATAGAACGTTTATCCAATAATAATTATCACCATTTAAACTATCC
AAACTACAATTGTGATCCAAGTTATGATGATTAATAGATGAACTGATTTAGGATT
TGAAAATAGATTTTCATCAAACAAAATGAGGGAAAGAATATGCAGGGAAATCAA 
                                                                                     >>>>>>>>>(F2)>>>>> 
CAATCGATTTCAAATCTTAATACTTCGGGATTATTTCGGGGTACAGCCGAGATAC
GTGTAAGAATAGACCGTATCCTTACCTTTATTTCTATATTGGATTTATTGAGCTTA
TAAATATTGTTTCTGTGGTTTCGTCTATTTTTATTAAGTAAATTGTCTATTATGGGT
TAACCCTAATCATTCATTAGTTACTGAAAACATTTTATTTCATTTGTGTGATTAGG
ATGAGTGATAATAGATTCAAAAACAAAAAAGCTGGATTAATGCCAGCTTTTTTTA
CAATTATAATTACCCATAAATATAAAATATTATTTTTGTGTTTCTCTTTCACCTAC
AACCTAAGCTAATAATAAAATAGAGCTAGTTACTAACAATGCTATAAAAACTCCC
ATTAAACATTTCTCCTTTTTACAAAAAATATTTTACCATATTATACCGCATCAGGA 
                                                                                                                                <<<<<< 
CGGATCAAATTGTAATAACAAGGAGCATTTATGTTGCAAATGTCACAGAAAAAT 
<<(R1)<<<<<<<< 
ATTTTTTGGAAAAGAATATATAAAAATGACCTATTTTTACACGTATCTCGGTTGTA 
                                                                                                                                    >>>>>> 
CCCCATACACAGAAACAGACATAAAACAGACATAAAACACACCTTCCTTTCCTAT 
>>(F3)>>>>>>>> 
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GATTTTACATAAAAAATAGCGTGTTTTTTCATTTTAAGAAAATTTAATTTTGTTAG
CGTAATAGCGATATATGTGCTTTTTAAATAAATTATTAAAATCTTAATGCTTTAAG
TAGAAAATTATATAAAACATAGAAAAATTGAGCTATCAAGGCACCTTGCCATAA
ACTTAAGTTAGAAGAAAGATAAGGGTGTTTTTTAAGATACATATGTAATATACAG
AGATTCGTTCCACTGGCTGAAAGAACGATTATTAGGCCTCTTTGAAGGTAGTCTC
GGAGCTTTGCTTTTGAAAGAGTGAAAATTGTGCCCAGTAGAAAGCAACGATTTGG
TTCTCGTTATCGAACTAAAGTCATAGGACTTATTGAGTTTATTTACCGTGAGGAA
ATAGAGAAACTGAGTGGTACCGCAATAATCACGCCTCAGGAATCAAGCGTATAA
TGCGTATTTGATTGTGGAGGTGAGATTTTTTATTGTTTAAAGTAAGAATAATATTT
TAAAAAGATCATAGAAATTCAAGGCAAAACAGGAGAGAATGATTAAGTTATTTA
AAATAGATTAGAAAAGGAAGGGATAATAATGTTTTAAAATTCTTTTTTTATTAAT
CTAAGAAAAACCGTGCAGGATGATATCAATGGTTCTGTTGCAAAGTTTGAAAAA
AATTATAAATGGGTGGATAAATAAGGGGAATAACTTATGCAGTGGCCATTGATTG
TTGTAATTCATTGTACACTGAAAAGGCAAGATTTGTTTGGAAATTTCGCCTCTGTT
TATATATAGCCTGAATCGTTTCGATTCCTTTTATGGTACGAGAAGCATGACGAGG
AGTTTGAAATCCAGCTGATTTCACAAACCGACGTTTGATATGTCGATGATCTTGTT 
                                                    <<<<<<<<(R2)<<<<<<<< 
CAATAAGATTATTACGATATTTAATGGTACAGTGATTGGTATGTACATAATACTC
AGCTTTCTGTAATTTTTTGAATGCACAAAGTAAAGCTGGGGCCTTGTCTGTCGTAA 
                                                                                          >>>>>>(F4)>>>>> 
GAACCGATGGTTCTCCAAAATGTTTGACCAATCTTTTCATAAAGGCATAAGCAGC
TTGATGGATTACGTGTTTTTCAAACTTGAAAGTCCAGTGTATGTCCATCACTATCA
ATCGCGCGGTATAAATAACACCATTCTCCTTTGACTTTGATATACGTCTCATCTAA
ATGCCAAGTATGGAGTGCCGATTTGTTTTTTTTCTTCCATATTCGATAGATTAGCT
GGCCATATTCATGAACCCAACGCATGATCGTTGTGGGATGATCTGACACACCACG
TTCCTGAAAAATCTCAGATACATCACGATAGCTTAAAGAAAAACGACAGTAATA
GCCAATGGCTACTAAAATAATGTCTTTCTTGAACTGTTTTCCTTTAAAATATCTCA
TGTAGCATTCTCCTCAGCACATTTTCCCTACAGTCTCCTTTTTCGTGGAATGGGCA 
                                                                                           <<<<<<<<(R3)<<<<<<<< 
AAAACATCCTGCTACCGAAACGCTGGATTGTGGAACAAACTTTTTCTTGGTTAGA
AAACTACCGCAGACTACGGAAGAACTGTGAGTAAACACTTGAAAATAGTAGACA
GAGTTGCTTATTGGCATCTGTGGTGATTTTATTAAAAAGATTCTAGATAGGTTCTA
AGGGTGAAGTAGGGAAATGGATACCTTTGTGCAAACAGGAGGGGTTTATGAACC
GCTGTGGTCTGGAGTTAGAACGTGGATGGATGAGAAGGGCTGGTATTATGAAGT
GAGACAAACAATGTGAACAGGATATCTTCCATCCAAGATGTCCTGTTTTTCTGTA
CTCTCTACTATGGTTGGACTCAAAACGCTTATAGAAGAATTTGAGGATGTTGAAG
GGGGATAGGAGGTGATTTGATATATTTTTGGGAAATGTAAAGGTTGATTGTCGGA
AAATGATGAGGTTATTTGTAGAAAAGATGTAACAGGAATACATATAGAAAATTA
CGAATACTTTAAAATGCATAAGACATATTGAAAAAAGAATGATCAATCACTACAT
AGGAAGGAATATCTATAGGATTTGCGAAAATGATAAATTATGTACAGATAGGTTC
TTGTTAAGTCATATGAATTAAAAAATGCTTTAAAATAATCTTTGTTGCAACAGAA
AAGAGTTGTGTCTAATTTGAGTATGGGAGGAATAGATATGAATCCATATCAAAAT 
                         >>(Cry10ASI)>                                           
AAGAATGAATATGAAATATTCAATGCTCCATCCAATGGTTTTAGCAAGTCTAATA 
                              >>(CRY10-1)>>>> >>>>> 
ACTATTCTAGATATCCATTAGCAAATAAGCCAAATCAACCACTGAAAAACACGA 
>>>>(F5)>> >>>>>>>>>>> 
ATTACAAAGATTGGCTCAATGTGTGTCAAGATAATCAACAATATGGCAATAATGC
GGGGAATTTTGCTAGTTCTGAAACTATTGTTGGAGTTAGTGCAGGTATTATTGTA 
GTAGGAACTATGTTAGGAGCTTTTGCTGCCCCTGTCTTAGCTGCAGGTATAATATC
TTTTGGGACTTTGTTGCCGATCTTTTGGCAAGGATCTGACCCTGCAAATGTTTGGC 
                                                           <<<<<<<<(R4)<<<<<<<< 
AGGATTTGTTAAACATCGGAGGAAGGCCTATACAAGAAATAGATAAAAACATAA
TTAATGTACTAACTTCTATCGTAACACCTATAAAAAATCAACTTGATAAATATCA
AGAATTTTTCGATAAATGGGAGCCAGCACGTACACACGCTAATGCTAAAGCAGT
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ACATGATCTCTTTACTACCTTAGAACCTATAATAGATAAAGATTTAGATATGTTA
AAAAATAATGCTAGCTATCGAATACCAACACTCCCTGCATATGCACAAATAGCTA
CTTGGCACTTGAATTTATTAAAACATGCTGCTACCTATTACAATATATGGCTGCAA    
<<<<<<(CRY10-2)<<<<< 
AATCAAGGTATAAATCCAAGTACTTTCAATTCATCTAATTACTATCAGGGCTATTT
AAAACGTAAAATACAAGAATATACTGACTATTGTATACAAACGTACAATGCAGG
ACTAACTATGATTAGAACTAATACTAACGCAACATGGAATATGTATAATACTTAC
CGTTTAGAAATGACTCTAACTGTGTTAGATCTTATTGCTATTTTTCCAAATTATGA
CCCAGAAAAATATCCAATAGGAGTTAAATCTGAACTTATCAGAGAAGTTTATACG
AATGTTAATTCAGATACATTTAGAACCATAACAGAACTAGAAAATGGATTAACTA
GAAATCCTACATTATTTACTTGGATAAACCAAGGGCGTTTTTACACAAGAAATTC 
                                                             >>>>>>>>(F6)>>>>>>>> 
TCGAGACATTCTTGATCCTTATGATATTTTTTCTTTTACAGGTAACCAGATGGCCT 
                                                                                                             <<<<(Cry10R40180)<<< 
TTACACATACTAATGATGATCGCAACATAATCTGGGGAGCGGTTCATGGAAATAT
TATTTCTCAAGACACATCCAAAGTATTTCCTTTTTATAGAAACAAACCTATTGATA
AGGTCGAAATTGTCAGACATAGAGAGTACTCAGATATAATATATGAAATGATATT
TTTTTCGAATAGCAGTGAAGTATTTCGATATTCATCCAATTCAACAATAGAAAAT
AATTATAAAAGAACTGATTCTTATATGATTCCAAAACAAACATGGAAAAATAAA
GAATATGGTCATACTCTATCGTATATAAAAACTGATAATTATATATTTTCAGTAGT
TAGAGAAAGAAGAAGAGTTGCATTTAGTTGGACACATACTAGTGTTGATTTCCAA
AATACAATAGATTTAGATAACATCACCCAAATCCACGCTCTAAAAGCTTTGAAGG
TAAGTTCTGATTCGAAAATTGTGAAAGGTCCTGGTCACACAGGTGGAGACTTGGT 
                                                                 <<<<<<<<(R5)<<<<<<<< 
AATTCTTAAAGATAGTATGGATTTTAGAGTTAGATTTTTAAAAAATGTTTCTCGAC
AATATCAAGTACGTATTCGTTATGCTACTAATGCTCCAAAGACAACAGTATTCTT
AACCGGAATAGATACTATAAGTGTGGAGCTCCCTAGTACCACTTCCCGCCAAAAC
CCAAATGCTACAGATTTAACATATGCAGATTTTGGATATGTAACATTTCCAAGAA
CAGTTCCAAATAAAACATTTGAAGGAGAAGACACTTTATTAATGACCTTATATGG
TACACCAAATCATTCATATAATATATATATTGACAAAATCGAATTTATTCCAATC
ACTCAATCTGTATTAGATTATACAGAGAAGCAAAATATAGAAAAAACACAGAAA
ATAGTGAATGATTTATTTGTTAATTAAAACAAAGTTCTTACTAAAATAGATAGTA
TGGCTGTTAAAAAGTAAGCGAGAAAGGTCGTGAACCCTATGTTTACAAGTGGTGC
GAAAAATAGGTTAAAGCTAGAAACGACAGATTATGAAATAGATCAAGTGGCTAA
TGCTATAGAATGTATGTCAGATGAACAATATTCAAAAGAAAAACTGATGTTATGG
GATCAAGTAAAACATGCAAAATACCTTAGTCAGTCTCGAAATTTGCTTCAAAATG
GTGATTTTGAAGATGTATTTCATGGATGGACTACAAGTGATCATATGTACATTCA
GTCGGATAATTCTACTTTTAAAGGAAATTATCTGAATATATCTGGGGCGCGAGAC
ATATACTTAACGATATTTCCAACATACATTTACCAAAAAATTGATGAATCAAAAT
TAAAACCGTATACACGTTACCTAGTAAGGGGATTTGTAGGAAGTAGTAAAGATGT
AGAACTAGTGGTTTCACGCTATGGAAAAGAAATAGATACAGTCATGAATGTACC 
                             <<<<<<<<(R6)<<<<<<<< 
ATTTGATATCCCGTATGTATCTTCTAGGCCTGTTTGTAATGAATTATATGATGGTG
AACAACAACCGTATCCAAATGGGAATGTAGGATATTATAATCCAATGTCAGCTTT
TACGCCTTCTTACACATCTGATGCTCGTCAGTGTATGCCAGGGAAAAAACAGATA
GTCTGTCAAGATTCTCATCAGTTTAAGTTCCATATTGATACAGGTGAAGTAGATT
ATAATACAAATATAGGGATTTGGGTCATGTTTAAAATATCTTCCCCAGATGGATA
CGCATTATTAGATAATTTAGAAGTAATTGAAGAAGGGCCAATAGATGGGGAAGC
ACTGTCACGCGTGAAACACATGGAGAAGAAATGGAACGATCAAATGGAAGCAAA
ACGTTCG 
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APPENDIX D: LC/MS data oBtained for Bti H14 and QBT555 from Spectrum 
Mill software 
Data for Bti H14 
numSp
ectra 
numPeps
Unique 
percentCo
verage 
accession_
number 
entry_name 
42 25 55.5 P21256 
Pesticidal crystal protein 
Cry11Aa 
14 10 56.3 
A0A141D
WM3 
Cry11 (Fragment) 
28 18 55.3 
A0A160L
GP4 
ATP synthase subunit beta 
17 14 35 
A0A160LF
20 
Succinate dehydrogenase 
22 16 26 
A0A160L
CR0 
Aconitate hydratase 
19 15 30.2 
A0A160L5
S6 
Elongation factor G 
15 15 38 
A0A160L
G56 
Acyl-CoA dehydrogenase 
19 16 18.1 P05519 Pesticidal crystal protein Cry4Ba 
19 16 16.8 Q1RN84 Delta-endotoxin 
6 6 10 Q8KNV1 Pesticidial crystal protein 
21 14 50.3 
A0A160L5
45 
Elongation factor Tu 
18 12 31 
A0A160L6
37 
60 kDa chaperonin 
17 13 32.6 
A0A160L
GW0 
ATP synthase subunit alpha 
15 13 37.2 
A0A160LF
66 
Isocitrate dehydrogenase [NADP] 
12 10 45.7 
A0A160L7
C7 
Ornithine aminotransferase 
45 10 74.2 P0A382 
Type-1Aa cytolytic delta-
endotoxin 
13 11 21.7 P09662 
Pesticidal crystal protein 
Cry10Aa 
15 9 32.3 
A0A160L
CH5 
Betaine aldehyde dehydrogenase 
13 11 23.7 
A0A160LF
44 
Chaperone protein DnaK 
10 8 32.9 
A0A160L
DN9 
Dihydrolipoamide 
acetyltransferase component of 
pyruvate dehydrogenase complex 
12 9 46.8 A0A160LF L-lactate dehydrogenase 
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U6 
12 9 34.9 
A0A160L
D53 
Protein RecA 
12 9 16.5 
A0A160L
G25 
3-hydroxyacyl-CoA 
dehydrogenase 
10 8 44.7 
A0A160L
H75 
ATP synthase gamma chain 
9 9 12.4 
A0A160L7
N6 
Peptidase M6 
11 10 34.9 
A0A160L
DB5 
Succinate--CoA ligase [ADP-
forming] subunit beta 
10 9 25.9 
A0A161J2
P3 
Aminopeptidase 
9 7 25.3 
A0A160L
A39 
2-methylcitrate dehydratase 
10 8 16.4 
A0A160L
CN8 
Peptide ABC transporter 
substrate-binding protein 
10 7 42.2 A9UF62 Camelysin 
9 8 25.2 Q8KNP4 Hemagglutinin-related protein 
9 8 19.3 
A0A160L5
W3 
Formate acetyltransferase 
10 7 19 Q8KNU9 Possible two-domain toxin 
8 8 32.6 
A0A161J2
75 
30S ribosomal protein S2 
9 7 36.7 Q8KNU0 Uncharacterized protein 
9 7 46.7 
A0A160LF
U4 
Universal stress protein 
8 7 16.6 
A0A160L
B62 
Methylmalonate semialdehyde 
dehydrogenase [acylating] 
8 7 18.8 
A0A160L6
A3 
Alkyl hydroperoxide reductase 
subunit F 
8 6 27.7 
A0A160LF
61 
Glyceraldehyde-3-phosphate 
dehydrogenase 
6 6 31.7 
A0A160L
A15 
3-hydroxyisobutyrate 
dehydrogenase 
7 6 26.8 
A0A169D
C63 
Sporulation protein 
8 7 18.6 
A0A160L6
29 
1-pyrroline-5-carboxylate 
dehydrogenase 
6 6 11.1 
A0A160L
DH2 
Translation initiation factor IF-2 
9 7 32.4 
A0A160L6
R5 
30S ribosomal protein S3 
7 6 20.1 
A0A160L
GT1 
3-hydroxybutyryl-CoA 
dehydrogenase 
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6 6 23.9 
A0A160L6
U0 
Iron-sulfur cluster carrier protein 
6 6 16.9 
A0A169D
RV7 
Fe-S cluster assembly protein 
SufB 
6 6 17 
A0A160L5
P5 
Aspartyl/glutamyl-
tRNA(Asn/Gln) amidotransferase 
subunit B 
7 5 21.1 
A0A160L
A65 
Ethanol-active 
dehydrogenase/acetaldehyde-
active reductase 
7 6 17 
A0A160L5
V8 
Glutamine--fructose-6-phosphate 
aminotransferase [isomerizing] 
7 6 10.4 
A0A160LF
C4 
Acetyl-CoA synthetase 
7 6 10.1 
A0A160L5
Z2 
Protein prkA 
7 6 7.8 
A0A160LE
W9 
Pyruvate carboxylase 
5 5 24.6 
A0A160L
D49 
4-hydroxy-tetrahydrodipicolinate 
synthase 
8 5 35.7 Q45723 
Type-2Ba cytolytic delta-
endotoxin 
4 3 24.3 O30895 
Cytolytic toxin homolog 
(Fragment) 
8 5 19.2 
A0A160L
BA3 
Peptide ABC transporter 
substrate-binding protein 
8 6 37 
A0A161J2
H1 
30S ribosomal protein S4 
7 6 27.6 
A0A169D7
Y5 
Cell division protein FtsN 
6 6 34.6 
A0A160L5
N5 
50S ribosomal protein L5 
5 5 22.1 
A0A160L
D69 
Aspartate-semialdehyde 
dehydrogenase 
5 5 18 
A0A160LF
R7 
Citrate synthase 
5 5 17.4 
A0A160LE
Z9 
ATP-dependent Clp protease 
ATP-binding subunit ClpX 
6 5 23.6 
A0A160LF
C2 
Electron transfer flavoprotein 
subunit alpha 
5 5 18.5 
A0A169D9
G9 
30S ribosomal protein S1 
7 6 20.2 
A0A169D
GE4 
Phosphoserine aminotransferase 
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5 5 18.7 
A0A160L
GB3 
Enolase 
6 4 35.5 
A0A160L
GF0 
Ribosome hibernation promoting 
factor 
7 5 29.3 
A0A160L
AK9 
Uncharacterized protein 
5 4 42.2 
A0A160L5
N2 
Alkyl hydroperoxide reductase 
6 4 45.3 
A0A160L7
X7 
Putative phosphoesterase 
ATN07_06430 
6 6 29.5 
A0A160L
G10 
Fe-S cluster assembly ATPase 
SufC 
5 5 31.6 
A0A160L
GA1 
Succinate dehydrogenase 
7 6 13.9 
A0A160L9
M5 
Lysine 2,3-aminomutase 
5 5 14.8 
A0A160L
DC0 
Glycosyl hydrolase 
6 5 14.6 
A0A160L
HA4 
Fe-S cluster assembly protein 
SufD 
5 4 21.6 
A0A169D9
J8 
Histidinol-phosphate 
aminotransferase 
5 5 21.3 
A0A160LF
K3 
Aminomethyltransferase 
4 4 21.2 
A0A160L5
T6 
Glyoxal reductase 
5 5 10.9 
A0A160L9
L1 
Glutamate dehydrogenase 
5 5 33.8 
A0A169D
T47 
ATP synthase subunit delta 
5 5 26.5 
A0A160L5
35 
50S ribosomal protein L1 
5 4 18.4 
A0A1L2Z0
56 
Uncharacterized protein 
6 4 16.5 
A0A160L7
09 
3'-5' exoribonuclease YhaM 
5 5 9.1 
A0A169DI
69 
Peptide ABC transporter 
substrate-binding protein 
4 4 15.9 
A0A160L6
22 
Alanine dehydrogenase 
5 5 15.3 
A0A160LE
75 
2-oxoisovalerate dehydrogenase 
4 4 41.7 
A0A160L
G72 
Uncharacterized protein 
7 4 77.9 
A0A160LE
F8 
Stage V sporulation protein S 
5 4 17.7 
A0A161JQ
F5 
Cell division protein FtsZ 
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5 4 31.8 Q7AL75 20 kDa accessory protein 
6 4 26.4 
A0A160L
GD8 
ATP-dependent Clp protease 
proteolytic subunit 
4 4 23.5 
A0A160L
GY3 
Fructose-bisphosphate aldolase 
4 4 10.5 
A0A160L
BR2 
Hydrolase 
4 4 5.7 
A0A169D
SL5 
Protein translocase subunit SecA 
4 4 12.9 
A0A169D
SF9 
Phosphoglycerate kinase 
3 3 14.8 
A0A160L8
C8 
Ketol-acid reductoisomerase 
(NADP(+)) 
4 4 11 
A0A161J6
W7 
Dihydrolipoyl dehydrogenase 
5 4 38.3 
A0A161JQ
U0 
ATP synthase epsilon chain 
5 4 33.3 
A0A160L6
Q7 
30S ribosomal protein S7 
5 4 11.8 
A0A160LF
48 
Asparagine--tRNA ligase 
6 4 15.8 
A0A160L
DC5 
GTP-sensing transcriptional 
pleiotropic repressor CodY 
4 3 11.9 
A0A160L
G78 
Pyridine nucleotide-disulfide 
oxidoreductase 
4 4 22.5 
A0A161J6
E1 
Putative pyruvate, phosphate 
dikinase regulatory protein 
4 4 12.9 
A0A160L9
77 
Beta-ketoacyl-ACP reductase 
4 4 29.1 
A0A160L
GN9 
ATP synthase subunit b 
4 4 15.5 
A0A169D7
F4 
Peptide ABC transporter ATP-
binding protein 
4 4 35.6 
A0A169D8
J9 
SSEB protein 
4 3 27.5 
A0A160LE
J9 
Superoxide dismutase 
4 4 17.9 
A0A160LF
01 
Rod shape-determining protein 
MreB 
4 3 14.3 
A0A169D
BU4 
Quinone oxidoreductase 
4 4 6.3 
A0A160L7
N5 
Bacillolysin 
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5 4 16.6 
A0A160L
DJ0 
Succinate--CoA ligase [ADP-
forming] subunit alpha 
4 4 9.2 
A0A160LE
46 
Dihydrolipoamide 
acetyltransferase component of 
pyruvate dehydrogenase complex 
3 3 14.9 
A0A160L
HH7 
UTP--glucose-1-phosphate 
uridylyltransferase 
3 3 13.6 
A0A161J7
A4 
Nucleotide-binding protein 
ATN07_26615 
4 4 6.9 
A0A160L
G26 
Aspartate--tRNA(Asp/Asn) ligase 
4 4 12.8 
A0A160L
HC3 
Acetyl-CoA acetyltransferase 
3 3 11.7 
A0A169D
C37 
Penicillin-binding protein 
4 3 12.1 
A0A160L
H82 
Serine hydroxymethyltransferase 
3 3 10.4 
A0A160L7
01 
4-hydroxyphenylpyruvate 
dioxygenase 
3 3 5 
A0A160L5
X5 
Glutamate synthase 
4 3 17.9 
A0A160L
GB2 
Glyceraldehyde-3-phosphate 
dehydrogenase 
4 3 31.6 
A0A160L7
Q4 
Putrescine importer 
4 3 11.3 
A0A160L4
Z9 
Ribose-phosphate 
pyrophosphokinase 
3 3 14.3 
A0A160LE
62 
Oxidoreductase 
4 4 13.3 
A0A160L6
R9 
Enoyl-CoA hydratase 
4 3 10.8 
A0A169D
F93 
Probable malate:quinone 
oxidoreductase 
3 2 10.3 
A0A160L
CY3 
Glutamine synthetase 
3 3 21 
A0A160L5
U1 
30S ribosomal protein S5 
3 3 32.4 
A0A169D
FA6 
Antibiotic biosynthesis 
monooxygenase 
3 3 22 
A0A160L5
Q6 
50S ribosomal protein L13 
3 3 15.5 
A0A161IQ
44 
2-methylisocitrate lyase 
3 3 28.7 
A0A160L
GX6 
Spore coat protein GerQ 
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3 3 16.4 
A0A160L8
35 
Glycerol-3-phosphate 
dehydrogenase [NAD(P)+] 
3 2 9.6 
A0A160L8
70 
Poly(R)-hydroxyalkanoic acid 
synthase 
3 3 22 
A0A160L
DH9 
Uridylate kinase 
4 3 7.5 
A0A160L5
R2 
ATP-dependent Clp protease 
ATP-binding subunit ClpC 
4 3 7.9 
A0A160L
AE4 
Uncharacterized protein 
4 3 19.3 
A0A160L5
T3 
50S ribosomal protein L4 
3 3 6.4 
A0A160L
CX7 
Anaerobic ribonucleoside-
triphosphate reductase 
2 2 10.9 
A0A160L
H29 
UDP-glucose 4-epimerase 
3 3 18.1 
A0A160L8
44 
Polyhydroxyalkanoate 
biosynthesis repressor PhaR 
3 3 20 
A0A160L
GQ3 
Uracil phosphoribosyltransferase 
3 3 26 
A0A160L5
M7 
50S ribosomal protein L23 
3 3 15 
A0A169D1
59 
50S ribosomal protein L10 
3 3 14.7 
A0A160L5
47 
50S ribosomal protein L3 
3 2 24.4 
A0A169D
BF2 
DNA starvation/stationary phase 
protection protein 
2 2 7.2 A9P7G0 Glucanase 
3 3 9.4 
A0A169D0
L3 
Inosine-5'-monophosphate 
dehydrogenase 
3 3 9.4 
A0A160L
AI8 
Tellurite resistance protein 
4 3 5.5 
A0A160L
A54 
AMP-dependent synthetase 
4 3 24.8 
A0A160L5
R5 
50S ribosomal protein L11 
3 3 10.7 
A0A160LE
05 
Pyruvate dehydrogenase (Acetyl-
transferring) E1 component 
subunit alpha 
3 3 5.7 
A0A160LF
H8 
Leucine--tRNA ligase 
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3 2 4 
A0A160LE
32 
5-
methyltetrahydropteroyltriglutam
ate--homocysteine 
methyltransferase 
3 2 11.6 
A0A160L
DG3 
Dipicolinate synthase subunit A 
3 3 15.3 
A0A161J6
A8 
Acetyltransferase 
4 3 16.5 
A0A160L
KA0 
Uncharacterized protein 
2 2 40 
A0A160L
A37 
DNA-binding protein 
2 2 12.1 
A0A160L
GV7 
Putative heme-dependent 
peroxidase ATN07_27860 
3 2 19.4 
A0A160L8
F1 
Uncharacterized protein 
2 2 23.3 
A0A160L5
73 
50S ribosomal protein L17 
2 2 8.9 
A0A160LE
64 
Probable butyrate kinase 
3 3 11.7 
A0A160L9
01 
Enoyl-[acyl-carrier-protein] 
reductase [NADH] 
3 2 5 
A0A160L9
41 
Peptide ABC transporter 
substrate-binding protein 
3 3 8.4 
A0A160L
C26 
3-phosphoglycerate 
dehydrogenase 
3 2 11.1 
A0A1L2Y
ZW6 
L-threonine dehydratase catabolic 
TdcB 
2 2 15.7 
A0A160L
HA6 
Methyltransferase 
2 2 13.7 
A0A160L
AC1 
Lipase 
2 2 15.8 
A0A160L8
L6 
Menaquinol-cytochrome C 
reductase 
3 3 11.9 
A0A160L
DI7 
Cell division protein FtsA 
3 2 18 
A0A160L5
56 
50S ribosomal protein L14 
3 3 9.4 
A0A169D3
F1 
Uncharacterized protein 
2 2 13.1 
A0A160L9
20 
Aspartate--ammonia ligase 
2 2 3.6 
A0A169D7
D1 
Chaperone protein ClpB 
3 2 13.8 
A0A160L
D44 
Spore coat protein 
2 2 8.5 
A0A160L
GP9 
Peptidase M4 
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2 2 8.8 
A0A160L
DI5 
Polyphenol oxidase 
2 2 5.1 
A0A160L
B36 
ABC transporter ATP-binding 
protein 
2 2 53 
A0A169D
HV2 
Cold-shock protein 
2 2 18.4 
A0A160L5
38 
50S ribosomal protein L7/L12 
2 2 15.7 
A0A161IQ
33 
Acetyltransferase 
2 2 7.4 
A0A160L7
44 
Stage V sporulation protein R 
2 2 25.5 
A0A160L8
J0 
DNA-binding protein 
2 2 16.3 
A0A169DJ
64 
2-oxoacid ferredoxin 
oxidoreductase 
2 2 9.6 
A0A160L7
F9 
Peptide ABC transporter ATP-
binding protein 
2 2 8.1 
A0A160L
DA7 
Elongation factor Ts 
3 2 11.5 
A0A160L
GS1 
Fructose-1,6-bisphosphatase 
2 2 19.8 
A0A160L
A06 
Uncharacterized protein 
2 2 9.6 
A0A160L
AX5 
Peptidase P60 
2 2 6.4 
A0A160L7
B5 
Adenylyltransferase 
2 2 11.3 
A0A160L6
09 
Fumarylacetoacetase 
2 2 5.6 
A0A160L
CB1 
Histidine kinase 
2 2 6 
A0A160L
GL8 
L-lactate dehydrogenase 
2 2 11.5 
A0A160L
H59 
Single-stranded DNA-binding 
protein 
2 2 7.3 
A0A169D
RJ8 
Glucose-6-phosphate isomerase 
2 2 5.4 
A0A161J6
04 
Zn-dependent hydrolase 
3 2 10.8 
A0A160LF
68 
Enoyl-CoA hydratase 
2 2 10.1 
A0A160LF
G1 
Site-determining protein 
2 2 9.5 
A0A160L
D52 
Uncharacterized protein 
2 2 21.3 
A0A169D6
09 
Uncharacterized protein 
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2 2 8.6 
A0A161IPI
5 
Glutamine ABC transporter 
substrate-binding protein 
2 2 10.8 
A0A160L6
A0 
Chemical-damaging agent 
resistance protein C 
2 2 8.1 
A0A161J5
J8 
Aspartate phosphatase 
2 2 6.5 
A0A160L8
L5 
SAM-dependent 
methyltransferase 
2 2 7.8 
A0A169D3
67 
Ornithine carbamoyltransferase 
2 2 17.8 
A0A160L6
T2 
30S ribosomal protein S11 
2 2 4.7 
A0A160L
DH7 
Uncharacterized protein 
2 2 10.8 
A0A160L8
43 
Nucleoside diphosphate kinase 
2 2 13.1 
A0A160L
DW2 
Protein RiBt 
2 2 8.3 
A0A160LF
H2 
Bifunctional protein FolD 
2 2 11.3 
A0A160L5
91 
30S ribosomal protein S8 
2 2 23.7 
A0A160L
DX6 
Uncharacterized protein 
2 2 16 
A0A169D8
55 
DNA recombinase 
2 2 8.3 
A0A160L6
M9 
Probable transcriptional 
regulatory protein ATN07_02915 
2 2 9.4 
A0A160L5
P1 
50S ribosomal protein L6 
2 2 11.7 
A0A160LF
42 
Adenine 
phosphoribosyltransferase 
2 2 6 
A0A160L9
S6 
Alkaline serine protease 
2 2 12.4 
A0A160L8
C5 
Methylthioribulose-1-phosphate 
dehydratase 
1 1 14.6 
A0A160L
B18 
PadR family transcriptional 
regulator 
2 2 4.5 
A0A160L
G46 
Phosphoenolpyruvate 
carboxykinase (ATP) 
2 2 6.8 
A0A169D1
A0 
50S ribosomal protein L2 
2 2 8 
A0A160LE
J4 
RNA polymerase sigma factor 
SigA 
1 1 5.5 
A0A160L7
F1 
3-oxoacyl-[acyl-carrier-protein] 
synthase 2 
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2 2 3.5 
A0A161J7
50 
Acyl--CoA ligase 
1 1 6 
A0A161J7
44 
Malate dehydrogenase 
2 2 12.3 
A0A160L
DQ6 
Uncharacterized protein 
1 1 6.8 
A0A160L
H58 
Ribosome-binding ATPase YchF 
2 1 24.4 
A0A160L
D72 
DNA-binding protein 
1 1 4.9 
A0A160LE
18 
Acetylornithine aminotransferase 
1 1 13.2 
A0A160L
AN3 
ESAT-6-like protein 
1 1 5.9 
A0A160L
HP2 
Histidine kinase 
1 1 7.8 
A0A169D
PW8 
Probable thiol peroxidase 
1 1 9.2 
A0A160L
AZ0 
Cytoplasmic protein 
1 1 11.8 
A0A160L
C95 
N-acetylmuramoyl-L-alanine 
amidase 
1 1 3.2 
A0A160LF
X0 
NADH dehydrogenase 
1 1 19.1 
A0A160L4
Y9 
Transition state regulator Abh 
1 1 14.8 
A0A160LF
J3 
Helix-turn-helix transcriptional 
regulator 
1 1 2.5 
A0A160L
GQ6 
Peptidase M24 
1 1 5 
A0A160L9
P5 
Alpha/beta hydrolase 
1 1 7 
A0A160L7
M5 
HTH-type transcriptional 
regulator Hpr 
1 1 6.8 
A0A161J7
32 
Uncharacterized protein 
1 1 9.4 
A0A169DI
91 
CoA-binding protein 
1 1 6.2 
A0A160L
AE7 
3-ketoacyl-ACP reductase 
1 1 4.9 
A0A160LE
89 
Leucine dehydrogenase 
1 1 4.9 
A0A161J1
S8 
Histidine kinase 
2 1 5.3 
A0A160L8
W5 
Flagellin 
2 1 7.8 
A0A160L5
M1 
30S ribosomal protein S12 
1 1 4.4 A0A160L D-alanine aminotransferase 
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A55 
1 1 10.6 
A0A160L5
F4 
10 kDa chaperonin 
2 1 6.9 
A0A160L
HH8 
Hydroxymethylpyrimidine/phosp
homethylpyrimidine kinase 
1 1 6.7 
A0A160L9
I2 
Flavohemoprotein 
1 1 8.1 
A0A160LE
M5 
Ribosome-recycling factor 
1 1 9.8 
A0A160LF
63 
Transcriptional repressor NrdR 
1 1 5.5 
A0A160LE
24 
Thymidine phosphorylase 
1 1 9.6 
A0A160LE
R7 
4a-hydroxytetrahydrobiopterin 
dehydratase 
1 1 14.7 
A0A169D1
82 
30S ribosomal protein S10 
1 1 14.5 
A0A160LE
Z3 
50S ribosomal protein L27 
1 1 5.2 
A0A160L
D39 
2-oxoglutarate ferredoxin 
oxidoreductase subunit alpha 
1 1 6 
A0A160LF
I3 
Potassium transporter 
1 1 3.1 
A0A169D3
13 
Uncharacterized protein 
1 1 7.9 
A0A160LE
Z1 
Delta-aminolevulinic acid 
dehydratase 
1 1 1.5 
A0A160L7
K6 
Flotillin 
1 1 2.4 
A0A160L8
55 
Stage IV sporulation protein A 
1 1 9.6 
A0A160L
DP5 
50S ribosomal protein L19 
1 1 1.8 
A0A160L
AA1 
Thymidine phosphorylase 
 
 
 
 
Data for QBT555 
Num 
Spectra 
Num 
Peps 
Unique 
Percent 
Coverage 
accession_nu
mber 
entry_name 
18 11 28.6 P21256 
Pesticidal crystal protein 
Cry11Aa 
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7 5 31.7 
A0A141DW
M3 
Cry11 (Fragment) 
15 13 40.6 
A0A160LDB
5 
Succinate--CoA ligase [ADP-
forming] subunit beta 
18 11 17.9 A0A160LCR0 Aconitate hydratase 
13 10 21.7 A0A160LF44 Chaperone protein DnaK 
13 9 30.5 A0A160LGP4 ATP synthase subunit beta 
15 10 30 A0A160LF66 
Isocitrate dehydrogenase 
[NADP] 
15 8 30.7 
A0A160LCH
5 
Betaine aldehyde 
dehydrogenase 
11 9 24.5 A0A160LI82 
Formate--tetrahydrofolate 
ligase 
13 9 21.9 A0A160L629 
1-pyrroline-5-carboxylate 
dehydrogenase 
10 9 20 A0A160LG56 Acyl-CoA dehydrogenase 
12 7 33.5 A0A160L7C7 Ornithine aminotransferase 
10 9 18.1 
A0A160L5W
3 
Formate acetyltransferase 
10 8 26.3 A0A160LA39 2-methylcitrate dehydratase 
15 8 28.6 A0A160L545 Elongation factor Tu 
12 8 16.4 A0A160L5S6 Elongation factor G 
7 6 25.7 
A0A160LGB
3 
Enolase 
11 6 55.4 P0A382 
Type-1Aa cytolytic delta-
endotoxin 
7 6 25.4 
A0A160LDN
9 
Dihydrolipoamide 
acetyltransferase component 
of pyruvate dehydrogenase 
complex 
11 8 15.9 
A0A160LGW
0 
ATP synthase subunit alpha 
8 7 35.3 
A0A160LAK
9 
Uncharacterized protein 
9 6 32.1 A0A160LF61 
Glyceraldehyde-3-phosphate 
dehydrogenase 
7 7 24.1 A0A160LD69 
Aspartate-semialdehyde 
dehydrogenase 
9 6 18.1 A0A160L6A3 
Alkyl hydroperoxide 
reductase subunit F 
8 8 13.7 A0A169DI69 
Peptide ABC transporter 
substrate-binding protein 
6 6 23.8 A0A160LF01 
Rod shape-determining 
protein MreB 
7 6 19 A0A160LEZ9 
ATP-dependent Clp protease 
ATP-binding subunit ClpX 
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7 5 19.1 A0A160LA65 
Ethanol-active 
dehydrogenase/acetaldehyde-
active reductase 
5 5 9 A0A160L5L9 
DNA-directed RNA 
polymerase subunit beta 
5 5 9.8 
A0A160LCX
7 
Anaerobic ribonucleoside-
triphosphate reductase 
2 2 5.3 A0A1L2Z063 
Anaerobic ribonucleoside-
triphosphate reductase 
8 5 13.6 A0A160L637 60 kDa chaperonin 
7 5 18.4 A0A169D0L3 
Inosine-5'-monophosphate 
dehydrogenase 
5 5 27 
A0A160LGN
2 
Rod shape-determining 
protein MreB 
6 5 18 A0A169D9G9 30S ribosomal protein S1 
7 5 15.3 A0A160LE46 
Dihydrolipoamide 
acetyltransferase component 
of pyruvate dehydrogenase 
complex 
8 6 55.4 A0A160L843 
Nucleoside diphosphate 
kinase 
6 5 12.8 A0A160L8I8 Asparagine synthetase B 
6 5 25.1 A0A160LFU6 L-lactate dehydrogenase 
6 5 9.7 A0A160LFC4 Acetyl-CoA synthetase 
6 5 12.6 
A0A169DRV
7 
Fe-S cluster assembly protein 
SufB 
5 5 24.4 A0A161J275 30S ribosomal protein S2 
5 5 14 A0A161J6W7 Dihydrolipoyl dehydrogenase 
5 5 22.1 A0A160LE89 Leucine dehydrogenase 
5 4 25.3 A0A160LD49 
4-hydroxy-
tetrahydrodipicolinate 
synthase 
7 5 40.6 A0A160L5N2 
Alkyl hydroperoxide 
reductase 
5 4 17.6 
A0A160LDA
7 
Elongation factor Ts 
6 5 19.7 A0A161JQF5 Cell division protein FtsZ 
6 6 22.8 A0A160L6R5 30S ribosomal protein S3 
5 5 25.1 A0A160LFH2 Bifunctional protein FolD 
5 5 10.7 A0A160LF20 Succinate dehydrogenase 
5 5 14 A0A160LFR7 Citrate synthase 
4 4 16.4 A0A160L6L9 
8-amino-7-oxononanoate 
synthase 
5 4 21 A0A169D367 
Ornithine 
carbamoyltransferase 
4 4 7.7 
A0A160LDH
2 
Translation initiation factor 
IF-2 
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6 5 20.8 A0A160L7R7 Uncharacterized protein 
5 4 17.2 A0A160LEE4 
Probable glycine 
dehydrogenase 
(decarboxylating) subunit 1 
5 5 21.7 A0A160LE64 Probable butyrate kinase 
5 4 14.1 A0A160L4Z9 
Ribose-phosphate 
pyrophosphokinase 
5 4 29.3 A0A160L7Q4 Putrescine importer 
6 5 8.8 A0A160LG25 
3-hydroxyacyl-CoA 
dehydrogenase 
4 4 17.4 A0A160LFK3 Aminomethyltransferase 
4 4 21.1 A9UF62 Camelysin 
4 4 13.1 
A0A169DAH
3 
Histidine kinase 
4 4 8.8 A0A160LB62 
Methylmalonate 
semialdehyde dehydrogenase 
[acylating] 
4 4 15.6 A0A160LF95 Alanine dehydrogenase 
5 4 11.5 A0A169D2P2 
Glutamyl-tRNA(Gln) 
amidotransferase subunit A 
5 3 22.4 
A0A160LGQ
3 
Uracil 
phosphoribosyltransferase 
4 4 24.7 A0A169D7F4 
Peptide ABC transporter 
ATP-binding protein 
4 4 16.9 
A0A160LHH
7 
UTP--glucose-1-phosphate 
uridylyltransferase 
4 4 10 A0A160LG46 
Phosphoenolpyruvate 
carboxykinase (ATP) 
4 4 5.2 A0A169DSL5 
Protein translocase subunit 
SecA 
4 4 10.3 
A0A160L9M
5 
Lysine 2,3-aminomutase 
3 3 41.1 A0A160L8J0 DNA-binding protein 
4 3 20.8 A0A160L835 
Glycerol-3-phosphate 
dehydrogenase [NAD(P)+] 
4 3 18.2 A0A160L535 50S ribosomal protein L1 
4 4 14.6 A0A160L6U0 
Iron-sulfur cluster carrier 
protein 
4 3 14.9 
A0A160LGB
2 
Glyceraldehyde-3-phosphate 
dehydrogenase 
5 4 13.5 A0A160LEF7 
2-oxoisovalerate 
dehydrogenase 
4 4 13.7 A0A160LGT1 
3-hydroxybutyryl-CoA 
dehydrogenase 
3 3 6.4 A0A160L5R2 
ATP-dependent Clp protease 
ATP-binding subunit ClpC 
3 3 7.1 A0A160LAY Asparagine synthetase B 
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6 
4 3 13.3 A0A160L977 Beta-ketoacyl-ACP reductase 
5 3 16 A0A160LD53 Protein RecA 
3 3 21.8 
A0A160LGV
7 
Putative heme-dependent 
peroxidase ATN07_27860 
3 2 13.1 A0A160LE24 Thymidine phosphorylase 
4 3 14.4 A0A160LFU4 Universal stress protein 
4 3 31.9 A0A169DBF2 
DNA starvation/stationary 
phase protection protein 
3 3 6.6 P09662 
Pesticidal crystal protein 
Cry10Aa 
4 4 4.2 A0A160L7N6 Peptidase M6 
4 3 10.7 A0A160LFC2 
Electron transfer flavoprotein 
subunit alpha 
3 3 17 A0A161J2H1 30S ribosomal protein S4 
3 3 12.7 A0A160LGT5 CTP synthase 
3 3 13.9 A0A169DSF9 Phosphoglycerate kinase 
4 3 18.9 A0A160L8F1 Uncharacterized protein 
4 3 13.2 A0A160L870 
Poly(R)-hydroxyalkanoic acid 
synthase 
4 3 13.7 A0A160LG78 
Pyridine nucleotide-disulfide 
oxidoreductase 
3 3 14.9 A0A161IQ44 2-methylisocitrate lyase 
3 3 7.4 A0A160LBR2 Hydrolase 
5 3 10.6 A0A160L5V8 
Glutamine--fructose-6-
phosphate aminotransferase 
[isomerizing] 
4 3 19.3 Q45723 
Type-2Ba cytolytic delta-
endotoxin 
4 3 24.3 O30895 
Cytolytic toxin homolog 
(Fragment) 
3 3 5.2 A0A160LA54 AMP-dependent synthetase 
3 3 12.6 
A0A160LGA
1 
Succinate dehydrogenase 
3 3 13 A0A161IQT9 Acetyl-CoA acetyltransferase 
3 3 0.9 
A0A160LAM
7 
Non-ribosomal peptide 
synthetase 
3 3 23.5 A0A160LF42 
Adenine 
phosphoribosyltransferase 
2 2 11.8 A0A161J744 Malate dehydrogenase 
3 3 2.5 
A0A160LEW
9 
Pyruvate carboxylase 
2 2 15.8 A0A160LEZ1 
Delta-aminolevulinic acid 
dehydratase 
4 2 9.2 A0A160LH82 
Serine 
hydroxymethyltransferase 
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4 3 17 A0A161J6E1 
Putative pyruvate, phosphate 
dikinase regulatory protein 
3 3 8.3 
A0A160LCY
3 
Glutamine synthetase 
4 2 10.9 A0A160LE09 Dihydroorotase 
2 2 10.2 A0A161J7A4 
Nucleotide-binding protein 
ATN07_26615 
3 2 40 A0A160LA37 DNA-binding protein 
4 3 28 A0A160LDP5 50S ribosomal protein L19 
3 3 7.7 
A0A160LAM
2 
Cytochrome P450 
3 2 18.8 A0A160L541 
Hypoxanthine 
phosphoribosyltransferase 
3 2 11.7 A0A160LB63 Chorismate mutase 
2 2 19.2 A0A160LEJ9 Superoxide dismutase 
3 3 3.1 A0A169D171 
DNA-directed RNA 
polymerase subunit beta' 
4 2 11.5 
A0A160LDC
5 
GTP-sensing transcriptional 
pleiotropic repressor CodY 
3 2 5.7 A0A169DPJ0 Threonine--tRNA ligase 
4 2 23.2 A0A160L7X7 
Putative phosphoesterase 
ATN07_06430 
2 2 8.7 A0A160L5Q2 Arginine deiminase 
2 2 14 
A0A160LGY
3 
Fructose-bisphosphate 
aldolase 
3 3 12.2 A0A160LG10 
Fe-S cluster assembly ATPase 
SufC 
3 2 13.9 A0A160LEC1 
3-hydroxybutyrate 
dehydrogenase 
2 2 8.1 A0A160L5E1 
Pyridoxal 5'-phosphate 
synthase subunit PdxS 
2 2 10.8 A0A160LG89 Phage shock protein A 
3 2 14.3 A0A169D7Y5 Cell division protein FtsN 
2 2 10.5 A0A160LFJ6 
S-adenosylmethionine 
synthase 
2 2 30.2 A0A160L6T2 30S ribosomal protein S11 
2 2 12.2 
A0A160LEM
3 
2-oxoisovalerate 
dehydrogenase 
3 2 5.8 A0A169DF93 
Probable malate:quinone 
oxidoreductase 
2 2 8.4 A0A169D9E4 
Two-component system 
response regulator 
3 2 8.1 A0A161J5J8 Aspartate phosphatase 
3 2 8.6 A0A160LDJ0 
Succinate--CoA ligase [ADP-
forming] subunit alpha 
2 2 6.9 A0A160L8M Carboxypeptidase 1 
  
292 
 
6 
2 2 9.1 A0A161J1I4 Aminotransferase 
2 2 16.3 A0A160L5R5 50S ribosomal protein L11 
2 2 16.1 A0A160LH59 
Single-stranded DNA-binding 
protein 
3 2 18 A0A160L556 50S ribosomal protein L14 
3 2 13.8 A0A169D159 50S ribosomal protein L10 
3 2 6.9 A0A160LAE4 Uncharacterized protein 
2 2 21.5 
A0A160LGX
6 
Spore coat protein GerQ 
4 2 25 A0A161JQF0 Uncharacterized protein 
2 2 6.5 A0A160LG37 Proline dehydrogenase 
2 2 4.8 A0A160L5P5 
Aspartyl/glutamyl-
tRNA(Asn/Gln) 
amidotransferase subunit B 
2 2 13.5 
A0A160L7M
5 
HTH-type transcriptional 
regulator Hpr 
2 2 16.6 
A0A160LDH
9 
Uridylate kinase 
2 2 5.3 
A0A160LCN
8 
Peptide ABC transporter 
substrate-binding protein 
2 2 20 A0A160L573 50S ribosomal protein L17 
2 2 10 A0A161JQE1 Aspartokinase 
2 2 5.2 A0A160LDS5 GTP-binding protein TypA 
3 2 13.3 A0A160LF68 Enoyl-CoA hydratase 
2 2 18.3 A0A160LF63 
Transcriptional repressor 
NrdR 
2 2 5.7 A0A160LEC4 
Probable glycine 
dehydrogenase 
(decarboxylating) subunit 2 
2 2 7.5 A0A160LE50 
Ornithine 
carbamoyltransferase 
2 2 11.4 A0A160L547 50S ribosomal protein L3 
2 2 7 A0A160LD39 
2-oxoglutarate ferredoxin 
oxidoreductase subunit alpha 
3 2 10.3 A0A161J6A8 Acetyltransferase 
3 2 6.5 
A0A169DNU
4 
Glutamate-1-semialdehyde 
2,1-aminomutase 
2 2 12.8 A0A160L6Q7 30S ribosomal protein S7 
2 2 5.8 A0A160LE75 
2-oxoisovalerate 
dehydrogenase 
2 2 7.1 A0A161J604 Zn-dependent hydrolase 
2 2 6.5 
A0A160LHA
4 
Fe-S cluster assembly protein 
SufD 
2 2 0.9 A0A169DD32 
Non-ribosomal peptide 
synthetase 
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3 2 9.4 A0A160LH75 ATP synthase gamma chain 
2 2 7 A0A160LA15 
3-hydroxyisobutyrate 
dehydrogenase 
2 2 8 A0A160LEJ4 
RNA polymerase sigma factor 
SigA 
2 2 5.2 A0A160LA52 Acyl-CoA dehydrogenase 
2 2 5 A0A160L5P9 Lysine--tRNA ligase 
3 2 9 Q8KNU0 Uncharacterized protein 
3 2 7.7 A0A160L804 
Dihydrolipoyllysine-residue 
succinyltransferase 
component of 2-oxoglutarate 
dehydrogenase complex 
2 2 15.9 A0A169D8J9 SSEB protein 
2 2 3.6 A0A160LF48 Asparagine--tRNA ligase 
2 2 11.7 A0A160L5N5 50S ribosomal protein L5 
2 2 4.1 
A0A160LDD
1 
Uncharacterized protein 
2 2 4.5 A0A161J2P3 Aminopeptidase 
2 2 4.4 A0A161JQ17 Carboxylase 
2 2 25.7 A0A160L553 50S ribosomal protein L29 
2 2 5.7 A0A169DC63 Sporulation protein 
1 1 5.5 A0A160L7F1 
3-oxoacyl-[acyl-carrier-
protein] synthase 2 
2 2 8.9 
A0A160LGN
9 
ATP synthase subunit b 
2 2 5.2 
A0A169DGE
4 
Phosphoserine 
aminotransferase 
2 2 10.8 A0A160L6A0 
Chemical-damaging agent 
resistance protein C 
2 2 7.3 A0A160LFE5 
UDP-N-acetylmuramate--L-
alanine ligase 
2 1 27.7 A0A169D1E5 
Translation initiation factor 
IF-1 
2 1 9.5 A0A161IQ33 Acetyltransferase 
2 2 7.2 A0A160LDT4 Ribonuclease J 
2 2 1.9 Q1RN84 Delta-endotoxin 
1 1 11.1 A0A160L5T3 50S ribosomal protein L4 
1 1 3.6 
A0A160LAU
3 
ATP-dependent DNA helicase 
RecQ 
1 1 6.5 A0A160L7Q1 UDP-glucose 4-epimerase 
2 1 4.3 A0A160LD99 
Transcription 
termination/antitermination 
protein NusA 
3 2 9.1 A0A169D4J6 Butanediol dehydrogenase 
2 2 3.4 A0A160LDI7 Cell division protein FtsA 
2 1 3.3 A0A161JQC7 Imidazolonepropionase 
  
294 
 
1 1 4.4 A0A160L709 3'-5' exoribonuclease YhaM 
2 1 6.3 A0A160L5U5 
DNA-directed RNA 
polymerase subunit alpha 
1 1 9.3 A0A160LGP5 Uncharacterized protein 
2 1 24.4 A0A160LD72 DNA-binding protein 
1 1 3.9 
A0A169DTB
1 
Acyl-CoA dehydrogenase 
2 1 8.7 A0A160LGI4 Triosephosphate isomerase 
1 1 1.8 A0A160LG26 
Aspartate--tRNA(Asp/Asn) 
ligase 
1 1 7.2 A0A160L5U1 30S ribosomal protein S5 
1 1 13 A0A160LG72 Uncharacterized protein 
1 1 10.4 
A0A160L5M
7 
50S ribosomal protein L23 
1 1 6.8 A0A160LIC5 Stage 0 sporulation protein A 
1 1 3.9 A0A160LFC9 Argininosuccinate synthase 
1 1 3.9 A0A160LGT2 Acyl-CoA dehydrogenase 
1 1 13.2 
A0A160LAN
3 
ESAT-6-like protein 
1 1 8.2 A0A160L8L6 
Menaquinol-cytochrome C 
reductase 
1 1 6.1 A0A160LGF0 
Ribosome hibernation 
promoting factor 
1 1 1.9 A0A169D7D1 Chaperone protein ClpB 
1 1 9.8 
A0A160LDQ
2 
Short-chain dehydrogenase 
1 1 5.6 
A0A160LBA
3 
Peptide ABC transporter 
substrate-binding protein 
1 1 5.8 A0A160LE62 Oxidoreductase 
2 1 19.1 A0A160L4Y9 Transition state regulator Abh 
1 1 3 Q8KNU9 Possible two-domain toxin 
1 1 4.7 A0A160L624 
Redox-sensing transcriptional 
repressor Rex 
1 1 26 
A0A160LFM
7 
ArsR family transcriptional 
regulator 
1 1 10.3 A0A169D855 DNA recombinase 
1 1 7.8 A0A169D9J8 
Histidinol-phosphate 
aminotransferase 
1 1 5.9 Q8KNU6 Uncharacterized protein 
1 1 2.3 
A0A160LGH
4 
Pyruvate kinase 
1 1 6.8 A0A160L591 30S ribosomal protein S8 
1 1 2.7 A0A169D0R5 Methionine--tRNA ligase 
1 1 2.9 Q8KNP4 Hemagglutinin-related protein 
1 1 3.6 A0A160LG02 Lipoyl synthase 
1 1 3 A0A160LF90 Lon protease 
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1 1 1 A0A169D7U8 
2-oxoglutarate dehydrogenase 
E1 component 
1 1 1 A0A160LF27 Alanine--tRNA ligase 
2 1 6.2 
A0A160LGD
8 
ATP-dependent Clp protease 
proteolytic subunit 
1 1 3.9 A0A160L901 
Enoyl-[acyl-carrier-protein] 
reductase [NADH] 
1 1 0.9 A0A1L2Z054 
Aldehyde-alcohol 
dehydrogenase 
1 1 2.3 A0A160L5J6 Serine--tRNA ligase 
1 1 3 A0A160LC26 
3-phosphoglycerate 
dehydrogenase 
1 1 6.1 A0A169D1A0 50S ribosomal protein L2 
1 1 3.4 A0A160LF25 Enoyl-CoA hydratase 
1 1 3.1 
A0A169DM1
8 
Acetyl-CoA carboxylase 
biotin carboxylase subunit 
1 1 1 A0A169DK17 
Carbamoyl-phosphate 
synthase large chain 
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APPENDIX E: Cytolytic activities of Bt strains tested  
Table 32. Cytolytic activity results of Bti strains against lung cancer epithelial cells 
Strains Concentrations of crystal proteins (µg/ml)  Treatment 
time  0 0.15 0.25 0.35 0.5  
H14 100 73.71 70.58 60.00 43.68 
P
ercen
tag
e o
f v
iab
le can
cer cells (%
) 
24 hrs 
 100 73.51 63.55 57.40 53.66 48 hrs 
 100 99.33 91.89 76.73 61.28 72 hrs 
QBT205 100 94.67 78.09 84.42 70.22 24 hrs 
 100 87.11 82.17 78.95 71.33 48 hrs 
 100 85.03 74.07 72.46 58.27 72 hrs 
QBT213 100 87.86 90.35 81.34 60.32 24 hrs 
 100 76.56 69.26 74.21 54.94 48 hrs 
 100 103.56 109.15 92.86 65.61 72 hrs 
QBT214 100 85.74 70.45 62.01 53.85 24 hrs 
 100 85.71 74.87 67.94 62.62 48 hrs 
 100 86.56 82.98 87.91 76.64 72 hrs 
QBT215 100 87.16 88.42 65.03 44.79 24 hrs 
 100 82.44 101.98 88.14 86.90 48 hrs 
 100 88.9 92.96 98.31 77.79 72 hrs 
QBT216 100 93.10 78.59 86.44 68.55 24 hrs 
 100 82.05 77.95 73.42 56.73 48 hrs 
 100 90.58 72.15 59.81 56.34 72 hrs 
QBT217 100 80.30 62.60 55.43 41.09 24 hrs 
 100 62.95 69.77 64.81 55.89 48 hrs 
 100 74.4 66.04 60.88 58.16 72 hrs 
QBT218 100 73.60 73.71 71.25 55.37 24 hrs 
 100 87.88 75.26 77.31 84.09 48 hrs 
 100 101.37 75.44 76.27 71.39 72 hrs 
QBT220 100 79.44 69.90 72.52 42.31 24 hrs 
 100 76.15 79.69 66.05 58.24 48 hrs 
 100 76.08 73.49 61.01 70.54 72 hrs 
QBT221 100 102.40 88.68 58.47 65.19 24 hrs 
 100 98.47 82.88 66.84 52.34 48 hrs 
 100 98.38 91.92 71.98 61.04 72 hrs 
QBT222 100 115.83 88.29 77.33 84.54 24 hrs 
 100 78.45 76.85 59.47 54.49 48 hrs 
 100 77.27 82.98 75.04 66.36 72 hrs 
QBT223 100 98.99 91.03 93.35 77.31 24 hrs 
 100 68.95 64.81 61.14 54.94 48 hrs 
 100 82.72 80.49 75.74 67.96 72 hrs 
QBT224 100 87.27 64.89 64.46 72.64 24 hrs 
 100 77.59 67.05 60.25 59.60 48 hrs 
 100 97.32 83.59 95.35 97.98 72 hrs 
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QBT225 100 83.44 90.57 75.94 52.56 24 hrs 
 100 75.04 64.67 61.87 57.34 48 hrs 
 100 101.07 74.09 83.73 85.32 72 hrs 
QBT226 100 95.40 98.54 78.14 68.27 24 hrs 
 100 94.72 96.09 74.40 66.76 48 hrs 
 100 85.28 79.27 76.64 79.47 72 hrs 
QBT227 100 106.66 103.80 61.72 60.43 24 hrs 
 100 94.03 79.20 66.23 59.05 48 hrs 
 100 81.51 73.76 75.38 73.2 72 hrs 
QBT228 100 96.64 92.15 66.49 61.28 24 hrs 
 100 103.33 96.56 83.05 75.40 48 hrs 
 100 89.95 83.39 81.21 75.34 72 hrs 
QBT229 100 52.14 74.33 64.63 66.40 24 hrs 
 100 54.55 69.00 70.43 67.71 48 hrs 
 100 51.3 47.98 52.44 49.62 72 hrs 
QBT230 100 72.48 99.74 77.86 61.56 24 hrs 
 100 80.79 73.65 76.73 72.95 48 hrs 
 100 92.25 54.98 51.43 40.75 72 hrs 
QBT608 100 93.86 87.03 72.38 68.02 24 hrs 
 100 103.66 88.87 58.76 48.76 48 hrs 
 100 96.2 87.87 80.02 75.74 72 hrs 
 
 
 
Table 33. Cytolytic activity results of Non Bti strains against lung cancer epithelial cells 
Strains 
Concentrations of crystal proteins (µg/ml)  Treatment 
time 0 0.15 0.25 0.35 0.5  
QBT3 100 95.83 95.98 93.96 99.22 
P
ercen
tag
e o
f v
iab
le can
cer cells (%
) 
24 hrs 
 100 73.36 72.60 69.71 73.86 48 hrs 
 100 85.93 91.99 76.11 72.16 72 hrs 
QBT6 100 86.27 90.22 87.19 86.44 24 hrs 
 100 82.36 101.64 84.99 79.09 48 hrs 
 100 97.58 89.56 89.27 78.40 72 hrs 
QBT34 100 99.15 104.60 94.65 91.01 24 hrs 
 100 68.56 84.73 78.12 73.27 48 hrs 
 100 84.24 81.53 72.05 72.67 72 hrs 
QBT39 100 98.58 90.98 94.47 94.92 24 hrs 
 100 75.52 81.19 73.98 73.54 48 hrs 
 100 77.38 73.04 87.30 70.78 72 hrs 
QBT41 100 96.67 101.09 96.82 89.40 24 hrs 
 100 95.35 87.48 91.95 75.17 48 hrs 
 100 80.57 85.71 83.84 78.45 72 hrs 
QBT43 100 74.75 94.65 65.15 57.46 24 hrs 
 100 69.73 63.73 60.74 56.32 48 hrs 
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 100 92.12 90.57 89.76 82.04 72 hrs 
QBT56 100 83.73 112.20 92.65 81.05 24 hrs 
 100 59.04 79.92 69.17 66.49 48 hrs 
 100 84.66 91.98 88.93 100.30 72 hrs 
QBT81 100 96.20 85.68 97.98 80.03 24 hrs 
 100 74.15 71.27 63.13 71.83 48 hrs 
 100 92.99 87.77 88.90 89.92 72 hrs 
QBT99 100 81.00 71.81 69.31 73.60 24 hrs 
 100 97.27 80.37 90.85 105.34 48 hrs 
 100 80.75 74.68 74.66 76.04 72 hrs 
QBT212 100 78.24 85.46 85.27 69.41 24 hrs 
 100 87.48 73.80 82.92 85.02 48 hrs 
 100 88.93 84.73 86.60 92.64 72 hrs 
QBT240 100 87.02 103.28 92.85 84.00 24 hrs 
 100 81.12 75.47 76.71 82.21 48 hrs 
 100 82.38 100.30 83.82 79.16 72 hrs 
QBT320 100 83.12 75.47 101.75 76.17 24 hrs 
 100 96.72 98.18 96.87 95.85 48 hrs 
 100 72.63 71.84 69.60 63.01 72 hrs 
QBT418 100 92.72 96.54 62.98 62.44 24 hrs 
 100 71.38 78.82 77.41 76.80 48 hrs 
 100 99.71 92.53 88.23 105.10 72 hrs 
QBT555 100 85.39 73.33 62.59 52.00 24 hrs 
 100 88.54 85.14 69.69 77.41 48 hrs 
 100 74.29 78.37 74.05 70.11 72 hrs 
 
